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Abstract 
 
Respiration is a complex rhythmic motor behaviour that metabolically supports all 
physiological processes in the body and is continuous throughout the life of mammals. A 
failure to generate a respiratory rhythm can be fatal. Understanding how the respiratory 
rhythm is generated by the brainstem presents a substantial challenge within the field of 
respiratory neurobiology. Studies utilising in vitro and in vivo rodent models have provided 
compelling evidence that a small bilateral region of the ventrolateral medulla, known as the 
preBötzinger complex (preBötC), is the site for respiratory rhythmogenesis. There is also 
evidence to suggest a second distinct neuronal group, the retrotrapezoid nucleus/parafacial 
respiratory group (RTN/pFRG), plays a specialised role in respiratory rhythm generation in 
the neonatal rodent. During early life in rodents and humans, the respiratory system is 
immature and an irregular breathing pattern is generated, making this period of life 
potentially vulnerable to external perturbations. However a step in maturity occurs early in 
life after which breathing becomes regular. Currently, the underlying mechanisms involved 
in respiratory rhythm generation during early life are not fully understood. It is 
hypothesised that the RTN/pFRG functions as the dominant respiratory rhythm generating 
oscillator during early life when the respiratory system is immature, after which the 
preBötC becomes the dominant rhythm generator. However, how the preBötC and the 
RTN/pFRG interact in vivo to produce rhythmic breathing during postnatal development 
remains elusive. 
 
The first aim of this thesis was to assess postnatal maturation of breathing patterns in the 
mouse using non-invasive whole body plethysmography. Between postnatal day (P) 2 and 
P3, a critical maturation step occurred, whereby breathing transitioned from an unstable 
and dysrhythmic pattern to a regular and robust pattern. The second aim of the thesis was 
to investigate the influence of this postnatal maturation on central respiratory control. Mu 
(µ) opioid receptor agonists are known respiratory depressants. The activity of the preBötC 
is depressed by µ opioids in vitro. Furthermore, fentanyl, a potent µ opioid receptor 
agonist, evokes respiratory frequency depression in vivo by exclusively targeting and 
depressing preBötC neurons. Conversely, the RTN/pFRG is insensitive to µ opioids. 
Accordingly, fentanyl was utilised as a pharmacological tool to selectively perturb the 
preBötC in vivo throughout postnatal development and through to early adulthood. The 
acute respiratory depressive effects of fentanyl were measured in order to investigate the 
level of involvement of the preBötC in respiratory rhythm generation throughout this 
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critical developmental time period. Based on the general hypothesis that the preBötC 
functions as the dominant respiratory rhythm generator when the respiratory system has 
matured, it was hypothesised that mice would be more susceptible to the respiratory 
depressive effects of fentanyl after the maturation step has occurred i.e. the respiratory 
sensitivity to fentanyl would be age-dependent. Initially, mice were repeatedly exposed to 
fentanyl throughout postnatal development. However, fentanyl failed to induce a 
respiratory depression at all postnatal ages, suggesting repeated exposure had induced a 
rapid desensitisation to fentanyl’s respiratory effects. The study design was consequently 
altered to allow the hypothesis to be sufficiently tested, whereby different mice were 
studied on each postnatal day i.e. each mouse was only exposed to fentanyl once. This 
study revealed a trend towards an age-dependent increase in respiratory sensitivity to 
fentanyl, where mice displayed a heightened respiratory frequency depression in response 
to fentanyl after the maturation step had occurred from P3 onwards. This data therefore 
lends support to the hypothesis that the preBötC functions as the dominant respiratory 
rhythm generator post-maturation. 
 
In the clinical setting fentanyl is widely utilised for treating chronic and acute pain. 
However, despite the potent respiratory depressive actions of fentanyl, the long-term 
respiratory consequences of repeated exposure remain unexplored both clinically and pre-
clinically. Owing to the immaturity of the respiratory system and the corresponding fragile 
nature of breathing patterns during neonatal life in mammals, a further aim of the thesis 
was to determine the long-term effects of fentanyl exposure during this vulnerable 
respiratory time period in the mouse. To establish if the postnatal age of fentanyl-exposure 
influences long-term respiratory effects, fentanyl exposure during juvenile life, which is 
regarded as being post-respiratory maturation, was also assessed. Neonatal mice were 
exposed to fentanyl (0.04 mg/kg daily) from P1-P5 and juvenile mice were exposed from 
P9-P13. When mice reached adulthood, baseline respiratory activity and the respiratory 
response to a subsequent fentanyl challenge were assessed during wakefulness and under 
anaesthesia. When awake, neonatal-exposed mice exhibited a reduced baseline respiratory 
frequency and an attenuated respiratory sensitivity to fentanyl. Under anaesthesia, 
neonatal-exposed mice displayed a depressed baseline minute ventilation and a high 
frequency of spontaneous augmented breaths. In direct contrast to the wakeful state, when 
anaesthetised, neonatal-exposed mice exhibited a striking hypersensitivity to the acute 
respiratory depressive actions of fentanyl. In all neonatal-exposed mice, fentanyl evoked a 
respiratory failure. In juvenile-exposed mice, baseline respiratory activity remained 
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unaltered in the wakeful state and fentanyl also failed to induce a respiratory depression. 
When anaesthetised, baseline minute ventilation remained unchanged and the high 
occurrence of augmented breaths exhibited by the neonatal-exposed mice was not 
observed. Unlike the wakeful state, fentanyl evoked a depression of respiratory activity in 
the juvenile-exposed mice when anaesthetised, however the augmented sensitivity to 
fentanyl and consequential respiratory arrest displayed by the neonatal-exposed was not 
observed. This data indicates that the anaesthetised state is more susceptible to respiratory 
depression. Furthermore, the data suggests that neonatal life represents a time period that is 
particularly vulnerable to the respiratory effects of opioid depression. The final aim of the 
thesis was to determine the long-term effects of neonatal fentanyl exposure on neurokinin-
1 (NK1R) and µ opioid receptor expression within the ventral respiratory column (VRC), a 
region of the ventrolateral medulla comprising the preBötC. Neonatal-exposed mice 
exhibited significantly less NK1R and µ opioid receptor expressing cells in the region of 
the preBötC. This data suggests that repeated fentanyl exposure in neonatal life induces a 
long-term downregulation of these receptors. 
 
In conclusion, fentanyl’s acute respiratory effects were age-dependent, which lends 
supports to the hypothesis that the preBötC functions as the dominant rhythm generator 
post-maturation. Furthermore, this thesis highlights the vulnerabilities of neonatal life to 
the lasting effects of opioid respiratory depression, whilst also providing invaluable insight 
into state-dependent respiratory modulation and depression. 
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1.1 Respiration: An essential function 
 
Respiration is a unique and fundamental physiological process in mammals and is 
continuous throughout life. It is a stringently controlled rhythmic motor output that 
functions to maintain blood oxygen (O2), carbon dioxide (CO2) and pH, essential to 
mammalian survival. Mammals have a high metabolic rate and therefore require a 
constant, rich supply of O2. In humans, the demand for O2 can rapidly change (e.g. triples 
during modest movements) and as a result, respiration must be highly labile, constantly 
responding and adapting to environmental and behavioural stimuli. Furthermore, it must 
also be coordinated with other complex behaviours such as speech, coughing, sneezing and 
swallowing. Given that irreversible brain damage can occur after only a few minutes of 
low blood O2, respiration must be unremitting. Despite the vital role of respiration in 
sustaining life, the underlying neuronal mechanisms by which the respiratory motor 
rhythm is generated and also modulated are still largely unknown, and identifying these 
mechanisms represents an important challenge in the field of respiratory neurobiology.  
 
1.2 Investigating central respiratory control 
 
It has been long established that the brainstem is the neural basis for the automatic control 
of breathing. The ultimate goal of respiratory research is to fully understand normal and 
pathological breathing in humans; however investigating the neural control of breathing in 
humans is limited. Invasive techniques are impractical due to the small size of the neural 
structures within the brainstem, as well as ethical considerations. Furthermore, non-
invasive neuroimaging of the brainstem is difficult, owing to the brainstem’s compact 
structure and extensive blood vessel innervation. Consequently, much of the existing 
knowledge of central respiratory control is derived from experimental studies undertaken 
in non-primate animal models, with rodents being the current model of choice. Respiratory 
control is particularly amenable to experimental research since respiratory activity that is 
present in the whole animal, including rhythmic respiratory neural and motor output, can 
be recorded in highly reduced vertebrate preparations (Smith et al., 1991). 
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1.3 Early central respiratory control studies 
 
Early investigations in the field of respiratory neurobiology found that respiratory 
movements persisted after complete removal of the cerebrum in rabbits and were only 
abolished when the brainstem was removed. In addition, specific lesions within the 
medulla induced a cessation of respiratory activity, leading to the conclusion that the 
circuitry essential for respiratory control was located within the medulla (LeGallois, 1813). 
In 1868, Hering and Breuer discovered that inflation and deflation of the lung initiated 
breathing reflexes which indicated that afferent inputs from the periphery could modulate 
central respiratory control (Hering and Breuer, 1868). The importance of the brainstem in 
ventilatory control was further acknowledged in 1923, by Lumsden (Lumsden, 1923), who 
performed brain transections in the anaesthetised cat. A transection through the medullary-
cervical junction evoked a complete cessation of respiratory function, supporting the 
theory that the brainstem contains critical respiratory centres. Further transections 
identified the caudal pons and rostral medulla as an apneusis centre, believed to produce 
prolonged inspiratory pauses and identified the rostral pons as a pneumotaxic site i.e. the 
site for normal rhythmic breathing. The introduction of single-cell recordings further 
advanced respiratory research allowing individual medullary neurons to be recorded from. 
This led to the description of respiratory neurons, defined as such because their firing 
pattern corresponded with particular phases of the respiratory cycle (Salmoiraghi and 
Burns, 1960). The primary focus of subsequent research was identifying the neural 
networks responsible for the generation of the respiratory rhythm. 
 
1.4 Respiratory neurons and their location in the brainstem 
 
Breathing is generated and modulated by a complex neural circuitry within the brainstem. 
There are distinct clusters of respiratory-related and functionally interacting neurons 
located bilaterally within the pons in an area defined as the pontine respiratory group 
(PRG), and in the medulla within a region named the dorsal respiratory group (DRG) and 
the ventral respiratory column (VRC). The VRC is located in the ventrolateral medulla and 
extends from the upper spinal cord through to the facial motor nucleus. Figure 1-1 
illustrates the location of the main respiratory neurones in the rodent brainstem.   
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Figure 1-1. Schematic illustrations showing the location of the principal 
respiratory neurons in the rodent brainstem. Parasagittal view (A) and 
horizontal, dorsal view (B) of the brainstem showing the pontine respiratory group, 
the dorsal respiratory group and the rostro-caudally distributed respiratory neurons 
within the ventral respiratory column. Abbreviations: 7n, facial nerve; Amb, nucleus 
ambiguus; BC, Bötzinger complex; cVRG, caudal ventral respiratory group, K-F, 
Köllicker-Fuse nucleus; LRt, lateral reticular nucleus; NTS, nucleus tractus 
solitarius; PB, parabrachial complex; preBötC, preBötzinger complex; RTN/pFRG, 
retrotrapezoid nucleus/parafacial respiratory group; rVRG, rostral ventral 
respiratory group; VII, facial motor nucleus. Modified from Spyer (2009). 
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Within the PRG, the Kӧ llicker-Fuse (K-F) and the parabrachial complex (PBc) are the 
main respiratory nuclei. The exact role of the pons in neural control of breathing remains 
elusive, but studies suggest it plays a modulatory role to shape and adapt the respiratory 
pattern. Anatomical and electrophysiological tracing studies have shown that the pontine 
nuclei have synaptic inputs into the medulla (Gang et al., 1995; Ezure et al., 1998; Jiang et 
al., 2004) and computational modelling studies suggest these areas regulate the output from 
the preBötzinger complex (Rybak et al., 2004). Electrical stimulation and glutamate 
injection into the PBc and K-F neurons has revealed that the lateral PBc modulates the 
inspiratory phase whereas the medial PBc and K-F modulates the expiratory phase (Lara et 
al., 1994). The K-F has also been proposed to control the transition from inspiration to 
expiration, as lesioning and pharmacological manipulation of this nucleus extends the 
duration of inspiration (Dutschmann et al., 2004; Dutschmann and Herbert, 2006). 
Furthermore, transection of the pons below the PBc evokes an apneusis breathing pattern 
(Feldman and Gautier, 1976), further indicating the role of the pons in modulating 
inspiratory activity. The K-F also comprises pharyngeal premotor neurons that act to 
regulate upper airway resistance (Dutschmann and Herbert, 2006).          
     
The DRG is located within the nucleus tractus solitarius (NTS) and provides an important 
interface between afferent information from the periphery and the brain circuitry. In terms 
of respiratory control, the NTS functions to relay afferent inputs allowing for modulation 
of respiratory activity. The NTS receives vagal inputs from lung and airway 
mechanoreceptors, peripheral chemoreceptors as well as other visceral sensory afferent 
inputs. NTS neurons project and terminate in the pons, the VRC of the medulla and the 
spinal cord (Alheid et al., 2011). 
 
The ventral respiratory group (VRG) is located within the rostro-caudally arranged VRC 
and is subdivided into a caudal and rostral region. The caudal ventral respiratory group 
(cVRG) contains excitatory expiratory bulbospinal premotor neurons that innervate spinal 
thoracic and lumbar motoneurons (Shen and Duffin, 2002), thereby shaping the patterns of 
expiratory motor output. The rostral ventral respiratory group (rVRG) comprises mainly 
excitatory bulbospinal premotor inspiratory neurons that project to both spinal phrenic 
motoneurons that in turn innervate the diaphragm (Dobbins and Feldman, 1994) and to 
external intercostal motoneurons in the thoracic spinal cord (Stornetta et al., 2003a).  
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Rostral to the VRG, resides the preBötzinger complex (preBötC). This small bilateral 
cluster of glutamatergic interneurons is considered the principal site of respiratory rhythm 
generation (Smith et al, 1991) and will be discussed in detail in section 1.5. 
 
The Bötzinger complex (BC) is located directly rostral to the preBötC and caudal to the 
facial motor nucleus. This neuronal group comprises mainly inhibitory expiratory neurons 
(Smith et al., 2007), including glycinergic and GABAergic neurons (Ezure et al., 2003) 
that provide widespread inhibitory projections throughout the VRC (Jiang and Lipski, 
1990) and to spinal phrenic motoneurons (Tian et al., 1998). The BC neurons are believed 
to inhibit inspiratory neurons allowing the switch between inspiration and expiration 
(Smith et al., 2007).  
 
In the most rostral region of the VRC lies the retrotrapezoid nucleus/parafacial respiratory 
group (RTN/pFRG), a cluster of neurons situated in close proximity to the facial motor 
nucleus and the ventral medullary surface. The RTN/pFRG has been implicated in both the 
generation of respiratory rhythm in early life (Onimaru and Homma, 2003) as well as 
central chemoreception (Mulkey et al., 2004; Guyenet et al., 2005) and will be fully 
discussed in section 1.6. 
 
1.5 The preBötzinger complex and respiratory rhythm generation 
 
Understanding where and how the rhythmic motor pattern of breathing is generated has 
fascinated scientists for decades, and consequently a great deal of research has been 
dedicated to uncovering this. There is now extensive evidence that a bilateral cluster of 
neurons known as the preBötzinger complex (preBötC), located in the ventrolateral 
medulla, are fundamental to respiratory rhythmogenesis. The preBötC has long been 
postulated to contain the kernel for respiratory rhythm generation (Smith et al., 1991). The 
advent of the isolated rodent brainstem spinal cord (en bloc) preparation and the 
rhythmically active medullary slice preparation have greatly facilitated the study of the 
preBötC and significantly advanced the understanding of the functional role of this neural 
group. The neonatal rat brainstem-spinal cord preparation continues to generate a 
respiratory-like rhythmic motor output that can be recorded from electrodes positioned on 
the hypoglossal and phrenic nerve rootlets. The hypoglossal nerve innervates the 
genioglossus and the phrenic nerve innervates the diaphragm, two inspiratory muscles. 
Recording this motor activity is therefore a measure of inspiratory activity. Serial 
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transections of this brainstem-spinal cord preparation in a rostral and caudal direction do 
not abolish the respiratory rhythm until a transection is made through the mid medulla, 
where the preBötC is located (Smith et al., 1991). The isolated neonatal rodent medullary 
slice preparation preserves the preBötC as well as hypoglossal respiratory motoneurons, 
and continues to generate a respiratory-like rhythm that is comparable to the rhythmic 
activity recorded from the more intact brainstem-spinal cord preparation (Smith et al., 
1991). Intracellular recordings of preBötC neurons in the slice preparation reveal intrinsic 
rhythmogenic activity that occurs simultaneously with inspiratory hypoglossal motor 
output (Figure 1-2). This further suggests the preBötC plays a role in respiratory 
rhythmogenesis and generates the inspiratory rhythm. PreBötC neurons are consequently 
referred to as being inspiratory modulated. Microinjection of 6-cyano-7-nitroquinoxaline-
2,3-dione (CNQX), a non-N-methyl-D-aspartate glutamate receptor antagonist into the 
preBötC in the slice preparation decreases and then eliminates the oscillatory respiratory 
output (Smith et al., 1991). This indicates that glutamatergic neurotransmission within the 
preBötC is essential for respiratory rhythm generation. These landmark experiments were 
the first to identify the preBötC as being necessary and sufficient for generating the 
inspiratory rhythm that in turn generates inspiratory motor output in vitro, indicating the 
preBötC functions as an oscillator driving inspiration. In light of these findings, an 
extensive array of studies within the field of respiratory neurobiology was then conducted 
in an attempt to further uncover the role of the preBötC in respiratory rhythm generation.  
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Figure 1-2. Schematic illustration of a medullary slice preparation that contains the preBötC and generates a respiratory-like 
rhythm. The preBötC sends neural signals to the hypoglossal nucleus (XII) which in turn drives the hypoglossal nerve (XII N). Respiratory-
related rhythmic activity can be intracellularly recorded from individual preBötC neurons (top trace) or extracellulary recorded from the XII 
N.  Note that the oscillatory activity of the preBötC occurs concurrently with the hypoglossal inspiratory motor output suggesting the 
preBötC drives inspiratory rhythm. 5SP, spinal trigeminal nucleus; preBötC, preBötzinger complex; scNA, subcompact formation of the 
nucleus ambiguus. Modified from Smith et al. (1991).
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1.5.1 Location and identification of preBötC neurons 
 
Elucidating the precise location and rostrocaudal boundaries of the preBötC has received a 
great deal of attention. Gray and colleagues (1999) investigated the effects of various 
peptides on rhythmic respiratory activity of the preBötC. Application of the neuropeptide 
substance P (SP) directly into the preBötC in the neonatal medullary slice preparation 
initiated an increase in the frequency of the endogenous respiratory bursting. It was 
concluded that the powerful respiratory excitation is mediated through the membrane 
neurokinin-1 receptor (NK1R) given that SP is the natural ligand for this receptor. 
Immunohistochemical analyses of the VRC in the rat have revealed that neurons within the 
level of the preBötC express high levels of NK1R (Gray et al., 1999; Guyenet and Wang, 
2001; Wang et al., 2001a; Guyenet et al., 2002); thus the NK1R has been proposed as an 
anatomical marker for preBötC neurons. The NK1R-expressing preBötC neurons have also 
been shown to express vesicular glutamate transporter 2 (VGLUT2) and are 
immunoreactive for glutamate indicating that the preBötC neurons are glutamatergic and 
therefore excitatory (Liu et al., 2001; Guyenet et al., 2002; Stornetta et al., 2003b), which 
further supports the work of Smith and colleagues (1991). Likewise, few NK1R expressing 
preBötC neurons express glutamic acid decarboxylase 67 (GAD67), a γ-aminobutyric acid 
(GABA) synthetic enzyme or glycine transporter 2 (GlyT2), indicating the neurons are not 
inhibitory (Wang et al., 2001a). Application of the synthetic µ opioid receptor agonist d-
Ala(2),NMePhe(4),Gly-ol(5)encephalin (DAMGO) directly into the preBötC in the 
medullary slice preparation evokes a significant depression of rhythmic inspiratory motor 
output. Furthermore, histological analyses have found a distinct population of NK1R-
expressing preBötC neurons co-express the µ opioid receptor (Gray et al., 1999) (Figure 1-
3), which explains the sensitivity of the preBötC to opioids. A subset of NK1R-expressing 
preBötC express the neuropeptide somatostatin (Stornetta et al., 2003b) and the 
glycoprotein reelin (Tan et al., 2012) which further facilitates the anatomical delineation 
and in vivo targeting of this neuronal group. Neurons within the preBötC are also 
predominantly propriobulbar (Guyenet et al., 2002) i.e. they originate and terminate in the 
brainstem. Within the rostral VRC, preBötC neurons are found to reside in the region 
ventral to the subcompact formation of the nucleus ambiguous (scNA) (Gray et al., 1999). 
From the extensive research, it is apparent that the preBötC consists of a heterogenous 
population of neurons whose function depends on glutamate-mediated synaptic 
connections.  
. 
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Figure 1-3. µ opioid receptor expressing neurons are found within the 
preBötC. Top: confocal image illustrating µ opioid receptor immunohistochemical 
staining within the preBötC i.e. the region ventral to the subcompact nucleus 
ambiguus. Bottom: confocal images illustrating NK1R expression on a preBötC 
cell soma and µ opioid receptor expression on a preBötC cell soma and process. 
Arrow indicates co-expression of NK1R and µ opioid receptor. Arrow head 
indicates absence of co-expression. Top scale bar= 200 µm, bottom scale bar= 25 
µm. µ-OR, µ opioid receptor; scNA; subcompact nucleus ambiguus. Reproduced 
from Gray et al. (1999).  
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1.5.2 PreBötC neuronal projections 
 
Elucidating the projections of the preBötC within the brainstem is vital in order to establish 
the role these neurons play in central respiratory control. Acute silencing a subset of 
preBötC neurons that express somatostatin (SST) induces a persistent apnoea in the adult 
rat indicating the importance of these neurons in respiratory control (Tan et al., 2008). 
These SST expressing, glutamatergic preBötC neurons have been further investigated in an 
attempt to establish their connectivity within the brainstem. They have been found to 
exhibit extensive projections throughout the brainstem in the adult rat (Tan et al., 2010). 
Specifically, these neurons project to the BC, rostral and caudal VRG, RTN/pFRG, NTS, 
DRG and the contralateral preBötC. This widespread connectivity with other principal 
respiratory brainstem nuclei confirms the integral role the preBötC plays in central 
respiratory control in the adult rodent. 
 
1.5.3 PreBötC lesioning 
 
Lesioning the preBötC and studying the respiratory effects can provide information 
regarding the functional importance of the preBötC in vivo. Bilateral microinjection of 
tetrodotoxin, a sodium channel blocker, into the preBötC in anaesthetised cats evokes an 
irreversible inactivation of the neurons and causes an abolition of phrenic nerve activity 
and a persistent apnoea (Ramirez et al., 1998). This suggests the preBötC is the source of 
respiratory rhythm. NK1R-expressing preBötC neurons can be ablated by substance P 
conjugated to the neurotoxin saporin (SP-SAP). SP is the natural ligand for the NK1R and 
when bound, internalisation of the receptor occurs. This means the neurotoxin conjugate is 
also taken into the cell thereby destroying it. The bilateral ablation of NK1R-expressing 
preBötC neurons (> 80%) using SP-SAP in adult rats in vivo, results in a profound 
deterioration in breathing during wakefulness, characterised by an ataxic pattern (Gray et 
al., 2001) (Figure 1-4). Furthermore, these irreversible breathing abnormalities are first 
observed during sleep before they progress into wakefulness (McKay et al., 2005). 
Interestingly, a unilateral preBötC lesion results in breathing disturbances during sleep 
only (McKay and Feldman, 2008). Bilateral preBötC lesioning also depresses the 
ventilatory response to hypercapnia and alters the hypoxic respiratory response (Gray et 
al., 2001), whereas unilateral ablation has no effect on chemoresponses (McKay and 
Feldman, 2008). Taken together, these studies signify the fundamental and dominant role 
the preBötC plays in generating a reliable and robust respiratory rhythm in the adult rodent 
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in vivo. Moreover, these studies suggest that pathological breathing patterns tend to first 
manifest in more depressed states e.g. sleep. However, in contrast to these findings, a 
gradual bilateral destruction of preBötC neurons in adult goats does not induce a disturbed 
breathing phenotype under normoxic and normocapnic conditions. The researchers suggest 
that plasticity changes within the respiratory network allows sufficient respiratory rhythm 
to continue that is capable of maintaining blood gas homeostasis in the absence of the 
preBötC (Krause et al., 2009). This data suggests that if enough time is given, respiratory 
network reconfiguration can overcome a defective or absent preBötC.   
 
 
 
Figure 1-4. Disordered breathing exhibited by awake adult rats after bilateral 
ablation of the preBötC. Top: respiratory recording showing normal, rhythmic 
breathing of a control mouse. Bottom: ataxic breathing pattern is exhibited by 
mouse with ablated preBötC (preBötC-). Reproduced from Gray et al. (2001). 
 
1.5.4 Mechanisms of respiratory rhythm generation in the preBötC  
 
Rhythmic motor behaviours including breathing are produced by central pattern generators 
(CPGs) which are neural circuits capable of generating rhythmic activity in the absence of 
sensory or descending inputs (Marder and Calabrese, 1996). The activity of CPGs must be 
able to be modulated by central and peripheral inputs. This is particularly important for 
respiratory motor output which needs to adapt quickly to changes in metabolic needs in 
order to sustain life. Unravelling the mechanisms that underlie respiratory rhythm 
generation has been at the forefront of respiratory research for decades. The highly reduced 
medullary slice preparation which contains the preBötC is ideally suited to experimentally 
investigate rhythm generation. Currently, there are two main hypotheses for the 
mechanism of preBötC rhythm generation. The first is the pacemaker hypothesis, which 
asserts that respiratory rhythmogenesis is exclusively generated by intrinsic pacemaker 
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neurons within the preBötC. The second is the group-pacemaker hypothesis which 
proposes that respiratory rhythm generation is reliant on recurrent excitation between 
preBötC neurons which leads to population bursting, and does not require specialised 
pacemaker neurons.     
 
1.5.4.1 Pacemaker hypothesis 
 
Respiratory rhythm continues in vitro after the blockade of chloride-mediated inhibition, 
which suggests rhythm generation is not dependent on postsynaptic inhibition (Feldman 
and Smith, 1989). This finding led to the hypothesis that pacemaker neurons must generate 
the rhythm (Feldman and Smith, 1989; Smith et al., 1991; Brockhaus and Ballanyi, 1998). 
PreBötC pacemaker neurons that depend on persistent sodium currents (INaP) have been 
identified (Smith et al., 1991; Johnson et al., 1994). These neurons are voltage-dependent, 
and are antagonised by riluzole, a INaP blocker (Del Negro et al., 2002). A second type of 
pacemaker activity that is sensitive to the calcium ion channel blocker, cadmium, was 
identified in the preBötC (Thoby-Brisson and Ramirez, 2001). Further work demonstrated 
that this pacemaker mechanism depends on calcium activated nonspecific and voltage-
insensitive cation currents (ICAN) (Del Negro et al. 2005; Pena et al. 2004). Experiments 
employing pharmacological interventions have been employed to better understand the 
potential contribution of pacemaker neurons to respiratory rhythm generation. Drugs that 
block either or both INaP and ICAN, have been utilised and the resultant changes in network 
activity are measured to determine if either or both types of pacemaker neurons generate 
respiratory rhythm. Within the preBötC, only 5% of neurons are found to rely on INaP. (Del 
Negro et al., 2005). Application of riluzole to the medullary slice preparation containing 
the preBötC from neonatal rats does not affect the frequency of rhythmic motor output 
(Del Negro et al., 2005). This finding is not congruent with the theory that INaP pacemakers 
are essential to rhythm generation. Riluzole does however prevent fictive gasping (slower 
frequency bursting) under anoxic conditions in vitro suggesting that respiratory rhythm 
generation during gasping is exclusively reliant on INaP (Pena et al., 2004; Paton et al., 
2006). This proposes that the contribution of pacemaker neurons in respiratory 
rhythmogenesis may be state-dependent. The coapplication of riluzole and the ICAN 
blocker, flufenamic acid (FFA), abolishes respiratory rhythm in vitro (Pena et al., 2004; 
Del Negro et al., 2005). It was therefore suggested that ICAN dependent pacemakers are 
important for driving respiratory rhythm in vitro. However given that almost all preBötC 
neurons express INaP and ICAN (Del Negro et al., 2002), these drugs will reduce the overall 
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excitability within the preBötC. This means that the loss of rhythm could be due to riluzole 
and FFA lowering excitability of all other neurons as well as pacemakers themselves. As a 
result it is difficult to make definitive conclusions regarding the importance of pacemaker 
neurons to rhythm generation based on the effects of riluzole and FFA alone. Following a 
complete cessation of rhythmic motor output in the slice preparation induced by riluzole 
and FFA, application of SP, which depolarises preBötC membrane potentials, restarts 
respiratory rhythm (Del Negro et al., 2005). From this finding it was suggested that high 
levels of cellular excitability are required to sustain respiratory rhythmogenesis. A recent 
study utilising transgenic mice in which neurons expressing the GlyT2 gene co-express 
enhanced green fluorescent protein, have found inspiratory-modulated glycinergic 
pacemaker neurons in the preBötC (Morgado-Valle et al., 2010). The precise role that 
these glycinergic pacemaker neurons play in rhythm generation remains elusive, but this 
finding challenges the view that preBötC pacemaker neurons are excitatory.  
 
1.5.4.2 Group-pacemaker hypothesis  
 
In contrast to the pacemaker theory, the group-pacemaker theory posits that respiratory 
rhythm generation is an emergent network property. It is believed that excitatory and 
inhibitory interactions between preBötC neurons underlie respiratory rhythmogenesis. At 
present there is limited conclusive data that support this theory. It is hypothesised that 
rhythmic inspiratory bursts in the preBötC result from excitatory connections between 
preBötC neurons which induce positive feedback through recurrent excitation (Rekling et 
al., 1996; Rekling and Feldman, 1998). This theory proposes that a proportion of preBötC 
neurons exhibit spontaneous activity which synapse with and excite silent neurons. These 
neurons in return excite more silent neurons as well as re-excite the neurons that are 
already active. It is therefore believed that pacemaker neurons in the preBötC that rely on 
INaP or ICAN, function to stabilise the rhythm and contribute to the general excitability of the 
whole network of respiratory neurons but are not necessary for respiratory rhythmogenesis 
per se. This theory is supported by the observation that in the presence of riluzole and FFA 
which abolish pacemaker activity in vitro, respiratory rhythm can continue as long as 
pharmacological excitation is provided e.g. with SP as mentioned in section 1.5.4.1 above 
(Del Negro et al., 2005). SP depolarises preBötC neurons thereby allowing the network 
rhythm generation to persist (Morgado-Valle and Feldman, 2004).  Taken together these 
data suggest that respiratory rhythm generation is a function of both synaptic connections 
and the intrinsic activity of pacemakers. 
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1.5.5 Prenatal development of the preBötC   
 
In order to sustain life, the mammalian respiratory rhythm generator must be functional by 
birth. The prenatal development of respiratory rhythmogenesis has thus received 
considerable attention. Breathing is one of the earliest detectable behaviours in the 
mammalian fetus. During prenatal life, mammals exhibit episodic rhythmic fetal breathing 
movements (FBMs) involving respiratory muscular contractions (Jansen and Chernick, 
1983; Kobayashi et al., 2001), which are believed to be generated by the respiratory 
rhythm generator. FBMs are postulated to induce appropriate maturation of the lungs as 
well as influence the development of respiratory motoneurons and musculature allowing 
for coordinated breathing at birth (Kitterman, 1988). It is therefore essential that the 
respiratory rhythm generator becomes active prior to postnatal life. 
 
1.5.5.1 Anatomical development of the preBötC  
 
The anatomical formation of the preBötC during prenatal life has been investigated in the 
rodent. Given that NK1R is an immunohistochemical marker for the preBötC, examining 
NK1R expression throughout prenatal development can determine when preBötC neurons 
are formed. At embryonic day (E) 14 in the mouse and E16 in the rat (analogous 
developmental time periods taking into account the longer gestational period of the rat), 
weak NK1R immunostaining is found in the region below the NA, believed to represent 
the preBötC.  Stronger NK1R immunolabeling within the region of the preBötC is then 
detected at E15 and E17 in the mouse and rat respectively (Pagliardini et al., 2003; Thoby-
Brisson et al., 2005). The birth date of neurons can be determined using 5-bromo-2-
deoxyuridine (BrdU) injections. BrdU is a structural analogue of thymidine that is 
incorporated into dividing cells and is therefore used as a marker of cell proliferation. 
BrdU expression can be detected using fluorescently labelled antibodies. Birth dating of 
NK1R expressing preBötC neurons in the rat has revealed that these neurons are born at 
E12.5-E13.5 and migrate to the area of the preBötC by E17-E18 (Pagliardini et al., 2003). 
  
1.5.5.2 Functional development of the preBötC  
 
In the rat, extracellular recordings of population activity within the preBötC in the 
transverse medullary slice preparation have shown that spontaneous rhythmic activity 
emerges at E17 (Pagliardini et al., 2003), which corresponds with the first detection of 
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rhythmic FBMs (Kobayashi et al., 2001). This emergence of rhythmic motor output also 
corresponds with the developmental time at which strong NK1R expression is first 
detected within the preBötC in the rat (Pagliardini et al., 2003). Using a combination of 
electrophysiology and calcium imaging in the brainstem-spinal cord and transverse 
medullary slice preparations, it has been shown that the preBötC becomes rhythmically 
active at E15.5 in the mouse. This neural activity can sustain the rhythmic activity of 
hypoglossal motoneurons. The rhythmic output from the embryonic preBötC relies on 
glutamatergic neurotransmission, is excited by SP and depressed by the µ opioid receptor 
agonist DAMGO (Thoby-Brisson et al., 2005). These characteristics are also exhibited by 
the neonatal preBötC (Smith et al., 1991; Gray et al., 1999; Mellen et al., 2003) suggesting 
that generation and modulation of respiratory rhythm during embryonic life is comparable 
with that in early postnatal life. The emergence of rhythmic activity in the embryonic 
mouse preBötC is concomitant to the anatomical formation of the NK1R-expressing 
preBötC neurons (Thoby-Brisson et al., 2005).  This suggests that in both rats and mice, 
the anatomical emergence of the preBötC correlates with the inception of preBötC 
functional activity.   
 
1.5.6 Transgenic mouse models 
 
The understanding of central respiratory control and the role of the preBötC has been 
greatly facilitated by the development of transgenic mouse models. There are an increasing 
number of studies where gene targeting techniques have been utilised to understand how 
gene disruptions impact the development of respiratory control. Genetic ablation of 
VGLUT2 causes the neural circuits within the preBötC to remain inactive. In vitro analysis 
has demonstrated that respiratory-like rhythmic activity from the preBötC is absent during 
prenatal development and through to birth. Null mutant mice lacking VGLUT2 die at birth 
from respiratory failure (Wallen-Mackenzie et al., 2006). This confirms that glutamate is 
an essential neurotransmitter for preBötC rhythmogenesis during development. Several 
studies have investigated and ascertained the genes that specify the identity of the preBötC 
neurons. The transcription factor v-maf musculoaponeurotic fibrosarcoma oncogene 
homologue B (MafB) is expressed in a subpopulation of preBötC neurons. Deletion of 
MafB in mice results in fatal prolonged apnoeas in vivo, defective respiratory rhythm 
generation in vitro and an anatomical deformation of the preBötC (Blanchi et al., 2003). 
This observation establishes an important role of MafB for sufficient development of 
preBötC neurons and highlights the importance of the preBötC for postnatal survival. 
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Studies utilising transgenic mice lacking the transcription factor developing brain 
homeobox protein 1 (Dbx1) have also revealed important information regarding the 
developmental origins of the preBötC. A loss of Dbx1 induces an elimination of all 
glutamatergic neurons within the ventrolateral medulla including SST and NK1R 
expressing preBötC neurons. Dbx1 null mutant mice fail to breathe at birth and inspiratory 
rhythmic activity is also absent in vitro (Bouvier et al., 2010; Gray et al., 2010). These data 
suggest that Dbx1 is required for the formation of rhythm generating preBötC neurons. 
Additionally, in Dbx1 mutant mice, commissural connectivity in the preBötC is impaired, 
and a mutation of Robo3, a gene essential for commissural axon path finding, results in a 
loss of bilateral synchrony of the preBötC (Bouvier et al., 2010). In further support of the 
critical role of Dbx1 in rhythm  generation of the preBötC, Dbx1-derived neurons within 
the preBötC are found to be rhythmically active and exhibit an inspiratory-modulated 
pattern of firing (Picardo et al., 2013). Furthermore, laser ablation of individual Dbx1-
derived preBötC neurons in a gradual manner in the neonatal medullary slice preparation 
induces a continuous depression of respiratory rhythm and eventually a complete cessation 
of inspiratory motor activity (Wang and Hayes, 2014). Taken together, these data provide 
strong evidence that rhythm generating preBötC neurons are derived from Dbx1-
expressing progenitors.    
 
1.5.7 Human preBötC  
 
The recent identification of the presumed preBötC in the human brainstem has confirmed 
the validity of studying the rodent as a model of central respiratory control. Some of the 
anatomical markers that delineate the preBötC in the rodent have also been identified in the 
ventrolateral medulla in human tissue. NK1R expressing and SST expressing cells have 
been located in the region ventral to the scNA in post-mortem brainstem tissue from 
fetuses, newborns and infants. These cells are believed to represent the human preBötC. 
Interestingly, structural alterations within the postulated preBötC are found in a high 
percentage of brains from fetuses and newborns who suffered from sudden unexplained 
death (Lavezzi and Matturri, 2008). Additionally, in the adult human brain, an area in the 
rostral ventrolateral medulla displaying co-localisation of NK1R and SST immunoreactive 
neurons is believed to represent the preBötC. These neurons exhibit small to medium sized 
soma which distinguishes them from larger motoneurons. Examination of the putative 
preBötC in post-mortem brain tissue from individuals who suffered from 
neurodegenerative diseases associated with pathological breathing has revealed a reduction 
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in the number of NK1R/SST expressing neurons (Schwarzacher et al., 2011) which could 
contribute in part to the respiratory disturbances observed in these patients. These studies 
provide evidence to suggest the human preBötC has a similar anatomical location and 
histological profile as the experimental rodent.  
 
1.6 The retrotrapezoid nucleus/parafacial respiratory group 
 
The retrotrapezoid nucleus/parafacial respiratory group (RTN/pFRG) consists of a bilateral 
cluster of interneurons in the ventrolateral medulla and has been implicated in central 
respiratory control. The exact function of the RTN/pFRG is currently debated. This group 
of respiratory neurons is located in the VRC, rostral to the preBötC and ventral to the facial 
motor nucleus, in close proximity to the ventral medullary surface (Onimaru and Homma, 
2003; Stornetta et al., 2006; Onimaru et al., 2008). Like preBötC neurons, RTN/pFRG 
neurons are anatomically defined by their expression of NK1R and VGLUT2 mRNA 
(Stornetta et al., 2006; Onimaru et al., 2008). However in contrast to preBötC neurons, 
RTN/pFRG neurons also express the transcription factor, paired-like homeobox 2b 
(Phox2b) and lack the µ opioid receptor (Stornetta et al., 2006; Kang et al., 2007; Onimaru 
et al., 2008). There is considerable debate as to whether the RTN/pFRG is one nucleus or if 
the RTN and pFRG are anatomically and functionally distinct. In the neonatal rodent, the 
group of neurons located in the parafacial region is often termed the pFRG whereas in the 
adult rodent they are named the RTN. Given the similarity in the histological profiles 
(NK1R
+
, Phox2b
+
 and VGLUT2
+
) and anatomical location, it is generally believed that the 
pFRG and RTN represent the same neural group at different developmental stages i.e. the 
pFRG develops into the RTN. In this thesis this neural group will be termed RTN/pFRG 
when referring to it in both neonatal and adult rodents. 
 
1.6.1 RTN/pFRG and respiratory rhythm generation  
 
The exact role the RTN/pFRG plays in respiratory control is not fully understood. There is 
a current hypothesis that the RTN/pFRG functions as a respiratory rhythm generator in the 
neonatal rodent (Onimaru and Homma, 2003). Studies utilising the neonatal brainstem-
spinal cord preparation, which preserves the RTN/pFRG as well as the preBötC, have 
provided great insight into the potential role of the RTN/pFRG in respiratory 
rhythmogenesis (Ballanyi et al., 1999). Onimaru and Homma (2003) employed this 
preparation from the newborn rat and for the first time demonstrated rhythmic activity in 
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the region of the brainstem that encompasses the RTN/pFRG using optical imaging and 
electrophysiology. By using these techniques simultaneously, neurons within the 
RTN/pFRG were found to fire prior to inspiratory motor output (phrenic nerve activity, 
recorded from C4 nerve rootlets). These RTN/pFRG neurons have thus been given the 
name preinspiratory (Pre-I) neurons, and are proposed to control the onset of inspiration 
(Onimaru and Homma, 2003). Importantly, this rhythmic preinspiratory patterning has not 
been detected in adult rodent preparations (Mulkey et al., 2004), indicating the RTN/pFRG 
may not function as a rhythm generator in adulthood. Partial bilateral lesioning of the 
RTN/pFRG in the brainstem-spinal cord preparation induces a reduction in respiratory 
frequency together with an altered spatiotemporal pattern of respiratory neuronal firing, 
suggesting the RTN/pFRG may be vital for respiratory rhythmogenesis in neonates 
(Onimaru and Homma, 2003). The concept that the RTN/pFRG is coupled to the preBötC 
in the intact neonatal mammal, whereby the RTN/pFRG functions as the master respiratory 
oscillator was subsequently proposed.  
 
Studies that utilise pharmacological tools to target only the preBötC have provided 
evidence to suggest a dual respiratory rhythm generator exists in early postnatal life. 
Application of DAMGO which depresses neural activity of the preBötC but not the 
RTN/pFRG (Takeda et al., 2001; Mellen et al., 2003), in neonatal brainstem-spinal cord 
preparations and anaesthetised juvenile rats, induces quantal slowing of respiratory 
activity. That is inspiratory output becomes irregular and skips cycles (Mellen et al., 2003; 
Barnes et al., 2007). It has been postulated that opioid-induced quantal slowing is due to a 
failure in functional connectivity between the RTN/pFRG Pre-I neurons and preBötC 
inspiratory neurons. These data suggest that during early life the RTN/pFRG is involved in 
respiratory rhythmogenesis and becomes functionally coupled to the preBötC.         
 
Studies utilising transgenic mouse models with targeted gene deletions affecting the 
development of the RTN/pFRG have provided invaluable insight into the possible role the 
RTN/pFRG plays in early postnatal life. In mammals there is a surge of endogenous 
opiates at birth (Jansen and Chernick, 1983). This increased level of opiates in the blood 
could result in a depression of the opiate-sensitive preBötC neurons, whereas the opiate-
insensitive RTN/pFRG in theory would remain unperturbed (Feldman and Del Negro, 
2006; Janczewski and Feldman, 2006). In this situation, in the absence of a functional 
preBötC, the RTN/pFRG may provide an alternative source of respiratory rhythm and 
ensure adequate breathing immediately after birth until opiate levels decrease. Experiments 
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in Krox-20 homozygous mutant mice support this hypothesis. The Krox-20 gene plays a 
role in controlling the hindbrain segmentation process during embryonic development. A 
Krox-20 mutation results in abnormal segmentation of rhombomeres (transient 
rostrocaudal compartments in the developing hindbrain) 3 and 5. Krox-20 mutant mice 
have neuroanatomical defects in the brain region that corresponds to the RTN/pFRG, 
whereas the anatomy of the preBötC is unaffected. At birth, breathing in the mutant mice is 
markedly depressed and mice die from prolonged apnoeas. This indicates that the preBötC 
alone is not sufficient for the generation of a robust respiratory rhythm in vivo. The 
administration of naloxone, a µ opioid receptor antagonist, within the first few hours after 
birth promotes survival by eliminating apnoeas (Jacquin et al., 1996) (Figure 1-5).  In the 
Krox-20 mutant mice it is likely that the malformed or deleted RTN/pFRG cannot function 
as a rhythm generator and since the perinatal opiate surge would also inhibit the preBötC, 
this would result in a complete failure of respiratory rhythm generation. It is hypothesised 
that naloxone antagonises the opiate depression of the preBötC thereby allowing normal 
rhythmic breathing to persist (Feldman and Del Negro, 2006). The results from the Krox-
20 study are in accordance with the hypothesis that the RTN/pFRG has a specialised role 
in rhythm generation to compensate for the opiate-induced preBötC depression.       
 
Investigating respiratory activity in transgenic mice that lack Phox2b-expressing 
RTN/pFRG neurons has also revealed the importance of this neural group in respiratory 
control. Mice that exhibit a human PHOX2B mutation (the Phox2b
27Ala
 allele) show a 
substantial loss of RTN/pFRG neurons and display fatal central apnoeas at birth (Dubreuil 
et al., 2008). This provides genetic evidence that the RTN/pFRG is essential for driving 
breathing at birth in the rodent. Further support of the critical role that the RTN/pFRG 
plays in rhythm generation in early postnatal life comes from a study conducted in mutant 
mice lacking the transcription factor, ladybird homeobox homolog 1 (Lbx1).These mice die 
of respiratory failure in the early postnatal period. Importantly, these mutant mice exhibit a 
depleted number of RTN/pFRG neurons but show no preBötC anatomical abnormalities 
(Pagliardini et al., 2008). Lbx1 mutant mice do however exhibit anatomical defects in 
neuromodulatory respiratory nuclei (e.g. the NTS) which could also contribute to the 
disordered respiratory phenotype. Furthermore, genetic deletion of the atonal homolog 1 
(Atoh1) transcription factor results in abnormal formation of the RTN/pFRG. The Atoh1 
mutation is fatal due to a severely depressed central respiratory rhythm. This finding also 
reinforces the idea that RTN/pFRG is imperative in driving breathing in early life. It is 
important to highlight the fact that null mutant mice lacking either the preBötC or the 
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RTN/pFRG do not generate sufficient breathing for survival (Jacquin et al., 1996; Blanchi 
et al., 2003; Dubreuil et al., 2008; Pagliardini et al., 2008; Rose et al., 2009; Bouvier et al., 
2010; Gray et al., 2010), indicating that sufficient development of both rhythm generators 
is necessary to sustain breathing rhythm essential to life.  
 
 
 
Figure 1-5. Naloxone eliminates apnoeas and increases respiratory 
frequency in Krox-20 null mutant mice. Respiratory traces illustrate prolonged 
apnoeas at birth in Krox-20-/- mice which are eliminated after administration of 
naloxone, a µ opioid receptor antagonist.   
 
1.6.2 Prenatal development of the RTN/pFRG  
 
By employing calcium imaging and neuronal population recording in the isolated 
embryonic mouse brainstem preparations, rhythmic activity within the parafacial region 
has been identified (Thoby-Brisson et al., 2009). These intrinsically rhythmogenic neurons 
border the facial motor nucleus and have been termed the embryonic parafacial oscillator 
(e-pF). Spontaneous rhythmic activity of the e-pF emerges at E14.5, which is 
approximately one day prior to the onset of preBötC rhythmic activity at E15.5 (Thoby-
Brisson et al., 2005). Application of riluzole abolishes rhythmic bursting of the e-pF, 
indicating the firing of these neurons is reliant on the INaP. In contrast to preBötC activity, 
e-pF rhythmic activity is unaffected by µ opioid receptor agonists. The e-pF neurons are 
derived from Krox20-expressing precursors and are identified anatomically by their 
expression of NK1R and Phox2b (Thoby-Brisson et al., 2009). Given the anatomical 
overlap and identical expression of histological markers, it is likely that the e-pF represents 
the embryonic precursor to the RTN/pFRG. Evidence has also revealed that the e-pF and 
Krox-20 -/- 
Pre-naloxone 
Krox-20 -/- 
Post-naloxone 
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the preBötC become functionally coupled when both oscillators are active at E15.5. When 
the e-pF is silenced by riluzole, the frequency of rhythmic bursting from the preBötC is 
greatly reduced, which suggests the preBötC receives inputs from the e-pF (Thoby-Brisson 
et al., 2009). These observations demonstrate that analogous with early postnatal life 
(Mellen et al., 2003), during embryonic development a dual respiratory rhythm generating 
network forms from two spatially separate neuronal groups. 
  
1.6.3 RTN/pFRG and active expiration 
 
Exploiting the differential sensitivity of the preBötC and RTN/pFRG to µ opioids has 
revealed that the RTN/pFRG may play an important role in generating active expiration. 
Under normal resting conditions, expiration is a passive process, caused by the elastic 
recoil of the inspiratory muscles, lungs and ribcage. Expiration becomes active when there 
is an increased respiratory drive e.g. during exercise, and is generated by the contraction of 
expiratory muscles which augment expiratory airflow (Aliverti et al., 1997). Fentanyl 
administration in juvenile rats induces quantal slowing of inspiratory activity, i.e. 
occasional skipped inspirations, whereas expiratory modulated abdominal muscle activity, 
which is believed to represent active expiration, remains unaffected. Furthermore, 
transection of the brainstem immediately caudal to the RTN/pFRG abolishes abdominal 
muscle expiratory activity but has little effect on inspiratory motor activity (Janczewski 
and Feldman, 2006). This observation that inspiration and expiration can be uncoupled has 
led to the belief that inspiratory and expiratory phases of respiration are not the product of 
a single oscillator but rather are generated by functionally distinct respiratory oscillators. In 
support of this theory, a study conducted in adult anaesthetised rats has revealed that 
stimulating the RTN/pFRG by local disinhibition or optogenetic excitation transforms 
normally silent RTN/pFRG neurons into rhythmically active neurons that exhibit an 
expiratory-modulated pattern of firing. This stimulation of RTN/pFRG rhythmic activity 
generates active expiration i.e. the generation of expiratory-related abdominal muscle 
activity (Pagliardini et al., 2011). These observations are consistent with the idea that the 
rhythm generating properties of the RTN/pFRG persist into adulthood, but under resting 
conditions synaptic inhibition silence these neurons. Taken together, these studies suggest 
that the RTN/pFRG acts as a conditional expiratory oscillator that generates active 
expiration.    
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1.6.4 RTN/pFRG and chemosensitivity 
 
In both neonatal and adult rodents, the RTN/pFRG has been implicated in central 
chemoreception because 1. RTN/pFRG neurons are located in the parafacial region of the 
ventrolateral medulla close to the medullary surface which has previously been identified 
as a site involved in the central respiratory chemoreflex (Loeschcke, 1982) 2. RTN/pFRG 
neurons are sensitive to increases in CO2  and acidification (Mulkey et al., 2004; Guyenet 
et al., 2005; Stornetta et al., 2006; Onimaru et al., 2008) and 3. mutant mice that exhibit a 
substantial depletion of Phox2b-expressing RTN/pFRG neurons display a reduced 
respiratory responsiveness to CO2 at birth (Dubreuil et al., 2008). The proposed 
chemosensitive role of the RTN/pFRG will be discussed in further detail in the section 
below (1.7.1.1).   
 
1.7 Chemosensitivity 
 
It is firmly believed that stimulation of breathing by decreases in the partial pressure of O2 
and increases in partial pressure of CO2 in the blood is fundamental to rhythmic breathing 
(Loeschcke, 1982). Failure of these processes can be fatal; therefore a sound understanding 
and identification of the central and peripheral sites involved in the detection of altered 
blood gases is highly desirable in respiratory research.  
 
1.7.1 Central chemosensitivity 
 
The central chemoreflex is the augmentation of ventilation evoked by an increase in the 
partial pressure of CO2 and therefore a reduction in blood pH which is detected within the 
central nervous system (CNS) (Feldman et al., 2003). Changes in the partial pressure of 
CO2 evokes a greater stimulatory effect on breathing compared to equivalent changes in 
the partial pressure of O2 (Haldane and Priestley, 1905). Failure of central chemoresponses 
have been implicated in a number of human genetic conditions including congenital central 
hypoventilation syndrome (CCHS), whereby patients have an attenuated response to 
hypercapnia (elevation of blood CO2 level) and in severe cases respiratory arrest (Spengler 
et al., 2001; Chen and Keens, 2004). 
 
For neurons to be considered chemosensitive they must possess an intrinsic sensitivity to 
changes in the partial pressure of arterial CO2 that is within physiological range and when 
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stimulated must evoke an appropriate alteration in ventilation (Putnam et al., 2004). It is 
generally believed that chemosensitive neurons detect pH changes in the blood as a result 
of increased CO2.    
 
1.7.1.1 RTN/pFRG 
 
There is substantial evidence to suggest the RTN/pFRG plays a significant role in central 
chemosensitivity in the rodent. RTN/pFRG neurons are intrinsically sensitive to increases 
in CO2  and acidification in vitro in neonatal rodents (Mulkey et al., 2004; Onimaru et al., 
2008). Furthermore, in the adult rat, RTN/pFRG neurons increase their firing rate in 
response to decreases in pH in medullary brain slices (Guyenet et al., 2005). CO2 sensitive 
RTN/pFRG neurons are found to project directly to the preBötC in adult rats, which further 
supports their role as central chemoreceptors (Mulkey et al., 2004). In adult rats with 
denervated peripheral chemoreceptors, CO2 sensitivity of RTN/pFRG neurons in response 
to hypercapnia is comparable to rats with intact peripheral chemoreceptors (Mulkey et al., 
2004). This suggests that chemoresponses of the RTN/pFRG in vivo are not fully reliant on 
input from the peripheral chemoreceptors and therefore RTN/pFRG neurons may exhibit 
intrinsic chemosensitive properties. Studies utilising the Phox2b
27Ala/+
 mouse model of 
CCHS suggest that the RTN/pFRG plays a vital role in central chemoreception at birth. 
The only anatomical deformation exhibited by these transgenic mice is a substantial loss of 
Phox2b-expressing RTN/pFRG neurons. Phox2b
27Ala/+
 mice completely lack a ventilatory 
response to hypercapnia and die soon after birth (Dubreuil et al., 2008), highlighting the 
importance of the RTN/pFRG neurons in CO2 sensitivity. An alternative explanation for 
these respiratory defects is the RTN/pFRG functions to relay chemosensitive information 
from all central chemoreceptors as opposed to being a chemosensory site per se (Guyenet 
et al., 2009). A study that examined the effects of a RTN/pFRG lesion has provided further 
support that the RTN/pFRG mediates central chemosensitivity in vivo. Destruction of 
approximately 70% of Phox2b expressing RTN/pFRG neurons using the aforementioned 
SP-SAP neurotoxin technique, decreases the ventilatory response to hypercapnia in adult 
rats (Takakura et al., 2008). Furthermore, photostimulation of Phox2b expressing 
RTN/pFRG neurons in adult rats in vivo induces a stimulation of breathing, seen as a long-
lasting increase in phrenic nerve activity (Abbott et al., 2009). The ability to evoke a 
ventilatory increase when activated is a key characteristic expected of a central 
chemoreceptor in vivo. Evidence supports the view that the RTN/pFRG may function as 
the principal central chemoreceptor in the adult and neonatal rodent.   
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1.7.1.2 Serotonergic Neurons  
 
Serotonergic neurons have also been proposed to act as central chemoreceptors. These 
neurons show intrinsic sensitivity to pH/CO2 changes in cell cultures and brainstem slices 
in vitro (Wang et al., 2001b; Severson et al., 2003) and are found in close proximity to 
medullary arteries (Bradley et al., 2002). The medullary raphe serotonergic neurons are 
believed to play a specialised role in the CO2 chemoreflex. Patch clamp recordings of 
raphe neurons in rat medullary slice preparations have revealed that these neurons increase 
their firing rate in response to increasing levels of CO2 in the bathing solution (Richerson, 
1995). Focal acidification of medullary raphe neurons in the anaesthetised rat results in an 
increase in ventilation as indicated by augmented amplitude of phrenic nerve discharge 
(Bernard et al., 1996).  Furthermore, lesioning of the medullary raphe results in a reduced 
ventilatory response to hypercapnia in vivo in awake goats (Hodges et al., 2004). Studies 
utilising transgenic mice that lack or have a substantial reduction of serotonergic neurons 
have provided further evidence that reinforces the concept that serotonergic neurons play a 
major role in the CO2 chemoreflex in vivo. These mutant mice exhibit normal baseline 
ventilation but an attenuated respiratory response to hypercapnia (Hodges et al., 2008; 
Hodges et al., 2011).  
 
1.7.1.3 Locus coeruleus 
 
The locus coeruleus (LC) lies in the dorsal pons (Dahlstrom and Fuxe, 1964) and consists 
of a cluster of noradranergic neurons that have been implicated in central chemosensitivity. 
In vitro, LC neurons exhibit chemosensory responses (Filosa et al., 2002; Putnam et al., 
2004). Furthermore, focal acidification of the LC noradrenergic induces a significant 
increase in phrenic nerve activity in cats in vivo (Coates et al., 1993). Chemical lesioning 
studies have demonstrated that bilateral destruction of approximately 80% of noradrenergic 
neurons of the LC results in a 64% decrease in the ventilatory stimulation to hypercapnia 
(Biancardi et al., 2008). This data suggests that the LC contributes significantly to the CO2-
induced drive to breathe. However it should be highlighted that chemical lesioning studies 
can also cause destruction to other neurons other than noradrenergic neurons of the LC, 
which could also influence the ventilatory effects.    
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1.7.2 Peripheral chemosensitivity 
 
An increase in ventilation in response to a decrease in the partial pressure of O2 in the 
blood is mediated by peripheral chemoreceptors. There is substantial evident which 
supports that the principal peripheral chemoreceptors are localised within the carotid 
bodies. Injection of sodium cyanide into the carotid artery and subsequent stimulation of 
the carotid bodies results in an augmentation of respiratory activity (Sapru and Krieger, 
1977) and exposure to hypoxia in the anaesthetised cat has been shown to increase 
discharge from the carotid bodies (Lahiri et al., 1981). Furthermore, removal of the carotid 
body in the adult rat reduces ventilatory stimulation in response to hypoxia (Chiocchio et 
al., 1984). Adenosine triphosphate (ATP) has been implicated in peripheral 
chemoreception. In vitro studies utilising the carotid body-sinus nerve preparation have 
found that application of ATP evokes a substantial increase in sinus nerve chemoafferent 
discharge. Additionally, in P2X2 receptor (ATP receptor) knockout mice, a blunted 
ventilatory response to hypoxia is observed. Furthermore, hypoxia-induced increases in the 
discharge of single chemoafferent fibres of the carotid sinus were attenuated in the 
knockout mice (Rong et al., 2003). From these studies it has been proposed that O2 
sensitive cells of the carotid body release ATP which activates the carotid sinus nerve via 
P2X receptors which in return relays these signals to the central respiratory centres to 
allow for appropriate respiratory responses.   
  
Several studies have also suggested that peripheral and central chemoreception is 
integrated. In rats it has been shown that the RTN/pFRG receives inputs from peripheral 
chemoreceptors (Takakura et al., 2006). Further studies in awake dogs have demonstrated 
that inhibition of the carotid body chemoreflex also depresses the central ventilatory 
response to hypercapnia, whereas stimulation of the carotid bodies causes an increase in 
the ventilatory response to central hypercapnia (Blain et al., 2010). 
 
1.8 Developmental plasticity and respiratory activity in early life 
 
Although the respiratory system is ready to function at birth, it is immature and requires a 
period of postnatal maturation. During early postnatal life in both humans and rodents, 
breathing patterns are immature and are characterised by a variable and irregular frequency 
(Fisher et al., 1982; Mortola, 1984; Read and Henderson-Smart, 1984). Whilst the 
hypercapnic ventilatory response appears to be mature at birth in the rodent (Renolleau et 
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al., 2001), the ventilatory response to hypoxia undergoes postnatal maturational changes 
(Robinson et al., 2000; Liu et al., 2006). In both neonatal and mature rodents, the 
ventilatory response to hypoxia is biphasic, with an initial ventilatory stimulation followed 
by a secondary decline. In adult mice, the secondary decline in ventilation following 
hypoxic stimuli tends to fall more slowly and still remains above baseline levels. However 
in neonatal mice, the ventilatory decline is greater in magnitude and can fall below 
baseline levels (Robinson et al., 2000). The immaturity and fragility of baseline respiratory 
patterns during early life means perturbations to the respiratory system during this time 
period could be detrimental. It is clear that mammals exhibit developmental plasticity, 
whereby long-term changes in the mature adult respiratory system are induced by 
experiences that occur during critical developmental time windows in development. 
Conversely, the same experiences after these critical developmental periods evoke little or 
no lasting changes (Carroll, 2003; Bavis and Mitchell, 2008). Several studies have 
demonstrated that exposure to various external stimuli in the neonatal period including 
hypoxia, hypercapnia, caffeine and stressful events can induce lasting changes in 
ventilatory control (Okubo and Mortola, 1998, Bavis and Kilgore, 2001; Bavis et al., 2004; 
Montandon et al., 2006; Gulemetova and Kinkead, 2011). These data are consistent with 
the idea that disrupting the respiratory system during development when respiratory 
activity is irregular can induce substantial lasting changes to respiratory activity.   
 
The mechanisms that underlie respiratory rhythm generation during early life are not fully 
understood. As previously discussed, both the preBötC and the RTN/pFRG are required for 
postnatal survival, given that an anatomical deformation or deletion of either of these 
neuronal groups results in respiratory failure at birth in the rodent (Jacquin et al., 1996; 
Blanchi et al., 2003; Dubreuil et al., 2008; Pagliardini et al., 2008; Rose et al., 2009; 
Bouvier et al., 2010; Gray et al., 2010). At present, how the RTN/pFRG and the preBötC 
interact in vivo to produce rhythmic breathing during early postnatal life remains to be 
ascertained. Furthermore, their level of involvement in rhythm generation throughout 
postnatal maturation remains elusive (see Figure 1-6). Determining the mechanisms 
underlying respiratory rhythm generation during postnatal development will be vital in 
developing a full understanding of the pathophysiology of many central respiratory 
disorders that manifest in early life e.g. SIDS.  
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Figure 1-6. Schematic illustration of the two proposed respiratory rhythm 
generators in early postnatal life. The preBötC is anatomically identified by 
expression of NK1R, µ-OR, SST, reelin and VGLUT2. The RTN/pFRG differs in 
that it expresses Phox2b and doesn’t express the µ-OR, SST or reelin. Both 
oscillators have different developmental origins. The development of the preBötC 
relies on the transcription factors MafB and Dbx1, whereas transcription factors 
Krox-20, Lbx1, Atoh1 and Phox2b are essential for the genetic development of the 
RTN/pFRG. Only the preBötC is sensitive to opioids. It is currently unknown how 
the RTN/pFRG interacts with the preBötC in vivo to produce rhythmic breathing 
during early postnatal development.    
 
 
 
 
preBӧtC  RTN/pFRG 
? 
NK1R 
µ-OR 
SST 
Reelin 
VGLUT2 
MafB 
Dbx1 
NK1R 
Phox2b 
VGLUT2 
Krox-20 
Lbx1 
Atoh1 
Phox2b 
µ opioid agonists 
Respiratory rhythm 
53 
 
1.9 Opioids and respiratory depression 
 
In clinical practice, µ opioid receptor agonists such as fentanyl are extensively utilised in 
pain management, treating both chronic and acute pain (Swarm et al., 2001; Niesters et al., 
2013). In addition, they are commonly administered to induce sedation and can be used as 
adjuncts to general anaesthesia (Anand et al., 1990; Booker, 1999; Tobias, 1999). The most 
severe and often fatal side effect of opioid treatment is respiratory depression which limits 
the therapeutic use of these drugs (Pattinson, 2008). Opioids depress respiratory frequency, 
alter tidal volume, induce rigidity of the chest wall and reduce patency of the upper 
airways in humans (Leino et al., 1999; Lotsch et al., 2005; Ferguson and Drummond, 
2006). Given the extensive use of opioid therapies in a wide range of patient groups, 
respiratory depression is a major clinical problem. Furthermore, there are subpopulations 
of patients who exhibit a hypersensitivity to the respiratory depressive effects of opioids 
including the elderly, obese and patients with pulmonary disease, which further 
complicates opioid therapeutic application (Desrosiers, 2006). A comprehensive 
understanding of opioid-induced respiratory depression is required in order to develop 
suitable therapeutics to overcome this depression thereby enabling more effective and safer 
treatment for patients. Opioid drugs are often administered for prolonged periods and long-
term treatment plans are commonly utilised to provide effective pain relief (Brill, 2013). 
This repeated exposure to opioids is associated with the development of tolerance to the 
analgesic effects of the drug (Bailey and Connor, 2005), that is a reduced sensitivity to the 
analgesic actions. Surprisingly, despite the potent respiratory depressive side effects, the 
potential long-term respiratory consequences of repeated opioid exposure remain largely 
unexplored.   
 
µ opioid agonists mediate their effects via the µ opioid receptor. This class of receptor is a 
member of the family of G-protein coupled receptors (GPCRs), which are made up of 
seven transmembrane subunits (Figure 1-7). Agonist binding evokes a conformational 
change in the receptor. The G–protein which is bound to the receptor becomes active and 
evokes an intracellular signalling cascade. Activation of the µ opioid receptor which is 
negatively coupled to adenylate cyclase (Law et al., 2000) initiates inhibitory intracellular 
pathways. This results in closing of voltage sensitive calcium channels, stimulation of 
potassium efflux, and reduction of cyclic adenosine monophosphate production. As a 
consequence of these intracellular changes, a reduction of neuronal excitability occurs. The 
µ opioid receptor is expressed throughout the brain in both respiratory-related and non-
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respiratory brain regions (Xia and Haddad, 1991; Lonergan et al., 2003; Kivell et al., 
2004), which indicates that µ opioid agonists can exert widespread effects throughout the 
body. Studies conducted in knockout mice that lack the µ opioid receptor have confirmed 
that opioids mediate their effects via this receptor. Knockout mice are insensitive to both 
morphine induced analgesia (Matthes et al., 1996) and respiratory depression (Romberg et 
al., 2003).  
 
 
 
 
Figure 1-7. Schematic illustration of the structure of the µ opioid receptor. µ 
opioid receptors are memebers of the G-protein coupled receptor family, and 
consist of seven transmembrane subunits. Modified from Davis and Pasternak 
(2009).  
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1.9.1 The preBötC and opioid-induced respiratory depression 
 
In vivo, respiratory rhythm generation is more susceptible to depression by opioids when 
compared to tidal volume (Lalley, 2003). Elucidating the brain sites that are responsible for 
the depression of respiratory activity by opioids has important clinical benefits which could 
help to aid the development of new pharmacological approaches to manage pain whilst 
avoiding respiratory depression. As previously mentioned in this chapter, the preBötC is 
sensitive to µ opioids in vitro (Gray et al., 1999; Takeda et al., 2001; Mellen et al., 2003; 
Montandon et al., 2011). When DAMGO is directly applied to the preBötC in vitro, 
respiratory-like motor output is depressed (Gray et al., 1999; Takeda et al., 2001; Mellen et 
al., 2003; Montandon et al., 2011). This opioid sensitivity is attributable to the fact that 
preBötC neurons express the µ opioid receptor (see Figure 1-3) (Gray et al., 1999; Manzke 
et al., 2003). An in vivo study conducted in the adult rat has identified the preBötC as being 
the critical brain site that mediates opioid-induced respiratory frequency depression in vivo. 
Injection of µ opioid receptor agonists, including DAMGO and fentanyl, directly into the 
preBötC via a microdialysis probe induces a sustained slowing of respiratory frequency. 
Continuous infusion of DAMGO into the preBötC at sufficient concentrations can also 
cause a complete respiratory arrest. Furthermore, the magnitude of respiratory depression 
induced by opioids bilaterally applied to the preBötC is greatest under depressed 
behavioural states when there is a reduction in cortical activation such sleep and 
anaesthesia, indicating the effects of opioids at the preBötC are state-dependent. 
Importantly, it has also been demonstrated that systemically administered fentanyl in the 
adult rat in vivo evokes a depression of respiratory frequency by acting exclusively on 
preBötC neurons. Bilateral application of naloxone directly into the preBötC alone 
completely prevents respiratory frequency depression by intravenously administered 
fentanyl (Figure 1-8). This suggests that µ opioid receptor agonists act solely on preBötC 
neurons to evoke respiratory frequency depression in vivo (Montandon et al., 2011). Given 
that fentanyl can induce a significant suppression of respiratory rhythm generation through 
actions at the preBötC alone, this further supports the theory that the preBötC is an 
essential respiratory rhythm generating site in the adult rodent. This study has also 
confirmed that µ opioid receptor agonists such as fentanyl can be utilised to selectively 
target and perturb the rhythmic activity of the preBötC in vivo. NK1R-expressing cells of 
the preBötC can be visualised in the rhythmically active medullary slice preparation by 
applying SP conjugated to a fluorophore, whereby the fluorescent conjugate is internalised 
into the NK1R-expressing cells. Targeted whole-cell recordings from NK1R-expressing 
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rhythmogenic preBötC neurons have revealed that DAMGO induces a slowing of 
inspiratory activity through postsynaptic membrane hyperpolarisation (Figure 1-9) 
(Montandon et al., 2011). 
 
Ampakines can alleviate opioid-induced respiratory depression in vitro and in vivo. 
Ampakines are a class of molecules that modulate amino-3-hydroxy-5-methyl-4-
isoxazolepropionate (AMPA) receptors by increasing the peak and duration of glutamate-
induced AMPA receptor-gated inward currents (Arai et al., 2004). Ampakines applied to 
medullary slice and brainstem-spinal cord preparations counteract the depression of 
respiratory-like rhythmic activity induced by DAMGO. Furthermore, ampakines can 
reverse fentanyl-induced respiratory depression in awake adult and neonatal rats (Ren et 
al., 2006; Greer and Ren, 2009). Glutamatergic neurotransmission is essential to preBötC 
rhythmogenesis (Greer et al., 1991; Smith et al., 1991; Funk et al., 1993). It has been 
hypothesised that ampakines increase glutamate-mediated neurotransmission within the 
preBötC, thereby increasing preBötC neuronal excitability which can overcome the 
depression induced by opioids. It is also possible that ampakines alleviate opioid-induced 
respiratory depression by affecting other neuronal populations that rely on AMPA-
mediated neurotransmission and have modulatory actions on the preBötC, including the 
NTS, RTN/pFRG and pontine respiratory nuclei. These findings from studies utilising 
ampakines also reinforce the idea that the preBötC is the key site at which opioids act to 
depress respiratory activity.  
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Figure 1-8. Systemically administered fentanyl mediates respiratory 
frequency depression by directly targeting the preBötC. Top: Schematic 
illustration of the position of the microdialysis probes in the preBötC allowing 
bilateral application of naloxone in vivo. A: Artificial cerebrospinal fluid (aCSF) 
injected directly into the preBötC does not prevent depression of respiratory rate or 
frequency of diaphragm contractions induced by intravenously administered 
fentanyl. B: Naloxone injected directly into the preBötC fully prevents fentanyl-
induced respiratory frequency depression. C+D are traces corresponding to A+B 
respectively shown in a shorter time scale. Dia: Diaphragm muscle activity 
recording. Reproduced from Montandon et al. (2011). 
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Figure 1-9. µ opioid receptor agonists supress the activity of NK1R-
expressing inspiratory preBötC neurons in vitro. Top: Recording of the 
hypoglossal (XII) nerve rootlet. Bottom: whole-cell intracellular recording of NK1R-
expressing preBötC neurons in the medullary slice preparation. Application of 
DAMGO to the bathing medium decreases the frequency of XII bursting and 
hyperpolarises NK1R-expressing preBötC neurons. Inspiratory depolarisation was 
prevented in the NK1R-expressig preBötC neurons, thereby precluding the 
generation of action potentials. Reproduced from Montandon et al. (2011). 
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1.10 Thesis aims 
 
The studies presented in this thesis were aimed at investigating central respiratory control 
in the mouse. Given the fragility of breathing in early postnatal life, it was of particular 
interest to determine the influence of postnatal maturation on the neural control of 
breathing. As extensively described in this chapter, µ opioid receptor agonists can be 
utilised as pharmacological tools to target the preBötC. Furthermore, µ opioid receptor 
agonists are used widely in clinical practice and are known to induce profound respiratory 
depressive effects. A large portion of the experimental work detailed in this thesis was 
aimed at investigating the effects of the µ opioid receptor agonist, fentanyl, on the 
immature respiratory system of the mouse to not only gain a better understand of central 
respiratory control during early life but to also gain insight into the potential clinical 
consequences of repeated opioid exposure during early life. 
 
Study 1  
 
The aim of study 1 was to investigate changes in breathing patterns through early postnatal 
life and through to early adulthood in order to assess respiratory maturation. It was of 
specific interest to determine the critical developmental time period by which maturation 
of respiratory activity occurs.   
 
Study 2 and 3  
 
Studies 2 and 3 were designed to determine the susceptibility of postnatal breathing 
patterns to fentanyl in order to better understand the influence of postnatal maturation on 
the central control of breathing. Fentanyl was utilised to pharmacologically manipulate and 
depress the preBötC in vivo throughout early postnatal development. The acute effect of 
fentanyl on respiratory activity was monitored to investigate the level of involvement of 
the preBötC in respiratory rhythm generation throughout early postnatal life.  
 
Study 4  
 
The aim of study 4 was to establish if repeated fentanyl exposure during neonatal life (P1-
P5) induces long-term alterations in respiratory activity and if it influences the acute 
respiratory response to subsequent fentanyl exposure in mice in vivo. 
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Study 5  
 
The aim of study 5 was to determine if repeated fentanyl exposure during juvenile life (P9-
P13) induces long-term alterations in respiratory activity and if it influences the acute 
respiratory response to subsequent fentanyl exposure in mice in vivo. 
 
Study 6  
 
The aim of study 6 was to ascertain if repeated exposure to fentanyl during neonatal life in 
the mouse induces long-lasting changes in NK1R and µ opioid receptor expression within 
a region of the VRC (including the preBötC), using immunohistochemistry. 
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Chapter 2. 
Methods 
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2.1 Animals 
 
All animal experimental procedures were carried out under licence from the UK Home 
Office (Personal Licence number 60/11740, working under project Licence number 
60/3924) and performed in accordance with the Animals (Scientific Procedures) Act, 1986. 
All experimental protocols were carried out using ICR mice. Male and female breeder 
mice were obtained from Harlan Laboratories UK. In house breeding of ICR mice was 
carried out at the Wellcome Surgical Institute animal research facility. Mouse pups were 
housed with their mother until weaning age (approximately 21 days old), after which male 
and female mice were housed separately in groups of no more than six. All mice were 
maintained on a 12 hour light/dark cycle with food and water available ad libitum. In this 
thesis mice are considered neonates from P0-P7 and juveniles from P8-P21. Mice over the 
age of P21 are classed as adults. The day of birth is referred to as P0. 
 
2.2 Fentanyl injections 
 
In all studies described in this thesis, fentanyl, a µ opioid receptor agonist was utilised. All 
neonatal, juvenile and adult mice were administered fentanyl citrate (Janssen-Cilag, UK) 
via an intraperitoneal (i.p.) injection. Fentanyl was decanted directly from the purchased 
vial (vial concentration: 50 µg/ml), and administered with no preparation required. 
Neonatal and juvenile mice were administered volumes in the range of 1-15 µl and adult 
mice were administered volumes in the range of 25-75 µl. Protocols for individual studies 
will be further discussed in chapters 3-5. 
 
2.3 Whole body plethysmography 
 
Whole body plethysmography is a non-invasive technique that can indirectly record 
respiration based on pressure deflections caused by a subject breathing within a closed 
chamber of fixed volume (Chapin, 1954). Whole body plethysmography is highly 
advantageous for in vivo respiratory research as it enables easy measurement of ventilation 
in unrestrained and freely behaving rodents. This technique is indispensable for recording 
breathing activity in very small neonatal animals where invasive respiratory measurements 
or restraint is impractical. In studies detailed in chapters 3 and 4, closed whole body 
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plethysmography was utilised to record and measure the respiratory behaviour of awake 
and freely behaving neonatal, juvenile and adult mice.  
 
2.3.1 Neonatal and juvenile plethysmography 
 
The neonatal/juvenile plethysmography set up (apparatus illustrated in Figure 2-1) was 
utilised for mice up to postnatal day 15. It consisted of a 45 ml recording chamber which 
housed the animal, and an adjoining reference chamber of equal volume (Buxco Research 
Systems, USA). This small chamber volume maximised the signal to noise ratio, enabling 
small neonatal breathing signals to be easily obtained. The recording chamber was fitted 
with an electrical heated plate designed to maintain the body temperature of the mouse 
within physiological range (32-34°C when recorded orally). An additional source of heat 
was supplied by a heat lamp to maintain the chamber temperature at the approximate nest 
temperature of between 30-32°C. To allow for continuous recording of the chamber 
temperature, a temperature probe (RET-3, Physitemp Instruments Inc, USA) was securely 
fitted within a small opening at the top of the chamber. Between respiratory recording 
sessions, a bias flow regulator (Buxco Research Systems, USA) was connected to and 
continually supplied the recording chamber with room air (rate of 0.5 l/min) enabling the 
chamber to be replenished with oxygen to prevent the accumulation of carbon dioxide.      
During each recording session, the recording chamber was hermetically sealed to 
atmospheric air. At the end of every recording session, which lasted approximately 2 
minutes, a calibration volume of 10 µl was injected into the recording chamber. Breathing-
induced pressure changes within the closed recording chamber, relative to the reference 
chamber, were recorded by a differential pressure transducer (model DP103-4, Validyne 
Engineering, Northridge, CA). The analogue signal was passed to an analogue-to-digital 
converter (CED, Cambridge Instruments, UK) with a sampling frequency of 100 Hz. The 
resultant respiratory trace was stored on a PC and analysed offline using Spike 2 software 
(Cambridge Instruments, UK). 
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Figure 2-1. Whole body plethysmography apparatus used for neonatal and 
juvenile mice. The mouse was housed in the recording chamber, and breathing-
induced pressure fluctuations relative to the reference chamber were measured by 
the differential pressure transducer. Between respiratory recordings, the recording 
chamber was continually flushed with room air (0.5 l/min) using a bias flow 
regulator. The calibration syringe was removed to allow circulating air to exit the 
chamber. The chamber temperature was monitored throughout experiments using 
a temperature monitor.  
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2.3.2 Adult plethysmography  
 
The adult plethysmography set up (apparatus illustrated in Figure 2-2) was used for mice 
over 15 days old. The apparatus consisted of a 700ml recording chamber (built in house) 
that housed the animal and a reference chamber of equal volume. A temperature probe 
(RET-3, Physitemp Instruments Inc, USA) was securely fitted through a port in the 
recording chamber to allow continual recording of chamber temperature, which was 
maintained at 25-26
o
C. To control for thermal related drifts in the pressure signal, two 
controlled leaks were integrated into the system by means of 26 gauge needles (Terumo, 
Exchange Supplies UK). Between recording sessions, the recording chamber was supplied 
with air or various hypercapnic and hypoxia gas mixtures delivered from gas tanks. Prior 
to entering the recording chamber the gas passed through a conical flask filled with water 
in order to humidify the air. The rate of flow was controlled by a flow meter and 
maintained at 2 l/min.  
 
During each recording session, the recording chamber was fully air tight. At the end of 
every recording session, which lasted approximately 2 minutes, a calibration volume of 
100 µl was injected into the recording chamber. Breathing-induced pressure changes 
within the closed recording chamber, relative to the reference chamber, were recorded by a 
differential pressure transducer (model DP103-4, Validyne Engineering, Northridge, CA). 
The analogue signal was passed to an analogue-to-digital converter (CED, Cambridge 
Instruments, UK) with a sampling frequency of 100 Hz. The resultant respiratory trace was 
stored on a PC and analysed offline using Spike 2 software (Cambridge Instruments, UK).  
 
The rectal temperature of the mice was recorded at the start and end of the experiment by 
means of a rectal temperature probe (IT-18 gauge isolated temperature probe, Linton 
Instrumentation, Norfolk UK). All adult mice were given a 2 hour habituation session in 
the recording chamber one day prior to the commencement of experiments.  
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Figure 2-2. Whole body plethysmography apparatus used for adult mice. The 
mouse was housed in the recording chamber and breathing-induced pressure 
fluctuations relative to the reference chamber were measured by the differential 
pressure transducer. Between respiratory recordings, the recording chamber was 
continually flushed with humidified air or hypercapnic and hypoxic mixtures 
through the in and out air ports at a rate controlled by the flow meter. The chamber 
temperature was monitored throughout experiments using a temperature monitor. 
Two controlled leaks were introduced to compensate for slow thermal pressure 
changes.  
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2.4 Neonatal/juvenile behavioural assessments 
 
The overall health status of the neonatal and juvenile mice was evaluated at regular 
intervals throughout plethysmography procedures, both before and after drug 
administration (see chapter 3, section 3.2.5 for further details). Mastication rate was 
measured by placing a small probe at the side of the mouth, and the number of mastication 
movements made in 10 seconds was counted. The righting reflex was evaluated by placing 
a mouse on its back and measuring the time taken to reach an upright position. In very 
young neonatal pups (P1-P3), the presence or absence of the milk sac was noted. In mice 
aged up to P11, body temperature was measured orally using a thin temperature probe (IT-
18 gauge isolated temperature probe, Linton Instrumentation, Norfolk UK) and maintained 
at 32-34°C.    
 
2.5 Analysis of plethysmograph respiratory traces 
 
To measure respiratory variables, the respiratory recordings were analysed on a breath by 
breath basis. Movement distorts the plethysmography pressure signal and prevents reliable 
respiratory measurements, thus only data from periods of quiet, resting breathing were 
analysed. Prior to analysing the respiratory trace any DC drift in the respiratory signal was 
digitally removed. For all data analysis, the entire 2 minute respiratory trace was analysed.  
 
2.5.1 Respiratory frequency, tidal volume and minute ventilation 
 
Respiratory frequency, tidal volume (Vt), and minute ventilation (Ve) were calculated for 
all plethysmography experiments. In adult mouse studies described in chapter 4, 
inspiratory duration, and expiratory duration were also calculated. The method of 
calculation of respiratory frequency is illustrated in Figure 2-3. The total breath time (Ttot) 
was measured from the respiratory trace and respiratory frequency was expressed in 
breaths per minute and calculated as 60/Ttot. Vt, which is defined as the volume of air 
inspired or expired during each respiratory cycle, was calculated as shown in Figure 2-4. 
The calculation of Vt from whole-body, closed plethysmography pressure oscillations is 
based on the principle that the animal is contained within an air-tight recording chamber of 
constant volume that has a lower temperature and relative humidity compared to the 
animal’s body. Thus, inspiratory and expiratory events will induce cyclic changes in 
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temperature and water vapour of the air. This in turn will cause the pressure inside the 
chamber to change by a magnitude proportional to the difference in volume from the 
chamber to airway conditions i.e. proportional to Vt (Drorbaugh and Fenn, 1955). By 
taking into account the temperature and humidity of the animal and chamber, as well as 
barometric pressure, it was therefore possible to derive tidal volume from plethysmography 
pressure changes by application of an equation proposed in 1955 by Drorbaugh and Fenn 
(equation detailed in Figure 2-4). An injection of a known calibration volume was also 
required to calculate Vt. Minute ventilation (Ve), which is defined as the total volume of 
air inspired or expired each minute, is a product of respiratory frequency and Vt, and is 
calculated by multiplying the two parameters (Ve = frequency x Vt). In the neonatal and 
juvenile mouse studies detailed in chapter 3, Vt is presented as a relative change from 
baseline following fentanyl administration rather than absolute values (further discussed in 
chapter 3 section 3.4.3).  
 
2.5.2 Neonatal and juvenile breathing patterns 
 
The prevalence of various breathing patterns was analysed throughout postnatal 
development in the neonatal and juvenile plethysmography studies described in chapter 3. 
The entire 2 minute respiratory trace was visually examined and the frequency of apnoeas, 
hyperpnoeas and hiccups during resting baseline breathing was calculated and expressed as 
number of breaths per 2 minutes. In this thesis an apnoea is defined as the cessation of 
breathing for more than two missed breaths following expiration (Jacquin et al., 1996; 
Renolleau et al., 2001). This was calculated as being at least 2 seconds in length. All 
apnoeas including post-hyperpnoeic apnoeas were analysed. Hyperpnoeas are defined as 
hyperventilatory periods of high amplitude breathing characterised by forced inspiratory 
and expiratory efforts that are often accompanied by a post-hyperpnoea apnoea. 
Hyperpnoeic episodes were calculated to last at least 2 seconds. Hiccups are defined as 
very short, high amplitude breaths. A hiccup breath typically lasts approximately 0.12 s 
and displays a very sharp inspiration and forced expiration. An example of each of these 
respiratory events is illustrated in Figure 2-5.  
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Figure 2-3. Calculation of respiratory frequency from plethysmograph trace. 
Upwards pressure deflection of the trace represents inspiration and downwards 
deflection represents expiration. The duration of inspiration and expiration were 
calculated as well as the total breath time (Ttot) which was measured from the 
start of inspiration to the end of expiration. The respiratory frequency is expressed 
in breaths per minute and calculated as 60/Ttot.  
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Figure 2-4. Calculation of tidal volume from plethysmograph trace. Tidal 
volume was determined from each respiratory trace (A) using the equation (B) 
derived by Drorbaugh and Fenn (1955). This equation enables pressure changes 
to be converted to volume changes. Upward deflections in the respiratory trace 
indicate a rise in pressure. PT was calculated as the pressure deflection from the 
start of inspiration to the peak of the breath. PK was calculated as the sharp 
pressure deflection induced by injecting the calibration volume.  
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Tidal volume was determined on the basis of the above equation, defined as follows:
Vt = tidal volume.
PT = pressure change associated with each respiratory cycle.
PK = pressure change associated with injection of the calibration volume.
VK = calibration volume injected into the recording chamber.
TR = body temperature of the mouse
Tc = temperature of recording chamber
PB = barometric pressure
PR = pressure of water vapour at body temperature (50mmHg)
PC = pressure of water vapour in the recording chamber (50mmHg)
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Figure 2-5. Representative respiratory traces illustrating various neonatal 
breathing patterns. Apnoeas are classified as long expiratory pauses that last for 
at least 2 missed breaths (approx. ≥ 2 seconds). Hyperpnoeic episodes are 
defined as periods of hyperventilation with forced inspiratory and expiratory efforts, 
illustrated by the high amplitude upward and downward deflections respectively. 
Hiccups are defined as very short breaths displaying sharp, large amplitude 
inspiratory and expiratory efforts. 
 
 
 
 
 
0.5 a.u 
1s 
Apnoea 
Hyperpnoea 
Hiccups 
-0.249
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
-0.1
-0.2
-0.3
-0.4
-0.5
 V
o
lt
S
A
L
IN
E
38 39 40 41 42 43 44 45 46 47 48 49 50 51 52
s
72 
 
2.6 Anaesthetised preparations 
 
2.6.1 General surgical preparation 
 
Animals were first transferred from the animal housing unit to the designated mouse 
operating theatre. Animals were weighed prior to the induction of anaesthetic. Urethane 
was used to anaesthetise the mice (see chapter 4, section 4.5.3 for further details on 
anaesthetic properties). Urethane crystals (Sigma, UK) were dissolved in 0.9% saline 
solution to prepare an injection solution of 0.1g/ml. Animals were administered an initial 
intraperitoneal (i.p.) injection of 1.5 g/kg urethane. Once unconscious, 3 supplementary 
doses of 0.25 g/kg urethane were administered approximately ten minutes apart. This 
dosing regime allowed for a stable plane of surgical anaesthesia to be maintained from the 
start and throughout the course of the experiment (approximately 2 hours). To test if 
animals were adequately anaesthetised prior to commencement of surgery, the hind limb 
reflex was assessed, whereby a firm pinch of the footpad evokes a withdrawal of the foot. 
Absence of this reflex is indicative of a sufficient depth of anaesthesia. Once animals were 
adequately anaesthetised, the muscarinic antagonist, atropine sulphate (Animalcare Ltd, 
York, UK), was subcutaneously administered (0.05 mg/kg) to reduce excess tracheal and 
lung secretions that can be detrimental to breathing. Mice were placed in the supine 
position and fur from the neck and abdominal regions removed using an electric shaver 
(Wahl, UK). Body temperature was monitored with a rectal probe and maintained between 
36.5-37°C using a heat lamp. All anaesthetised experiments were terminal, and on 
conclusion of the experiment mice were euthanised by cervical dislocation.     
 
2.6.2 Respiratory airflow measurements 
 
To allow respiratory airflow to be measured, mice were transorally intubated. The ventral 
skin of the neck region was incised to expose the lobes of the thyroid gland which were 
separated by blunt dissection. The sternohyoid muscles were bluntly split and laterally 
retracted to expose the underlying larynx and trachea. This allowed for visualisation of the 
trachea when performing the tracheal intubation. The intubation cannula was made from an 
intravenous catheter (20 gauge; Vasofix, Braun, Germany) that was shortened to 30 mm in 
length and tapered distally to facilitate insertion into the trachea. The tongue of the mouse 
was pulled to one side using forceps and the tracheal cannula was inserted into the mouth 
and advanced into the trachea. A small animal pneumotachometer (AD Instruments, USA) 
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was securely connected to the top of the tracheal intubation cannula. Laminar airflow 
(corresponding to inspiratory and expiratory airflow) across a fine gauze mesh within the 
pneumotachometer produces a pressure difference which is linearly proportional to the 
velocity, thereby enabling changes in respiratory airflow to be continually monitored. 
These pressure differences were measured using a differential pressure transducer 
(Validyne DP103, USA). The analogue signal was passed to an analogue-to-digital 
converter (CED, Cambridge Instruments, UK) with a sampling frequency of 100 Hz and 
the resulting airflow signal was stored on a computer and analysed offline using Spike2 
software (Cambridge Instruments, UK). Throughout the experimental period mice 
spontaneously breathed room air without ventilatory aid. At the end of every experiment a 
calibration volume of 0.2 ml was injected across the pneumotachometer.     
  
2.6.3 Respiratory musculature EMG measurements 
 
Genioglossus EMG 
 
Electromyography (EMG) is the study of muscle function through the measurement of 
electrical activity produced during muscular contraction. EMG activity of the genioglossus 
(GG) muscle was recorded. The GG is the principal protruder muscle of the tongue which 
also plays a critical role in maintaining upper airway patency. In the rodent, the GG 
becomes active during inspiration and has therefore been referred to as an inspiratory 
muscle (Liu et al., 2003; Hajiha et al., 2009; Pagliardini et al., 2012); thus GG muscle 
activity can provide a measure of inspiratory function. The ventral surface of the GG was 
exposed via a submental incision using fine scissors, and blunt dissection of the overlying  
diagastric and mylohyoid muscles. Two fine monopolar needle electrodes (Linton 
Instrumentation, Norfolk, UK) with modified hooked tips were inserted into the GG 
muscle approximately 3-4 mm apart. The muscle was covered with oil throughout 
experiments to prevent desiccation. The electrical signals were amplified at 5000X gain 
and filtered between 100 and 5000 Hz using a differential amplifier (model EMG 100C; 
Bipoac system Inc, USA). The EMG activity was sampled at 1000 Hz via an analogue to 
digital interface (CED, Cambridge Instruments, UK), stored on a computer and analysed 
offline using Spike2 software (Cambridge Instruments, UK). 
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Abdominal muscle EMG 
 
Abdominal muscles (ABD) have been shown to exhibit a rhythmic expiratory-related 
mode of activity in adult rodents in vivo (Pagliardini et al., 2011; Pagliardini et al., 2012; 
Pagliardini et al., 2013). In an attempt to measure expiratory muscle activity, ABDEMG 
activity was measured in the anaesthetised preparation. A large incision was made in the 
abdominal region to expose the underlying musculature. Two monopolar needle electrodes 
(as described for GGEMG measurement) were inserted approximately 3-4 mm apart into the 
right external oblique abdominal muscle. Muscle desiccation was prevented by application 
of oil to the muscle surface. The electrodes were attached to the differential amplifier 
(model EMG 100C; Bipoac system Inc, USA) and the analogue signal was amplified at 
5000X gain and filtered between 1 and 5000 Hz. The signal was sampled at 1000 Hz by an 
analogue to digital converter (CED, Cambridge Instruments, UK) and analysed offline. 
 
A ground electrode made of multistrand, insulated stainless steel wire with the last 2 mm 
uninsulated (Cooner wire, Chatsworth, CA, USA) was sutured into the hind paw of the 
mouse. The uninsulated portion of the electrode was in contact with the bony region of the 
paw which is an electrically neutral area. The ground electrode was also connected to the 
differential amplifier. The purpose of the ground electrode was to provide a common 
reference to the differential input of the GG and ABD muscle EMG signals. The 
differential amplifier generated the raw GGEMG and ABDEMG muscle activity by 
subtracting the EMG signals from the ground electrode signal. 
 
2.6.4 Analysis of airflow and GGEMG activity 
 
To determine the respiratory parameters, respiratory recordings were analysed on a breath 
by breath basis. Respiratory frequency, Vt, Ve and GGEMG activity were analysed and 
quantified for all the anaesthetised preparations before and after fentanyl application. The 
number of augmented breaths, defined as a breath with a Vt 50% greater than the previous 
breath, was quantified during baseline breathing. ABDEMG activity was not quantified 
because on recording, the muscle bursting was not synchronised with the expiratory phase 
and appeared to be sporadic in nature. Consequently this tonic muscle activity was not 
analysed as it did not represent expiratory activity. Occasionally, expiratory-related 
abdominal activity did appear intermittently in a small number of mice, but this was not 
sufficient for quantification purposes (discussed further in chapter 4, section 4.3.5). The 
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respiratory frequency was determined from the respiratory airflow signal as shown in 
Figure 2-6. Vt for each inspiratory cycle was calculated by integrating the area under the 
inspiratory signal and the area under the calibration signal. To determine Vt the following 
calculation was applied: (calibration volume/area under calibration signal) x area under 
inspiratory signal. Ve was subsequently calculated (Ve = frequency x Vt). Vt and Ve 
values were always standardised to the weight of the mouse. A digital low pass filter was 
applied to the GGEMG signal to remove high frequency noise. The filtered signal was then 
rectified and smoothed with a time constant (τ) of 0.05s. The peak amplitude of the 
integrated signal was used as a measure of GGEMG activity.   
 
 
 
Figure 2-6. Calculation of respiratory frequency from airflow trace. The 
airflow signal above the dotted zero baseline represents inspiration and the signal 
below the line represents expiration. The duration of inspiration and expiration 
were measured. Ttot was measured as the time from start of inspiration to end of 
expiration. Respiratory frequency in breaths per minute was calculated by: 60/Ttot.   
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2.7 Perfusion fixation 
 
Animals repeatedly exposed to fentanyl or saline in neonatal life were transcardially 
perfused once they reached adulthood (6 weeks old), to allow for detailed histological 
analyses of brainstem respiratory areas. Mice were i.p administered an overdose of 
pentobarbital (0.1 ml) and on abolition of the hind limb withdrawal reflex the procedure 
commenced. The ventral skin was superficially cut to expose the thoracic and peritoneal 
membranes. An incision was made in the peritoneal membrane below the sternum to 
expose the diaphragm. In order to open up the chest cavity and expose the underlying 
viscera, the diaphragm was incised and the lateral aspects of the rib cage were cut. The rib 
cage was then reflected towards the head of the mouse and secured in place, allowing full 
access to the beating heart. A butterfly needle (Butterfly-23 INT, Venisystems) connected 
to the perfusion apparatus was inserted into the apex of the heart until it entered the left 
ventricle. The right atrium was cut and heparanised saline (10 ml heparin/1 litre 0.9% 
saline solution) was pumped through the circulation at a constant pressure of 80 mmHg for 
approximately 30 seconds or until the perfusate ran clear and the liver turned pale, 
indicating the blood had been sufficiently cleared from the body. The animal was then 
immediately perfused with 250 ml of 4% paraformaldehyde at the same pressure. 
Twitching of the limbs and rigidity of the mouse tissue indicated a successful perfusion.  
On completion of perfusion fixation, the brain and rostral portion of the spinal cord were 
carefully excised from the skull and vertebrae. Tissue was post-fixed in 4% 
paraformaldehyde for 4 hours and then transferred to a 30% sucrose solution. Sucrose 
functions as a cryoprotectant to remove excess water from the tissue, preventing ice 
crystals forming when brain tissue is frozen. Brains were stored in sucrose for up to one 
week or stored long-term in liquid nitrogen prior to tissue processing.     
 
2.8 Cryostat sectioning 
 
Prior to sectioning, the forebrain and excess spinal cord were removed. The brain was then 
mounted on a chuck using cryomatrix compound (Thermo Scientific, Cheshire, UK) and 
frozen with dry ice. Forty micrometer coronal, medullary sections were cut at -21°C using 
a cryostat. Sections were collected sequentially into 48 well plates containing 0.3M 
phosphate buffered saline (PBS).    
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2.9 Fluorescent immunohistochemistry 
 
2.9.1 Staining protocol 
 
In chapter 5, immunohistochemical fluorescent staining was performed to detect and 
quantify the expression of various anatomical markers of the principal respiratory nuclei 
located in the ventral respiratory column (VRC). This was carried out on adult brainstems 
from control mice repeatedly exposed to saline and mice repeatedly exposed to fentanyl in 
early life. Prior to the immunohistochemistry procedures, the brainstem sections were split 
into 4 groups (see Figure 2-7 for illustration). This enabled the staining of different 
neuronal markers to be carried out within each group.  
 
All immunohistochemistry protocols were carried out on free floating brainstem sections. 
For details of all solution preparation, see Appendix I. The sections were bathed in 50% 
ethanol for 30 mins to aid with tissue penetration of antibodies. The sections then 
underwent three 10 min washes in 0.3M PBS followed by a 15 min incubation in 3% 
hydrogen peroxide (H2O2) diluted in 0.3M PBS. The purpose of the H2O2 step was to 
quench endogenous peroxidase activity, which can be a source of background staining if 
amplification techniques are being utilised. Three 10 min washes in 0.3M PBS followed. 
Sections were then incubated in primary antibodies diluted in a solution of 1% normal 
donkey serum (NDS; blocks non-specific binding sites) and 0.3M PBS with 0.3% Triton 
X-100 (PBST) for 24 hours at 4°C. After a further 3 x 10 min washes in PBST, sections 
were exposed to species-specific fluorescent or biotinylated secondary antibodies also 
made up in 1% NDS and PBST. Secondary antibody incubation lasted 12 hours at room 
temperature. When no amplification of the fluorescent signal was required, a final 3 x 10 
min washes in 0.3M PBS took place before sections were mounted in sequential 
rostrocaudal order on uncoated slides using Vectashield hard set anti-fade mounting 
medium (Vector Laboratories). When a fluorescent signal required amplification, this was 
achieved by the tyramide signal amplification (TSA) protocol described in Figure 2-8. 
Three 10min washes in PBST followed secondary antibody incubation. Sections were then 
incubated for 4 hours at room temperature in Streptavidin horseradish peroxidase complex 
(PerkinElmer Inc, UK) diluted in PBST, followed by 3 x 10 min washes in PBST. Sections 
were then incubated with fluorophore-conjugated tyramide (PerkinElmer Inc, UK) made 
up in amplification diluent (containing H2O2) for 7 mins at room temperature. Following a 
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final three 10 min washes in 0.3M PBS, sections were mounted on slides as described 
above. All sections were stored at -20°C.  
 
 
              
 
 
Figure 2-7. Schematic diagram illustrating how brainstem sections were split 
into 4 groups. Different combinations of primary and secondary antibodies were 
added to each group.   
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Figure 2-8. Schematic diagram illustrating the principle of tyramide signal 
amplification (TSA) in immunohistochemistry. TSA is an enzyme-mediated 
detection method that can amplify fluorescent labelling of a target protein by 
utilising the catalytic activity of horseradish peroxidase (HRP) enzyme. The target 
antigen is detected by the primary antibody which is subsequently bound by a 
biotinylated secondary antibody. Streptavidin conjugated to HRP binds to the 
biotin molecules on the secondary antibody. In the presence of H2O2, the 
immobilised HRP catalyses the conversion of fluorophore- labelled tyramide, a 
phenolic compound, into a highly reactive, short-lived intermediate that covalently 
binds to electron-rich regions of adjacent proteins. Multiple deposition of the 
labelled tyramide occurs very quickly, thereby amplifying the signal of the target 
protein.  
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Chapter 3. 
Postnatal Maturation of Central Respiratory Control 
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3.1 Introduction    
 
The neural circuitry underlying respiratory rhythmogenesis must be fully functional at 
birth to allow postnatal survival in mammals. However, in spite of its fundamental role for 
survival, the respiratory system is immature at birth. The immature respiratory system 
generates a dysrhythmic and fragile breathing pattern during early life in both rodents and 
humans (Fisher et al., 1982; Mortola, 1984; Read and Henderson-Smart, 1984), thereby 
potentially making this period of life vulnerable to external perturbations. At birth mice are 
immature and their irregular breathing is comparable to that of preterm infants (Matrot et 
al., 2005). It is widely accepted that the mammalian respiratory system undergoes 
significant postnatal maturation (Hilaire and Duron, 1999). In the mouse there is a 
proposed respiratory maturational step believed to occur early in postnatal life, after which 
breathing increases in frequency and follows a more regular and robust pattern (Mortola, 
2001). The central mechanisms underlying this step in maturity remain to be elucidated as 
does the exact time-frame by which it occurs. Any disruptions or alterations to this 
postnatal respiratory maturation could be detrimental to survival and it is therefore an 
important time period to investigate. There is a paucity of studies that have thoroughly 
examined early postnatal changes in the respiratory patterns of mice. In particular the 
immature respiratory phenotype of neonatal mice has yet to be fully characterised. To 
better understand the mechanisms of respiratory rhythm generation during early postnatal 
life, ascertaining the changes in the respiratory phenotype as the respiratory system 
matures postnatally is fundamental. Furthermore, unravelling the mechanisms of 
respiratory rhythmogenesis will be vital in understanding the pathophysiology of many 
central respiratory disorders that manifest in early life e.g. sudden infant death syndrome 
(SIDS). 
 
As described in chapter 1, there is compelling evidence and a general consensus that a 
small bilateral region of the ventrolateral medulla, known as the preBötzinger complex 
(preBötC), is involved in respiratory rhythmogenesis (Smith et al., 1991). The preBötC is 
postulated to function as an inspiratory oscillator driving rhythmic inspiratory muscular 
activity in the rodent (Smith et al., 1991; Janczewski and Feldman, 2006). Recent advances 
in respiratory neurobiology have revealed that a second group of bilateral respiratory 
neurons known as the retrotrapezoid nucleus/parafacial respiratory group (RTN/pFRG) 
may function as a respiratory rhythm generator in the neonatal rodent (Onimaru and 
Homma, 2003; Onimaru et al., 2008). Also located in the ventrolateral medulla, this group 
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of neurons exhibit endogenous rhythmic activity with a pre-inspiratory mode of firing 
which can be recorded from neonatal rodent brainstem-spinal cord preparations (Onimaru 
and Homma, 2003). These Pre-I neurons have been proposed to control the onset of 
inspiration in the neonatal rodent (Ballanyi et al., 1999; Onimaru and Homma, 2003). 
Importantly, this pre-inspiratory rhythmic discharge has not been observed in adult rodent 
preparations (Mulkey et al., 2004; Stornetta et al., 2006), suggesting the RTN/pFRG may 
not exhibit a rhythm generating role in adulthood. As thoroughly discussed in chapter 1, 
there is evidence to suggest that an absent or malformed RTN/pFRG results in disordered 
respiratory rhythm at birth in the rodent, further suggesting its key role in respiratory 
rhythm generation (Jacquin et al., 1996; Dubreuil et al., 2008; Pagliardini et al., 2008). 
There is emerging evidence that the preBötC and RTN/pFRG become functionally coupled 
during embryonic development and form a dual respiratory rhythm generator (Thoby-
Brisson et al., 2009). The precise interaction between the preBötC and RTN/pFRG and 
their functional significance throughout postnatal maturation in vivo remains an open issue. 
Elucidating this interaction and the level of involvement each plays in generating the 
respiratory rhythm will be essential in understanding the central mechanisms that can lead 
to respiratory disorders and failure in early life.    
 
Riluzole, a INaP blocker, has been demonstrated to selectively abolish rhythmic activity of 
embryonic parafacial neurons (e-pF neurones, proposed embryonic forerunner of the 
RTN/pFRG) in brainstem-spinal cord preparations of embryonic mice (Thoby-Brisson et 
al., 2009), and can therefore be postulated to also selectively target the neonatal 
RTN/pFRG. Conversely, when applied to medullary slice preparations containing the 
preBötC from neonatal and embryonic rodents, riluzole does not affect the frequency of 
respiratory motor output (Del Negro et al., 2005; Thoby-Brisson et al., 2009), suggesting 
the preBötC activity is insensitive to riluzole. Further support of the theory that the 
RTN/pFRG functions as a respiratory rhythm generator in early postnatal development 
comes from a study investigating the susceptibility of postnatal breathing patterns to 
riluzole in the mouse (Dr Leanne McKay, personal communication, SFN abstract 2009). 
Riluzole was proposed to selectively perturb the functioning of the RTN/pFRG in vivo 
throughout postnatal development in the mouse and induce minimal depression of preBötC 
activity. The acute effects of this RTN/pFRG perturbation on respiratory activity were 
measured to determine if respiratory sensitivity to riluzole changes with age. Preliminary 
findings have shown that systemic riluzole administration from P1-P3 reduces respiratory 
frequency but evokes no respiratory depression or alteration in respiratory patterns beyond 
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P3. These data further supports the hypothesis that the riluzole-sensitive RTN/pFRG is 
involved in respiratory rhythmogenesis, but only in early postnatal life i.e. pre-maturation. 
Based on these findings we have hypothesised that the RTN/pFRG may function as a 
respiratory rhythm generating oscillator during development and early postnatal life when 
the respiratory system is immature, after which the preBötC becomes the dominant 
respiratory oscillator driving breathing when the respiratory system is mature (Gray et al., 
2001; McKay et al., 2005; McKay and Feldman, 2008).  
 
Several in vitro and in vivo studies have revealed that preBötC neurones are sensitive to the 
depressive actions of µ opioid receptor agonists, When applied to rodent medullary slice 
and en bloc preparations, µ opioid receptor agonists depress the firing of preBötC neurons 
and slow respiratory-related motor output (Gray et al., 1999; Takeda et al., 2001; Mellen et 
al., 2003; Montandon et al., 2011). This opioid sensitivity is attributable to the fact that 
preBötC neurons express the µ opioid receptor (Gray et al., 1999). Fentanyl is a highly 
selective µ opioid receptor agonist with respiratory depressive actions. Importantly, when 
administered systemically in rats, fentanyl has been demonstrated to induce respiratory 
frequency depression in vivo by exclusively targeting and depressing NK1R-exressing 
preBötC neurons (Montandon et al., 2011). Conversely, RTN/pFRG neurons do not 
express the µ opioid receptor, thus µ opioids do not alter or depress their rhythmic neural 
output in vitro (Takeda et al., 2001; Janczewski et al., 2002; Mellen et al., 2003). Taken 
together, these findings suggest that fentanyl can be utilised as an effective tool to 
pharmacologically perturb the rhythm generating properties of the preBötC in vivo, whilst 
leaving the RTN/pFRG unperturbed. By exploiting their differential opioid sensitivity, 
fentanyl should allow for a dissociation of the functioning of these two postulated 
respiratory oscillators.  
 
3.1.1 Study aims and rationale 
 
Study 1: Investigation of postnatal changes in respiratory patterns of mice. 
Given that neonatal breathing patterns have not been fully characterised in the mouse, the 
aim of study 1 was to investigate changes in breathing patterns during early postnatal life 
and through to early adulthood in order to assess postnatal respiratory maturation. It was of 
particular interest to determine the critical developmental time period by which maturation 
of respiratory activity occurs.   
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Study 2: Susceptibility of postnatal breathing patterns to fentanyl: A longitudinal 
study.  
The aim of study 2 was to determine the influence of postnatal maturation on the central 
control of breathing. Fentanyl was utilised to pharmacologically manipulate the respiratory 
system of mice in vivo throughout early postnatal development. The acute respiratory 
effects of fentanyl were measured in order to investigate the level of involvement of the 
preBötC in respiratory rhythm generation throughout this time period.  
 
Study 3: Susceptibility of postnatal breathing patterns to fentanyl: A single exposure 
study. 
Similar to study 2, the aim of study 3 was also to investigate the influence of postnatal 
maturation on the central control of breathing. Fentanyl was utilised as a pharmacological 
tool to manipulate the respiratory system of mice in vivo throughout postnatal development 
and through to early adulthood. The acute respiratory effects of fentanyl were measured in 
order to establish the level of involvement of the preBötC in respiratory rhythm generation 
throughout this time period.  
 
Studies 2 and 3 were designed to follow on from and compliment the in vivo work by Dr 
Leanne McKay who investigated the susceptibility of postnatal breathing patterns to 
riluzole (Dr Leanne McKay, personal communication). It was proposed that fentanyl 
would selectively depress the activity of the preBötC, but leave the opioid–insensitive 
RTN/pFRG unperturbed, thereby allowing for the dissociation of the functioning of these 
two postulated respiratory oscillators throughout the maturation period of breathing. Study 
2 was longitudinal in nature and mice were repeatedly exposed to fentanyl throughout 
early postnatal life. In study 3 different mice were studied on each postnatal day i.e. each 
mouse was only exposed once. The rationale for conducting both studies will be discussed 
further within this chapter.  
 
Hypothesis for study 2 and 3: If the preBötC functions as the dominant respiratory 
rhythm generator when the respiratory system is mature then mice should be more 
susceptible to the respiratory depressive effects of fentanyl after the maturation step has 
occurred i.e. the respiratory sensitivity to fentanyl will be age-dependent.    
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3.2 Methods 
 
3.2.1 Animals  
 
All experimental procedures were carried out under licence from the UK Home Office and 
performed in accordance with the Animals (Scientific Procedures) Act, 1986. Experiments 
detailed in this chapter were performed on both male and female ICR mice with ages 
ranging from P1-P30. A total of 79 mice were utilised in study 1, 84 mice in study 2 and 
79 mice in study 3. All mouse pups were housed with their mother until postnatal day (P) 
21. Adult mice (P21 and older) were housed according to their gender in groups of no 
more than six.  
 
3.2.2 Study design 
 
Study 1  
 
Changes in respiratory patterns were assessed throughout postnatal development through to 
adulthood. Mice were studied from P1-P5 (n=54), P7 (n=6), P10 (n=9) and P30 (n=10). 
P30 mice were classed as adults. Different mice were studied on each of the postnatal days. 
 
Study 2  
 
The respiratory depressive effects of fentanyl were assessed throughout postnatal 
development. Mice were studied from P1-P5 (n=60), P9 (n=12) and P11 (n=12). In the 
fentanyl experiments, the acute respiratory response to a single dose of 0.04 mg/kg 
fentanyl was measured on each postnatal day. In the control experiments, the acute 
respiratory response to a saline vehicle was measured on each postnatal day. The study 
design was longitudinal so mice were continually studied throughout early postnatal life 
i.e. they were repeatedly exposed to fentanyl or saline. 
 
Study 3  
 
The respiratory depressive effects of fentanyl were assessed throughout postnatal 
development. Mice were studied from P1-P5 (n=54), P7 (n=6), P10 (n=9) and on P30 
(n=10). In the fentanyl experiments, the acute respiratory response to a single dose of 0.04 
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mg/kg fentanyl was measured on each postnatal day. In the control experiments, the acute 
respiratory response to a saline vehicle was measured on each postnatal day. In this study, 
different mice were studied on each postnatal day thus mice were never exposed to 
fentanyl or saline on more than one occasion.  
 
In both study 2 and 3, fentanyl was administered at a dose of 0.04 mg/kg as previous in 
vivo studies, including studies within our lab have found that this dose induces a significant 
respiratory depression in neonatal rodents without having significant side effects (Greer et 
al., 1995; Laferriere et al., 2005).  
 
3.2.3 Respiratory measurements 
 
Respiratory activity was measured in freely behaving, awake mice using the non-invasive 
technique of whole body plethysmography (see chapter 2, section 2.3). Respiratory 
monitoring of the neonatal and juvenile pups (P1-P11) took place in the neonatal 
plethysmograph set up, whereas the larger adult set up was utilised for P30 mice. 
Respiration was recorded under eupneic conditions. Before experimental sessions began, 
animals were given 45 minutes to habituate to the recording chamber. Between respiratory 
recordings the recording chamber was continually supplied with room air using a bias flow 
regulator (neonatal set up; flow rate of 0.5 l/min) or humidified air supplied from a gas 
tank (adult set up; 21% O2, balanced N2, supplied at 2l/min) to prevent CO2 accumulation. 
In study 1, only resting breathing was recorded. Three baseline respiratory recordings that 
were 2 minutes in length were taken approximately 15 minutes apart. In studies 2 and 3, in 
addition to baseline respiratory measurements, the acute respiratory response to fentanyl or 
a saline vehicle was also measured. Following baseline measurements, mice were removed 
from the recording chamber and given an i.p injection of 0.04 mg/kg fentanyl. Control 
mice were administered an equivalent volume of physiological saline. Mice were then 
immediately returned to the recording chamber and their ensuing respiratory activity was 
recorded at 5, 15, 30 and 45 minutes post drug application. Each respiratory recording 
lasted 2 minutes. At the end of every recording, a calibration volume of 10 µl (neonatal 
chamber) or 100 µl (adult chamber) was injected into the recording chamber. Control and 
fentanyl experiments were run simultaneously. On conclusion of experiments, all mice 
were transcardially perfused and their brain tissue was removed for studies unrelated to 
this thesis.    
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3.2.4 Respiratory analysis 
 
To measure respiratory variables, the plethysmography recordings were analysed using 
Spike 2 software (see section 2.5). Only periods of quiet resting breathing were analysed 
given that movement distorts the respiratory signal.  
 
In study 1, respiratory variables under resting conditions were assessed throughout 
postnatal development. All three baseline respiratory recordings were analysed. 
Respiratory frequency was analysed on a breath by breath basis (see section 2.5.1 for 
further details of measurement). In order to measure respiratory variability, the coefficient 
of variation (CV) of respiratory frequency was measured for each respiratory trace and is 
calculated by: [SD/mean respiratory frequency] x100. The higher the CV value is, the 
greater the level of breathing instability. Additionally, individual respiratory patterns e.g. 
apnoeas, hyperpnoeas, and hiccups, were identified and their frequency was quantified for 
each 2 minute respiratory trace (see chapter 2, section 2.5.2 for definition of each 
respiratory characteristic). The frequency of each respiratory pattern was expressed as 
number of episodes/2 mins.  
 
In study 2 and 3, respiratory frequency and Vt were measured during the baseline period 
and at 5, 15, 30 and 45 minutes post-fentanyl or saline administration. Vt is presented as a 
relative change from baseline as opposed to an absolute change (discussed in section 3.4.3 
of this chapter).  
 
3.2.5 Behavioural assessments 
 
To evaluate potential side effects of drug administration that could have an indirect impact 
on respiratory activity, various behavioural assessments were performed on the neonatal 
and juvenile mice in studies 2 and 3 before and after injection of fentanyl or saline vehicle. 
Given that fentanyl has sedative properties (Bell and Ellis, 1987; Walsh et al., 1991; 
Chevillard et al., 2009), righting reflex and mastication rate (see section 2.4 for description 
of measurements), which can both be altered if an animal is sedated, were assessed in 
animals up to P11. Since fentanyl is also known to induce hypothermia, particularly in 
young rodents (Colman and Miller, 2002), body temperature was regularly monitored 
throughout experiments. Body temperature was measured orally in mice aged between P1-
P11 (rectal measurements are not feasible in small pups) and rectally in adult P30 mice. All 
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behavioural measurements were recorded immediately after removal from the nest, 5 
minutes and 60 minutes post drug administration. 
 
3.2.6 Statistical analysis  
 
All statistical analyses were performed using GraphPad Prism4 software. All data are 
presented as mean ± SD. The level of statistical significance was set at p<0.05. 
 
Study 1 
 
A one way Analysis of Variance (ANOVA) with Bonferroni’s post test was carried out to 
analyse the change in number of apnoeas, hyperpnoeas, hiccups, respiratory frequency and 
CV of respiratory frequency throughout the postnatal development period.  
 
Study 2 and Study 3 
 
To compare body temperature, righting reflex and mastication rate before and after saline 
or fentanyl administration throughout the study period, a 1-way ANOVA was performed. 
To analyse the acute effects of both saline and fentanyl on respiratory frequency and Vt at 
each postnatal day, a 2-way ANOVA with Bonferroni’s post test was performed. To 
directly compare the magnitude of the fentanyl-induced change in respiratory parameters 
across all the age groups, a 2-way ANOVA with Bonferroni’s post test was performed.  
 
3.3 Results of Study 1: Investigation of postnatal changes in 
respiratory activity of mice 
 
Results from study 1 are presented in section 3.3  
 
3.3.1 Respiratory traces 
 
As mentioned previously, the main aim of study 1 was to monitor and characterise the 
evolution of breathing patterns throughout postnatal life in the mouse to better understand 
respiratory maturation.   
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It was evident that mice exhibited an immature respiratory phenotype during early life, 
particularly from P1-P2, with a striking feature being a rapidly changing and unstable 
respiratory pattern. Figure 3-1 displays respiratory traces recorded from two P1 mice, a P2, 
P3, P5 and an adult P30 mouse under resting eupneic conditions. The P1 and P2 mice 
displayed dysrhythmic, unstable breathing. The respiratory pattern was often interspersed 
with hyperpnoeic episodes as well as apnoeas. Respiratory frequency was therefore highly 
variable, owing to the periods of very slow breathing coupled with the transient 
hyperventilatory episodes. Hyperpnoeas were observed with and without a post-
hyperpnoea apnoea and commonly occurred in an episodic manner throughout the 
respiratory recordings. A defining feature of hyperpnoeic breaths was forced expiration (an 
increased expiratory airflow), clearly illustrated in Figure 3-1 as pronounced downward 
deflections from baseline. The most profound change in the respiratory patterns occurred 
in the period between P2 and P3 in the majority of mice. By P3, most mice exhibited a 
rhythmic and robust breathing pattern devoid of respiratory abnormalities indicating a 
maturation of respiratory activity. The exact time window by which this transition of 
breathing activity occurred did vary between animals, however it was generally between 
P2-P4. Figure 3-1 illustrates stable, eupneic respiration recorded from a P3 and a P5 
mouse. At these postnatal ages apnoeas were virtually absent and hyperpnoeas were rare. 
Respiratory frequency had increased and was less variable, and the respiratory pattern was 
comparable to that of the mature P30 mice (oldest mice studied).  
 
Hiccup breathing patterns were observed from P1-P5 only and are illustrated in Figure 3-2, 
which shows example respiratory traces from a P1 and a P5 mouse. The number of hiccups 
exhibited by individual mice varied considerably. Hiccups often occurred intermittently 
and in bursts. Furthermore, hiccups were always interspersed with regular breaths i.e. they 
never appeared consecutively. A distinctive feature of hiccups was forced sharp inspiration 
and expiration. Figure 3-2 shows representative plethysmography traces illustrating 
rhythmic breathing in a P1 and a P2 mouse that was disturbed by intermittent bursts of 
hiccup breathing patterns.  
 
From the outset of study 1 the aim was to also quantify the frequency of sighs throughout 
postnatal development as they are prevalent in neonates and young infants (Cross et al, 
1960), thus are proposed to signify an immature respiratory system. Sighs are generally 
defined as spontaneous large amplitude breaths followed by a post-sigh apnoea. These 
particular breaths were however not observed at any age and therefore no data is shown.  
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Figure 3-1. Representative respiratory traces illustrating postnatal 
maturation of breathing patterns. Representative whole-body plethysmography 
traces recorded from two P1 mice, a P2, P3, P5 and P30 (adult) mouse. Breathing 
was irregular from P1-P2, characterised by periods of hyperpnoea and apnoea 
and thus a highly variable respiratory frequency. By P3, breathing exhibited a 
stable and rhythmic pattern and was similar to adult, P30 respiratory patterns. 
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Figure 3-2. Representative respiratory traces illustrating hiccup breathing 
patterns in a P1 and P5 mouse. Hiccups occurred sporadically and when present 
were interspersed with regular breaths. Hiccups commonly occurred in bursts and 
were only observed from P1-P5. Hiccups were characterised by high amplitude 
inspiration and forced expiration.  
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3.3.2 Quantification of postnatal changes in respiratory activity 
 
3.3.2.1 Apnoeas 
 
The average number of apnoeas observed per 2 minutes was quantified throughout 
postnatal development (Figure 3-3). P1 and P2 mice displayed a high number of apnoeas; 
however there was high degree of variability between individual animals. P1 mice 
displayed a significantly greater number of apnoeas compared with P2 mice (P1: 7.1±8.5 
apnoeas/2 mins vs P2: 4.0±5.4 apnoeas/2 mins, p<0.05). By P3-P4, the frequency of 
apnoeas was significantly lower than P1 and P2 (P3: 0.7±2.1 apnoeas/2 mins; P4: 0.7±2.1 
apnoeas/2 mins, p<0.05). Apnoeas were no longer observed after P4. Given the high 
variability in the data, only calculating the average frequency of apnoeas for each age 
group does not fully represent their occurrence. Thus it is important to also calculate the 
proportion of mice that actually exhibited apnoeas at each postnatal age in order to provide 
a more comprehensive representation of their occurrence throughout development. Table 
3-1 shows the percentage of mice in each age group that exhibited at least one apnoeic 
episode during the three, 2 minute respiratory recordings that were taken. All of the P1 
mice and 82% of the P2 mice displayed apnoeas. The proportion of mice exhibiting 
apnoeas at P3 decreased to 27% and by P5 mice no longer exhibited apnoeic periods.    
 
3.3.2.2 Hyperpnoeas 
 
The average number of hyperpnoeic episodes observed per 2 minutes was quantified 
throughout postnatal development (Figure 3-4). Hyperpnoeas were most frequently 
observed in P1 and P2 mice (P1: 2.6±2.6 hyperpnoeas/2 mins; P2: 4.0±3.7 hyperpoeas/2 
mins). All of the P1 mice and 91% of P2 mice studied exhibited at least one hyperpnoeic 
episode (Table 3-1). The number of hyperpnoeas observed significantly decreased by P3 
(1.2±2.0 hyperpnoeas/2 mins) and remained infrequent until P7 (0.2±0.9 hyperpnoeas/2 
mins), with only 17% of mice displaying them (Table 3-1). Hyperpnoeas were no longer 
exhibited at P10 or beyond.  
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3.3.2.3 Hiccups 
 
The average number of hiccup breathing episodes observed per 2 minutes was analysed 
and quantified throughout postnatal life (Figure 3-5). Hiccups were only observed from 
P1-P5. At P1, P2 and P5 an average of 1.9±4.2, 1.9±6.3 and 1.9±9.0 hiccups/2 mins was 
observed respectively. At P3 and P4 the average frequency of hiccup episodes was very 
low at 0.2±1.0 and 0.4±2.0 hiccups/2 mins, respectively. There was no statistical difference 
in the occurrence of hiccups between any of the age groups due to the high degree of 
variability in the data. It is imperative to highlight the fact that the proportion of mice that 
exhibited hiccups at each postnatal age was also highly variable. At P1, 50% of mice 
exhibited hiccups whereas 27% of P2 mice displayed hiccup episodes (Table 3-1). At P3, 
P4 and P5, 20%, 10% and 30% of mice exhibited hiccups respectively (Table 3-1). 
Whenever hiccups were present they occurred in large bursts and periodically interrupted 
eupneic breathing (see Figure 3-2 for illustration).  
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Figure 3-3. Number of apnoeas exhibited throughout postnatal development. 
The number of apnoeas observed within the 2 minute respiratory traces and under 
baseline conditions was quantified. Group averages for each postnatal age are 
shown. Apnoeas were most frequent in P1 and P2 mice and were no longer 
observed by P5. Data presented as mean±SD. * significantly different (p<0.05) 
from P1; # significantly different (p<0.05) from P2. One-way ANOVA with 
Bonferroni’s post test performed. 
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Figure 3-4. Number of hyperpnoeas exhibited throughout postnatal 
development. The number of hyperpnoeas observed within the 2 minute 
respiratory traces under baseline conditions was quantified. Group averages for 
each postnatal age are shown. Hyperpnoeas were most frequent in P1 and P2 
mice. Hyperpnoeas were no longer observed from P10 through to adult life. Data 
presented as mean±SD. * significantly different (p<0.05) from P1; # significantly 
different (p<0.05) from P2. One-way ANOVA with Bonferroni’s post test performed. 
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Figure 3-5. Number of hiccups exhibited throughout postnatal development. 
The number of hiccups observed within the 2 minute respiratory traces and under 
baseline conditions was quantified. Group averages for each postnatal age are 
shown. Hiccups were only observed between P1-P5. The number of hiccups 
observed by individual mice of each age group was highly variable. Data 
presented as mean±SD. No significant difference in the number of hiccups 
observed across the age groups (p<0.05), one-way ANOVA with Bonferroni’s post 
test. 
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Table 3-1. Percentage of mice displaying apnoeas, hyperpnoeas and hiccups at each postnatal age. The percentage of mice from 
each age group that exhibited at least one episode of each of the breathing characteristics was calculated.
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3.3.2.4 Respiratory frequency 
 
In addition to analysing individual breathing patterns, postnatal developmental changes in 
respiratory frequency were also assessed. Respiratory frequency was comparable at P1 and 
P2 (P1: 154±43 bpm vs P2: 157±43 bpm, p<0.05, Figure 3-6). Mice first displayed a 
significant increase in respiratory frequency at P3 (219±37 bpm, p<0.05) which continued 
to increase and reached a peak of 266±42 bpm by P5. This high respiratory frequency was 
maintained until P10 (256±58 bpm). By adulthood (P30), mice displayed a significantly 
lower respiratory frequency compared to P5 mice (196±17 bpm, p<0.05). 
 
In addition to measuring the average respiratory frequency for each respiratory recording, 
the coefficient of variation (CV) of respiratory frequency was also measured to gain an 
index of how variable and irregular the frequency was within a single respiratory 
recording. Respiratory frequency showed a high degree of variability at P1 and P2 (P1: 
36±21 % CV; P2: 24±10 % CV; Figure 3-7), likely due to the high occurrence of 
hyperpnoeas and apnoeas and therefore a rapidly changing frequency. By P3, the CV was 
significantly lower than P1 (P3: 15±6 % CV, p<0.05, Figure 3-7) indicating a more stable 
respiratory frequency. This reduced variability in respiratory frequency was maintained 
through to adulthood (P30: 12±5 % CV, Figure 3-7).  
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Figure 3-6. Changes in average respiratory frequency (bpm) throughout 
postnatal development. Respiratory frequency gradually increased from P2-P5 
and reached a plateau at P5 and was maintained until P10. Respiratory frequency 
had declined by adulthood (P30). Data presented as mean±SD. * significantly 
different (p<0.05) from P1; # significantly different (p<0.05) from P2; † significantly 
different (p<0.05) from P5. One-way ANOVA with Bonferroni’s post test performed.  
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Figure 3-7. Coefficient of variation (CV) of respiratory frequency throughout 
postnatal development. The variability in respiratory frequency was high at P1 
and P2. A significant reduction in variability occurred at P3 and this was 
maintained through to adulthood. Data presented as mean±SD. * significantly 
different (p<0.05) from P1. One-way ANOVA with Bonferroni’s post test performed. 
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3.4 Discussion of study 1: Investigation of postnatal changes in 
respiratory activity of mice 
 
Adequate ventilation at birth is essential for postnatal survival in mammals, thus 
understanding early postnatal maturation of breathing is of major clinical relevance. 
Researchers have sought for many years to identify the mechanisms that underlie immature 
respiratory control. In the mouse, the respiratory system undergoes significant postnatal 
maturation (Hilaire and Duron, 1999). The rationale of study 1 was to characterise the 
postnatal evolution of respiratory behaviour in the mouse and determine the critical 
developmental time period when the respiratory system undergoes a step in maturity. This 
study was designed to gain further insight into immature respiratory control in early life as 
well as the subsequent maturation. From this study we have shown that respiratory patterns 
of ICR mice underwent rapid postnatal developmental changes that were particularly 
evident between P2 and P3. These postnatal changes manifested as a transition from an 
unstable and dysrhythmic respiratory pattern to a regular and robust rhythmic respiratory 
output. To our knowledge, this study is the first to characterise the immature respiratory 
patterns of the mouse as well as assessing the time-frame of postnatal maturational of 
respiratory activity. 
 
3.4.1 Respiratory activity undergoes significant postnatal changes 
 
3.4.1.1 Apnoeas  
 
It is well documented that apnoeas are indicators of respiratory instability in mice and 
humans. Apnoeas are commonly displayed by neonatal rodents (Matrot et al., 2005; Niane 
and Bairam, 2011; Niane and Bairam, 2012; Niane et al., 2012) and transgenic mice that 
exhibit respiratory control abnormalities (Jacquin et al., 1996; Dubreuil et al., 2008; 
Hodges et al., 2009; Abdala et al., 2010; Gray et al., 2010). Our findings show that the 
prevalence of apnoeas change significantly during early life in the mouse and display a 
decline in frequency with advancing age which has previously been demonstrated in both 
rodents and humans (Matrot et al., 2005; Mathew, 2011; Niane and Bairam, 2011; Niane 
and Bairam, 2012). We have shown that apnoeas were only observed from P1-P4 and 
importantly were most prevalent at ages P1 and P2. After P2 a sharp decline in apnoea 
frequency was observed suggesting the occurrence of a respiratory maturational step. In 
the clinical setting, a high frequency of apnoeic episodes can be used indicator of an 
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immature respiratory control system, and is a common respiratory feature exhibited by 
preterm human neonates (Hiatt et al., 1981; Eichenwald et al., 1997). It was not determined 
if the apnoeas observed in this present study were of central origin (caused by a cessation 
of inspiratory rhythmogenesis), if they were obstructive (caused by a closure of the upper 
airways) or if they were a mixture of both types. It is therefore difficult to ascertain the 
exact source of the apnoeas, but in speculation, apnoeas in neonatal mice could be due to a 
reduced central respiratory drive reflecting immature central respiratory control. To further 
examine the potential central origin of this respiratory behaviour, rhythmically active 
medullary slice or brainstem-spinal cord preparations could be employed to directly record 
central respiratory motor output throughout postnatal development. Any cessation of 
respiratory motor activity would indicate a central apnoea. In vitro investigations in 
addition to the in vivo studies would give a more comprehensive analysis of the maturation 
of this respiratory characteristic throughout early life.  
 
3.4.1.2 Hyperpnoeic breathing 
 
In this study, hyperpnoeas are defined as hyperventilatory periods of high amplitude, 
forced inspiratory and expiratory efforts that are often accompanied by a post-hyperpnoea 
apnoea. This present study is the first to examine the frequency of hyperpnoeic episodes 
throughout postnatal development in the rodent under normoxic, resting conditions. 
Hyperpnoeas were most prevalent at ages P1 and P2 after which they displayed a notable 
decline in occurrence and were no longer exhibited beyond P10. They occurred 
spontaneously and resulted in a rapid change in both respiratory frequency and Vt and 
hence increased respiratory variability. The source of these hyperpnoeas is unknown and 
the mechanism(s) underlying their generation is also elusive. Hyperpnoeic breathing 
patterns have been observed in preterm human neonates (Fenner et al., 1973; Razi et al., 
2002) and patients with chronic heart failure (Sin et al., 1999; Bradley and Floras, 2003) 
and are generally believed to be an indicator of respiratory control instability (Khoo et al., 
1982). These breathing patterns have been specifically referred to as hyperpnoeic episodic 
breathing (HEB), which is defined as periods of quiet breathing interspersed with 
consistent and cyclic periods of hyperpnoes (a cyclic waxing and waning of breathing). 
Previous investigations by Guimarães and colleagues in 2007 found that administration of 
retinoic acid (vitamin A metabolite) during the onset of hindbrain segmentation in 
embryonic development in the mouse disrupts the formation of the rostral pons and 
induces HEB in postnatal life (Guimaraes et al., 2007). This resultant breathing pattern is 
103 
 
similar to the transient hyperpnoeic episodes observed in the young neonatal mice in this 
present study. Since the retinoic acid treated mice exhibited anatomical abnormalities in 
the rostral pons, it is likely that this contributed to the hyperpnoeic breathing. Whether the 
presence of hyperpnoeas in early life signifies an immaturity of rostral pontine functions 
cannot be deduced from our study alone, however it is an intriguing speculation. 
Guimarães and colleagues suggested that hyperpnoeic episodes may be centrally generated 
but are not due to an abnormality in the rhythm generators per se as normal baseline 
rhythmic respiratory motor output was maintained in vitro in mice that displayed HEB in 
vivo. Further in vitro analyses using the brainstem-spinal cord preparation from retinoic 
acid-treated mice demonstrated that excitation of the RTN/pFRG with AMPA induced an 
increase in the respiratory rhythm followed by a decrease which resembled hyperpnoeic 
breathing in vivo. The authors suggested that the responsiveness of the RTN/pFRG to 
afferent excitation may be exaggerated, which could cause hyperpnoeic breathing in vivo 
(Guimaraes et al., 2007). It is therefore possible that the hyperpnoeic breathing observed 
during early life in the present study could be the result of a hypersensitivity of the 
RTN/pFRG rhythm generator to excitatory inputs. Given that hyperpnoeic episodes appear 
to represent instability in respiratory control, it is likely that the decline in the hyperpnoea 
frequency observed after P2 in this study represents respiratory maturation. A prominent 
feature of hyperpnoeas is the present of forced inspiratory and expiratory efforts. It is 
intriguing to speculate that this increased expiratory effort could represent active expiration 
(i.e. increased expiratory airflow), which is commonly induced when there is an increased 
respiratory drive. The abdominal muscles are believed to function as the dominant 
expiratory muscles driving active expiration (Pagliardini et al., 2011). In order to 
determine if abdominal expiratory-related muscle activity accompanies hyperpnoeic 
breathing in young immature animals, recordings of muscle activity using surface EMG 
electrodes placed on the skin could be employed. The RTN/pFRG has been postulated to 
function as a conditional expiratory oscillator that drives active expiration in the rodent 
(Janczewski and Feldman, 2006; Pagliardini et al., 2011). Active expiration in early life 
and potentially hyperpnoeic breathing could therefore be generated by the RTN/pFRG, 
which would indicate the RTN/pFRG plays a functional role in rhythm generation in early 
postnatal life.    
 
 
 
 
104 
 
3.4.1.3 Hiccups  
 
In this study, hiccup breathing patterns were defined as very short, high amplitude breaths 
displaying a sharp inspiration and expiration. This is the first study to our knowledge that 
has identified this respiratory behaviour in the neonatal mouse. The occurrence of hiccups 
was quantified throughout postnatal development, and like both apnoeic and hyperpnoeic 
episodes, they were only observed during early life. After P5, hiccups were no longer 
exhibited. Given that these breaths have never been documented before, the mechanism(s) 
involved in their generation as well as their functional significance are unknown. Similar to 
hyperpnoeas, hiccups are also characterised by a forced expiratory effort, and as discussed 
above (section 3.4.1.2) this could signify active expiration. Since the occurrence of hiccups 
was age dependent, it is possible that hiccups represent a novel marker of immature 
respiratory control and an immature breathing phenotype. There was a high degree of 
variability in the frequency of hiccups exhibited by individual animals at each age. Due to 
the sporadic nature of hiccups, it is likely that these breaths were not always captured in 
the short recording sessions. It could be beneficial to employ an open flow 
plethysmography system that delivers a continuous air supply, which would allow for 
longer recording sessions. This would enable the rapidly changing breathing patterns of 
young neonatal mice to be fully assessed in real time, thereby providing a more accurate 
representation of respiratory activity.    
 
3.4.1.4 Respiratory frequency  
 
Baseline respiratory frequency was assessed throughout postnatal development under 
normoxic conditions. After P2, respiratory frequency displayed a gradual increase with 
advancing age and reached a peak by P5 which was maintained until P10. Additionally, 
respiratory frequency instability was high at P1 and P2 after which a notable decline in 
variability was observed by P3. The reduction in the number of apnoeic episodes would 
have partly accounted for the increased respiratory frequency during the first week of life. 
Furthermore, the substantial decline in respiratory pattern abnormalities after P2 would 
have contributed to the increase in respiratory stability. These findings strongly indicate 
the presence of significant maturation of respiratory control between P2 and P3. In 
agreement with our findings from the whole animal, in vitro studies utilising brainstem-
spinal cord preparations have demonstrated an increase in the frequency of rhythmic 
respiratory motor output at approximately P3-P4 in the rat and the mouse (Balkowiec and 
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Katz, 1998; Shvarev and Lagercrantz, 2006), indicating a similar time frame of maturation 
of respiratory motor output. Our study also demonstrated that by P30, respiratory 
frequency had declined. This is congruent with the findings from previous in vivo studies 
investigating postnatal changes in respiratory frequency in the rat, where frequency was 
found to gradually decline from approximately P10 through to adulthood (Huang et al., 
2004; Liu et al., 2006). Similarly, a study utilising the tilted-sagittal brainstem slice from 
the mouse has demonstrated an age-dependent change in respiratory motor output. The 
frequency of the rhythmic hypoglossal motor output was found to decrease in preparations 
from mice aged 15 days or older (Paton and Richter, 1995). The reason for this frequency 
decline observed in both the in vitro setting and the intact animal remains elusive, but 
could denote a second maturational process that occurs before the final mature respiratory 
pattern is achieved.  
 
3.4.2 Critical developmental time window between P2 and P3 
 
The data from study 1 have clearly demonstrated developmental changes in respiratory 
activity during early postnatal ontogenesis. Analysis of both respiratory patterns and 
respiratory frequency has indicated that the time period between P2 and P3 is 
developmentally distinct. At P1 and P2, changes in respiratory activity were rapid and 
unpredictable. Apnoeas and hyperpnoeas appear to be the hallmark of an immature 
respiratory system and hiccups may also represent a novel indicator of immature 
respiratory control. Importantly, a striking transformation in the respiratory activity from 
an unstable pattern to a regular and rhythmic pattern occurred between P2 and P3, 
signifying a critical developmental time window during which a maturational step occurs. 
The mechanisms that underlie this postulated step in maturity remain to be elucidated. The 
identification of a critical developmental period could mean respiratory insults during this 
time induce long-term respiratory defects, which would have significant clinical 
implications.  
 
3.4.3 Study limitations and future directions 
 
Postnatal changes in Vt were not analysed in the present study and therefore maturation of 
the overall ventilatory profile of mice could not be assessed. There are a number of reasons 
for this. Firstly there was a problem with the calibration method used to determine Vt in 
the commercially designed neonatal and juvenile plethysmography chambers (Buxco 
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Research Systems, USA). A rapid injection of a known volume of air into the chamber 
induced a distinctly different pressure change compared to the injection induced pressure 
change in the adult plethysmography chamber. As illustrated in Figure 2-4 in chapter 2, an 
injection of air into the recording chamber should evoke a rapid increase in pressure and 
hence a sharp upward deflection of the signal, followed by a slow decline back to baseline. 
However this was not seen in the neonatal/juvenile plethysmography system. Instead the 
calibration injection induced a rapid increase in the pressure signal which was of a lower 
magnitude, followed be a rapid decline. As a consequence of this, Vt could not be 
accurately calculated. The reason for this technical issue is not known but it could indicate 
that there was a small air leak in the system. Another reason for the exclusion of Vt 
calculations in this study is the fact that Vt measurements derived from plethysmography 
recordings in neonatal mice have not been validated against pneumotachography (direct 
recording of respiratory airflow). As a consequence, the accuracy of absolute Vt values 
based on the small plethysmography pressure signals is questionable (Mortola and 
Frappell, 1998; Szewczak and Powell, 2003), and are therefore are not presented in this 
study.  
 
In terms of future directions of the study, it would be beneficial to increase the range of 
postnatal ages that were studied, particularly from P5 through to adulthood. This would 
allow a more detailed assessment of potential respiratory changes that occur later in 
postnatal life. Given the high level of variability in the data from the young mice, 
particularly at P1 and P2, increasing the sample size in these age groups would also help to 
increase the validity of the data. The genetic background of mice is known to influence 
maturation of respiratory control (Arata et al., 2010). It would therefore be advantageous to 
repeat the study using a variety of mouse strains, which would provide a more generalised 
description of postnatal respiratory maturation. This knowledge could also aid in the 
understanding of early life respiratory abnormalities exhibited by transgenic mouse models 
of respiratory control, which would have an important clinical benefit.  
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3.5 Results of Study 2. Susceptibility of postnatal breathing 
patterns to fentanyl: A longitudinal study 
 
Results from study 2 are presented in section 3.5  
 
The design of study 2 was longitudinal and mice were repeatedly studied from P1-P5, on 
P9 and finally on P11. Based on the results from study 1, we have proposed that the time 
period between P2 and P3 represents a critical developmental window when breathing 
undergoes a step in maturity and exhibits a transition from an immature, irregular state to a 
stable, eupneic pattern. To determine if respiratory sensitivity to fentanyl was influenced 
by postnatal age, the acute respiratory depressive effects of fentanyl were assessed on each 
postnatal day. It was hypothesised that fentanyl would induce a more pronounced 
respiratory depression after the respiratory maturation step had occurred.  
 
3.5.1 Behavioural assessments   
 
The acute effects of the saline vehicle (control experiments) and fentanyl on body 
temperature, righting reflex and mastication rate were assessed. Neither saline nor fentanyl 
induced any significant changes from baseline in any of the variables which were recorded 
at both 5 and 60 minutes following administration (Tables 3-2 to 3-4). Body temperature 
was always maintained within physiological range between 32-34°C throughout control 
and fentanyl experiments (Table 3-2).  
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Age 
Body Temperature (°C) 
Saline Fentanyl 
Baseline 5 mins 
post-
saline 
60 mins 
post-
saline 
Baseline 5 mins 
post-
fentanyl 
60 mins 
post-
fentanyl 
P1 32.4±0.1 32.5±0.1 32.7±0.4 32.6±0.3 32.8±0.2 33.0±0.1 
P2 33.1±0.3 33.2±0.3 33.2±0.2 33.0±0.3 33.0±0.3 32.9±0.3 
P3 33.0±0.5 32.9±0.4 32.9±0.4 33.1±0.3 33.1±0.3 33.1±0.3 
P4 33.4±0.5 33.6±0.4 33.3±0.2 33.3±0.4 33.1±0.6 33.3±0.5 
P5 33.4±0.4 33.6±0.3 33.3±0.3 33.2±0.2 33.4±0.6 33.3±0.3 
P9 33.4±0.6 33.3±0.4 33.5±0.5 33.5±0.4 33.3±0.5 33.4±0.4 
P11 33.8±0.2 33.7±0.4 33.5±0.2 33.6±0.6 33.7±0.5 33.6±0.6 
 
Table 3-2. Assessment of body temperature before and after saline or 
fentanyl administration. Body temperature was measured orally. Population data 
for each age group is shown. Data presented as mean±SD. No significant change 
in body temperature found after saline or fentanyl administration at any age 
(p>0.05), 2-way ANOVA.  
 
 
 
 
Age 
Time to upright position (s) 
Saline Fentanyl 
Baseline 5 mins 
post-
saline 
60 mins 
post-
saline 
Baseline 5 mins 
post-
fentanyl 
60 mins 
post-
fentanyl 
P1 9±1 8±3 10±0 8±2 7±2 9±2 
P2 6±2 7±3 7±2 9±1 9±2 7±4 
P3 7±3 8±2 7±2 7±3 6±1 6±2 
P4 5±3 4±3 4±2 5±2 5±3 5±3 
P5 3±1 3±1 2±1 2±1 3±2 3±2 
P9 1±0 1±0 1±1 1±0 2±1 1±1 
P11 1±0 1±0 1±0 1±0 1±0 1±0 
 
Table 3-3. Assessment of righting reflex before and after saline or fentanyl 
administration. The time taken to move from supine to an upright position was 
measured. Population data for each age group is shown. Data presented as 
mean±SD. There was no significant change in time to upright position after saline 
or fentanyl administration at any age (p>0.05), 2-way ANOVA.       
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Age 
Mastications/10 seconds 
Saline Fentanyl 
Baseline 5 mins 
post-
saline 
60 mins 
post-
saline 
Baseline 5 mins 
post-
fentanyl 
60 mins 
post-
fentanyl 
P1 11±2 10±2 12±3 11±4 11±3 11±5 
P2 11±3 11±2 10±2 12±5 12±4 12±4 
P3 12±3 14±5 12±4 13±3 13±3 12±2 
P4 12±3 13±4 12±5 12±4 12±6 13±8 
P5 12±3 13±5 11±5 10±4 10±4 11±4 
P9 12±2 12±3 11±3 12±4 12±4 12±6 
P11 11±3 10±6 12±5 9±4 11±6 10±4 
 
Table 3-4. Mastication rate before and after saline or fentanyl administration. 
The number of mastication movements made in 10 seconds was counted. 
Population data for each age group is shown. Data presented as mean±SD. There 
was no significant change in mastication rate after saline or fentanyl administration 
at any age (p>0.05), 2-way ANOVA.    
 
3.5.2 Respiratory traces 
 
Figure 3-8 illustrates the acute effects of both saline and fentanyl on respiratory activity in 
P1, P2, P5 and P11 mice. In the control experiments, administration of a saline vehicle did 
not induce any apparent change in respiratory activity at any age. There was however an 
augmentation in Vt at 15 minutes post-saline at P1. Respiratory frequency and Vt 
following saline injection was comparable with baseline values. From the respiratory 
traces, it is apparent that respiratory activity of P1 and P2 mice was immature, 
characterised by apnoeic episodes and slow respiratory frequency. Fentanyl failed to 
induce a substantial respiratory depression at all ages. Respiratory frequency and Vt 
remained unaltered. It is apparent that the respiratory effects of fentanyl and the saline 
vehicle were indistinguishable at all ages studied.  
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Figure 3-8. Representative plethysmography respiratory traces illustrating the effects of saline and fentanyl in P1, P2, P5 and P11 
mice. Saline administration induced no apparent change in respiratory activity at any age. Fentanyl also failed to evoke a respiratory 
depression in all age groups. Respiratory frequency and Vt was comparable before and after fentanyl administration. Note the immature 
breathing patterns in the P1 and P2 age groups.    
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3.5.3 Respiratory frequency 
 
In the control experiments, saline did not evoke any significant changes in respiratory 
frequency at any of the postnatal ages studied (P1-P5, P9 and P11, Figure 3-9A). 
Respiratory frequency was comparable with baseline values at all time points following 
administration. At P1, there was a trend towards a reduction in respiratory frequency from 
baseline at 15, 30 and 45 minutes following saline administration, however it should be 
noted that there was a high degree of variability in respiratory frequency between 
individual animals at all time points. 
 
Interestingly, fentanyl also failed to induce a significant change in respiratory frequency at 
all postnatal ages (P1-P5, P9 and P11, Figure 3-9B). Fentanyl did not evoke a significant 
depression in respiratory frequency at any postnatal age. On the first exposure to fentanyl 
at P1, respiratory frequency remained unaltered (baseline: 133±40 bpm; 5 minutes post-
fentanyl: 114±10 bpm; 15 minutes post-fentanyl: 128±25 bpm; 30 minutes post-fentanyl: 
111±34 bpm; 45 minutes post-fentanyl: 145±49 bpm, p>0.05). There was a small but 
insignificant reduction in respiratory frequency post fentanyl application at P2-P5; 
however the changes in respiratory frequency are congruent with those seen in response to 
saline administration and could therefore represent natural variation in the respiratory 
activity throughout the experimental procedure as opposed to the depressive actions of 
fentanyl itself. From these data there was no trend towards a more pronounced fentanyl-
induced depression in respiratory frequency after the maturation step (i.e. after P2). Mice 
appeared to be insensitive to fentanyl’s respiratory depressive actions at all ages.  
 
3.5.4 Tidal volume 
 
Vt response to saline or fentanyl is presented as a relative change from baseline (Figure 3-
10) In the control experiments, saline did not induce a significant change in Vt at any age 
(P1-P5, P9 and P11, Figure 3-10A). At P1 there was an increase in Vt from baseline values 
at 5 and 15 minutes following saline administration but this was not significant (5 minutes: 
39±49% increase; 15 minutes: 44±55% increase). The variability in baseline Vt as well as 
the percentage change in response to saline administration was high at all ages. Similarly, 
fentanyl did not evoke a significant alteration in Vt at any postnatal age (Figure 3-10B), 
indicating the effects of fentanyl on Vt were not age-dependent. It should be noted that 
there was also a high level of variability in the data in all of the age groups. The Vt 
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changes in response to saline and fentanyl throughout postnatal development were 
indistinguishable.  
 
 
Figure 3-9. Acute changes in respiratory frequency in response to saline or 
fentanyl throughout postnatal life. Mice were repeatedly exposed to either 
saline (A) or fentanyl (B) from P1-P5, P9 and P11. Population data for each age 
group shown. Control mice: n=5; fentanyl-exposed mice: n=7. Data presented as 
mean±SD. Neither saline nor fentanyl evoked a significant reduction in respiratory 
frequency at any of the postnatal ages studied. 2-way ANOVA performed.   
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Figure 3-10. Acute changes in tidal volume (Vt) in response to saline or 
fentanyl throughout postnatal life. Mice were repeatedly exposed to either 
saline (A) or fentanyl (B) from P1-P5, P9 and P11. Population data for each age 
group shown. Data shows the percentage change in Vt from baseline values in 
each age group, where baseline represents 100%. Control mice: n=5; fentanyl-
exposed mice: n=7. Data presented as mean±SD. Neither saline nor fentanyl 
evoked a significant change in Vt at any of the postnatal ages studied. 2-way 
ANOVA performed.   
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3.6 Results of Study 3. Susceptibility of postnatal breathing 
patterns to fentanyl: A single exposure study 
 
The failure of fentanyl to evoke a respiratory depression throughout postnatal life in study 
2 may have been due to the mice becoming desensitised to fentanyl’s actions (fully 
discussed in section 3.7.1). Mice were continually studied throughout postnatal 
development and therefore were subjected to multiple fentanyl exposures throughout the 
study period, which could have in turn evoked the desensitisation. The study design was 
consequently altered and different mice were studied at each postnatal age, thereby 
preventing multiple fentanyl exposures. The change in the study design allowed the 
proposed hypothesis to be sufficiently tested.  
 
3.6.1 Behavioural assessments   
 
The acute effects of the saline vehicle (control experiments) and fentanyl on righting reflex 
and mastication rate were assessed in mice up to P10. Neither saline nor fentanyl induced 
any significant changes from baseline in either of the variables which were recorded at 
both 5 minutes and 60 minutes following administration (Tables 3-6 and 3-7). In the adult 
P30 mice, only body temperature was assessed, and was recorded rectally. In the mice 
aged P1-P10, body temperature was recorded orally and was therefore always 
underestimated. No significant change in body temperature was seen after saline or 
fentanyl administration in any of the age groups. Body temperature was always maintained 
within physiological range of between 32.0-34.0°C (oral) or 36.5-37.0°C (rectal) 
throughout control and fentanyl experiments (Table 3-5).  
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Age 
Body Temperature (°C) 
Saline Fentanyl 
Baseline 5 mins 
post-
saline 
60 mins 
post-
saline 
Baseline 5 mins 
post-
fentanyl 
60 mins 
post-
fentanyl 
P1 32.6±1.2 33.1±0.8 32.8±0.8 32.4±1.7 32.4±1.7 32.2±1.3 
P2 32.3±0.8 32.2±0.2 32.5±0.4 32.6±0.8 32.8±0.8 32.8±0.7 
P3 32.0±1.4 32.5±1.4 31.9±1.7 32.6±1.0 32.0±1.2 32.2±1.6 
P4 32.4±1.4 31.6±1.4 32.1±0.2 32.6±0.4 32.2±0.4 32.3±0.7 
P5 32.6±1.2 32.7±1.2 32.8±1.9 32.8±0.9 32.6±1.9 32.3±1.7 
P7 33.7±0.7 33.7±0.9 33.6±0.7 33.4±0.6 33.7±1.0 33.7±0.9 
P10 32.6±0.6 32.5±0.6 33.1±0.6 32.7±1.0 32.6±0.6 32.9±0.6 
P30 36.9±0.2 36.7±0.3 36.8±0.1 36.8±0.3 36.7±0.4 36.8±0.2 
 
Table 3-5. Assessment of body temperature before and after saline or 
fentanyl administration. Body temperature was measured orally in mice aged 
P1-P10 and rectally in the P30 mice. Population data for each age group is shown. 
Data presented as mean±SD. No significant change in body temperature was 
found after saline or fentanyl administration in all of the age groups (p>0.05), 1-
way ANOVA.  
 
 Time to upright position (s) 
 
Age 
Saline Fentanyl 
Baseline 5 mins 
post-
saline 
60 mins 
post-
saline 
Baseline 5 mins 
post-
fentanyl 
60 mins 
post-
fentanyl 
P1 8±3 8±3 7±2 9±3 9±3 8±2 
P2 8±3 8±2 9±1 6±3 8±3 8±3 
P3 7±4 6±3 7±3 6±3 7±3 8±3 
P4 3±2 3±1 5±3 6±3 8±3 5±4 
P5 1±0 2±1 1±1 2±2 2±1 3±2 
P7 1±0 1±1 2±2 1±0 2±1 2±1 
P10 1±0 1±0 1±0 1±0 1±0 1±0 
 
Table 3-6. Assessment of righting reflex before and after saline or fentanyl 
administration. The time taken to move from supine to an upright position was 
measured. Population data for each age group is shown. Data presented as 
mean±SD. There was no significant change in time to upright position after saline 
or fentanyl administration in all of the age groups (p>0.05), 1-way ANOVA.     
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 Mastications/10 seconds 
 
Age 
Saline Fentanyl 
Baseline 5 mins 
post-
saline 
60 mins 
post-
saline 
Baseline 5 mins 
post-
fentanyl 
60 mins 
post-
fentanyl 
P1 13±6 11±9 12±8 12±5 11±7 11±7 
P2 9±3 9±3 10±2 9±3 8±2 10±1 
P3 17±5 16±6 15±8 16±6 13±8 15±8 
P4 10±4 10±3 10±3 11±4 8±6 9±5 
P5 11±7 11±7 10±8 12±5 9±8 9±7 
P7   14±10 10±4 11±5 11±4 8±4 10±7 
P10 10±4 9±5 8±4 11±4 10±3 9±5 
 
Table 3-7. Mastication rate before and after saline or fentanyl administration. 
The number of mastication movements made in 10 seconds was counted. 
Population data for each age group is shown. Data presented as mean±SD. There 
was no significant change in mastication rate after saline or fentanyl administration 
in all of the age groups (p>0.05), 1-way ANOVA.    
 
3.6.2 Plethysmography respiratory traces 
 
Figure 3-11 illustrates the acute effects of both saline and fentanyl on respiratory activity in 
P1-P3 mice and in mature adult, P30 mice. In the control experiments, administration of 
saline vehicle did not evoke any alteration in respiratory output in the P1 and P2 mice. 
Both respiratory frequency and Vt were similar before and after injection. It is evident 
from the respiratory traces that respiratory activity of P1 and P2 mice was irregular with 
periods of apnoeas and hyperpnoeas throughout the experimental procedure. In some P3 
mice there was a depression in respiratory frequency at15 minutes following saline 
administration, highlighting the high degree of variability in respiratory activity even in the 
absence of pharmacological intervention. The respiratory activity of the P30 mice was 
followed a stable pattern before and at all time points following saline administration with 
no change in respiratory frequency or Vt evident. Fentanyl failed to induce a depression of 
respiratory activity in both the P1 and P2 mice. Respiratory frequency and Vt remained 
unaltered and it is apparent that breathing displayed an irregular rhythm before and after 
fentanyl injection. It is evident that the respiratory effects of fentanyl and the saline vehicle 
at P1 and P2 were indistinguishable. Conversely, fentanyl did induce a clear depression in 
respiratory frequency and Vt in the P3 mice. The adult, P30 animals also displayed a 
reduction in respiratory frequency as well as a contrasting increase in Vt in response to 
fentanyl.  
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Figure 3-11. Representative plethysmography respiratory traces illustrating the effects of saline and fentanyl in P1, P2, P3 and 
P30 mice. Saline administration induced no change in respiratory activity in the P1, P2 and P30 mice however a reduction in respiratory 
frequency was seen following saline injection in the P3 mice. Fentanyl did not induce any respiratory depression in P1 or P2 mice, but 
induced a clear reduction in respiratory frequency and Vt in the P3 mice. In the adult, P30 mice, fentanyl evoked a decrease in frequency 
but an increase in Vt. Note the different scale for the P30 traces. 
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3.6.3 Respiratory frequency 
 
Interestingly, when observing only the baseline respiratory frequency data in each 
postnatal age group (Figure 3-12), an increase in respiratory frequency throughout 
postnatal development (P1-P10) and a subsequent decline by P30 is evident in both the 
control and fentanyl experiments, which reiterates the data from study 1 where the 
postnatal evolution of breathing frequency was investigated (Figure 3-6).  
 
In the control experiments, respiratory frequency was generally comparable before and 
after the saline vehicle administration as expected (Figure 3-12A). There was however a 
significant reduction in respiratory frequency from baseline seen at 15 minutes following 
saline injection in the P3 mice (baseline: 219±36 bpm vs 15 minutes: 155±26 bpm, p<0.05) 
and at 30 minutes post saline injection in the P4 mice (baseline: 230±41 bpm vs 30 
minutes: 157±36 bpm, p<0.05). Additionally, there was a trend towards a reduced 
respiratory frequency from baseline at 30 minutes post saline administration at P5 
(baseline: 266±55 bpm vs 30 minutes: 197±44 bpm, p>0.05). When observing the data as a 
percentage change in respiratory frequency from baseline (Figure 3-13A), the reduction in 
respiratory frequency at P3 and P4 is evident. However, when comparing the magnitude of 
the respiratory frequency change post saline injection between the age groups, there was no 
significant difference (2 way ANOVA, p>0.05). It is important to note that the decreases in 
breathing frequency observed in the control experiments must be taken into consideration 
when interpreting the respiratory effects of fentanyl.  
 
Fentanyl did not evoke a significant reduction in respiratory frequency at P1 and P2. When 
observing the absolute respiratory frequency changes of the P1 and P2 mice (Figure 3-
12B), respiratory frequency was comparable before and at all time points following 
injection of fentanyl. It is apparent that this data parallels that of the control experiments. 
In contrast, fentanyl did induce a significant decrease in respiratory frequency at P3 and 
P5, seen at 5, 15 and 30 minutes following administration. In addition, fentanyl also 
evoked a significant reduction in respiratory frequency in the P10 and P30 mice, evident at 
30 minutes post administration. There was also a clear trend towards a reduction in 
respiratory frequency at 30 minutes post fentanyl in the P4 (baseline: 204±82 bpm vs 30 
minutes: 154±65 bpm, p>0.05) and P7 mice (baseline: 295±5 bpm vs 30 minutes: 207±48 
bpm, p>0.05). From Figure 3-12B, it is clear that a gradual decline in the frequency of 
breathing occurred from 5 minutes to 30 minutes post fentanyl injection, observed in all 
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mice from P3 through to P30. By 45 minutes following fentanyl application, respiratory 
frequency had returned to baseline levels. When studying the absolute changes in 
respiratory frequency at each postnatal age (Figure 3-12B), the magnitude of the fentanyl-
induced respiratory frequency depression appeared to be greatest from P3 onwards i.e. 
after the proposed respiratory maturation process. It is however important to highlight the 
high variability in the data, particularly in the younger age groups of P1-P10. Figure 3-13B 
illustrates the fentanyl-induced alteration in respiratory frequency as a percentage change 
from baseline in each age group. This set of data allows for a direct comparison of the 
magnitude of the fentanyl-induced respiratory frequency depression across the age groups. 
The respiratory frequency depression from P3 through to P30 is evident, reiterating the 
absolute respiratory changes (Figure 3-12B). The depression of respiratory frequency 
induced at 5, 15 and 30 minutes following fentanyl was significantly greater in the P3 mice 
compared to the P2 mice (5 mins: 36±16% vs 4±35% reduction; 15 mins: 46±18% vs 
16±27% reduction: 30 mins: 43±18% vs 3±21% reduction , p<0.05). In addition, compared 
with the P2 mice, fentanyl induced a significantly greater respiratory depression from 
baseline at 15 and 30 minutes in the P5 mice (15 mins: 46±11% vs 16±27% reduction; 30 
mins: 40±11% vs 3±21% reduction, p<0.05) and at 30 minutes in the P10 mice (33±5% vs 
3±21% reduction, p<0.05) and P30 mice (21±21% vs 3±21% reduction, p<0.05). There 
was also a trend towards a greater depression of respiratory frequency at 30 minutes in the 
P4 and P7 mice compared to the P2 mice. The magnitude of fentanyl-induced respiratory 
frequency change was similar between the P1 and P2 groups. There was no significant 
difference in the degree of fentanyl-induced respiratory frequency depression between the 
P1 mice and the other age groups; however there was a distinct trend towards the P1 mice 
exhibiting a smaller frequency depression in response to fentanyl when compared with the 
P3-P30 mice. Furthermore, there was no significant difference in the magnitude of 
fentanyl-induced respiratory depression between the P3-P30 age groups. It is important to 
highlight that at P4 the percentage change in respiratory frequency from baseline observed 
at 30 minutes following fentanyl is comparable with the relative change seen after saline 
injection (30 mins post saline: 30±19% reduction; 30 mins post fentanyl: 23±35% 
reduction).  
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Figure 3-12. Absolute changes in respiratory frequency in response to saline 
or fentanyl throughout postnatal life. The influence of postnatal age on the 
acute respiratory frequency effects of saline (A) or fentanyl (B) were assessed. 
Mice were studied from P1-P5, P7, P10 and P30. Different mice were studied on 
each postnatal day. Data presented as mean±SD. * denotes a significant reduction 
(p<0.05) in respiratory frequency from corresponding baseline value, 2-way 
ANOVA with Bonferroni’s post test. 
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Figure 3-13. Relative change in respiratory frequency in response to saline 
or fentanyl throughout postnatal life. The influence of postnatal age on the 
acute respiratory frequency effects of saline (A) or fentanyl (B) were assessed. 
Data shows the percentage change in respiratory frequency from baseline in each 
age group, where baseline represents 100%. Mice were studied from P1-P5, P7, 
P10 and P30. Different mice were studied on each postnatal day. Data presented 
as mean±SD. * denotes a significant difference (p<0.05) from the corresponding 
P2 time point, 2-way ANOVA with Bonferroni’s post test.  
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3.6.4 Tidal volume 
 
Figure 3-14 illustrates the relative change in Vt from baseline levels after saline and 
fentanyl administration (baseline represents 100%). In the control experiments, saline 
administration did not evoke any significant change in Vt in any of the age groups (Figure 
3-14A). Vt remained stable and was always comparable before and at all time points after 
saline injection. Fentanyl induced a reduction in Vt from P1 to P7 and the magnitude of 
this depression was not significantly different between these age groups (Figure 3-14B, 
p>0.05, 2- way ANOVA). In the P1-P7 mice, the percentage reduction in Vt from baseline 
ranged from 26-44% at 5 minutes post-fentanyl administration and between 20-41% at 15 
minutes following fentanyl administration. Vt always returned to baseline levels by 45 
minutes post-fentanyl. There was a high degree of variability in the data in all the age 
groups. In the P10 mice, fentanyl did not appear to induce a substantial reduction in Vt (5 
minutes post-fentanyl: 15±29% reduction; 15 minutes post-fentanyl: 18±5% reduction), 
however the magnitude of depression was not significantly different from the younger age 
groups. The degree of variability in the data was notably high. The Vt response evoked by 
fentanyl differed significantly in the adult P30 mice compared with the younger age 
groups. At P30, fentanyl produced an average increase in Vt from baseline at all time point 
studied (5 minutes post-fentanyl: 24±69% increase; 15 minutes post-fentanyl: 16±79% 
increase; 30 minutes post-fentanyl: 10±62% increase, 45 minutes post-fentanyl: 19±55% 
increase). There was however a high level of variability in the Vt response to fentanyl 
between individual P30 animals, which should be taken into account when interpreting the 
data.    
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Figure 3-14. Relative change in tidal volume in response to saline or fentanyl 
throughout postnatal life. The influence of age on the tidal volume effects of 
saline (A) or fentanyl (B) are shown. Data shows the percentage change in tidal 
volume from baseline in each age group, where baseline represents 100%. Mice 
were studied from P1-P5, P7, P10 and P30. Different mice were studied on each 
postnatal day. Data presented as mean±SD. * denotes a significant difference 
from the corresponding time point in the P30 group, 2-way ANOVA with 
Bonferroni’s post test.  
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3.7 Discussion of studies 2 and 3 
 
In studies 2 and 3, fentanyl was utilised to pharmacologically manipulate the respiratory 
system of mice throughout postnatal development. The aim of these studies was to 
investigate the level of involvement of the preBötC in respiratory rhythm generation 
throughout early life and test the hypothesis that the preBötC only functions as the 
dominant respiratory oscillator when the respiratory system has matured. Study 2 was 
longitudinal in nature and mice were repeatedly exposed to fentanyl throughout life. This 
repeated exposure induced a rapid desensitisation to the respiratory effects of the drug and 
therefore our proposed hypothesis could not be tested using this particular study design. 
The study was therefore repeated with an altered design where mice were only studied 
once (different mice utilised at each postnatal age), thereby avoiding repeated exposure to 
the drug (study 3). This study revealed there was a trend towards an age-dependent 
increase in respiratory sensitivity to fentanyl, where mice displayed a heightened 
respiratory depression in response to fentanyl from P3 onwards. 
 
3.7.1 Repeated exposure induced an acute respiratory tolerance to fentanyl 
 
From study 1 we found that repeated exposure to fentanyl in early postnatal life evoked a 
rapid reduction in the sensitivity to the respiratory depressive effects of subsequent 
applications of the drug. Fentanyl did not induce a depression in either respiratory 
frequency or Vt at any postnatal age and therefore did not alter overall ventilation. 
Importantly, the respiratory effects of fentanyl were indistinguishable from the saline 
control at all ages. This is consistent with previous work indicating that analgesic tolerance 
to fentanyl occurs rapidly following continuous exposure in neonatal rats (Thornton and 
Smith, 1997; Choe and Smith, 2000). It is important to note however, that at P1, all mice 
were naïve to fentanyl. Even so, fentanyl did not elicit a depression in respiratory activity 
at this age, which lends support to our hypothesis that mice are less susceptible to the 
depressive actions of fentanyl in early life suggesting the RTN/pFRG may be functioning 
as the dominant respiratory oscillator driving the breathing rhythm at this time. However 
given that mice continued to be unresponsive to the depressive actions of fentanyl at all 
ages, it is likely that the multiple exposures to fentanyl influenced the acute respiratory 
response to the drug and therefore our hypothesis could not be fully tested.  
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It is probable that the repeated fentanyl administration induced a tolerance to the 
respiratory actions of the drug. In this study, tolerance is defined as an attenuated 
physiological response to a pharmacological agent given at a dose that is known to induce 
an effect. Given that the dose of fentanyl administered in this study (0.04 mg/kg) has 
previously been shown to induce acute respiratory depression in neonatal rodents (Greer et 
al., 1995; Laferriere et al., 2005), we concluded that repeated exposure to fentanyl had 
evoked a respiratory tolerance. Congruent with this finding, previous clinical and pre-
clinical investigations have demonstrated reduced responsiveness to the analgesic effects 
of fentanyl after repeated exposure (Thornton and Smith, 1997, 1998; Bailey and Connor, 
2005). There are however few studies that have examined tolerance to fentanyl’s 
respiratory effects. The mechanisms that underlie the respiratory tolerance to fentanyl 
reported in this present study are unknown. A number of pre-clinical studies have explored 
the development of analgesic tolerance which is a significant clinical problem associated 
with repeated or prolonged opioid exposure, and various mechanisms that may evoke such 
tolerance have been proposed. The mechanisms underlying the development of tolerance to 
µ opioid receptor agonists including fentanyl are thought to occur at the level of the 
receptor. The µ opioid receptors belong to the family of G-protein coupled receptors 
(GPCRs) and are negatively coupled to adenylate cyclase (Law et al., 2000). Alterations in 
µ opioid receptor regulation throughout the brain have been implicated in the development 
of tolerance in the rodent. Several radioligand binding studies have shown that repeated 
exposure to µ opioid receptor agonists in rodents elicit downregulation of the µ opioid 
receptor within the brain (Bhargava and Gulati, 1990; Bernstein and Welch, 1998; Stafford 
et al., 2001) through receptor internalisation, thereby reducing the number of functional 
receptors and evoking tolerance. Conversely, a study in mice using radioligand binding has 
demonstrated that changes in the regulation of µ opioid receptors in response to repeated 
fentanyl administration occurs independently of the development of tolerance and is 
related to the dose itself (Yoburn et al., 1993). Repeated exposure to a low dose of fentanyl 
(0.03-0.1 mg/kg/day for 7 days) induced upregulation of µ opioid receptors whereas 
exposure to a high dose (0.5 mg/kg/day for 7 days) evoked a downregulation. However, 
irrespective of the fentanyl dose and corresponding change in receptor density, tolerance 
always developed. More recent studies have proposed an alternative relationship between 
µ opioid receptor regulation and tolerance. It has been suggested that receptor 
internalisation and downregulation actually prevents or delays tolerance. An in vitro study 
has shown that morphine is ineffective at producing µ opioid receptor internalisation but 
rapidly induces tolerance, whereas DAMGO can effectively produce internalisation of µ 
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opioid receptors but does not readily evoke tolerance (Koch et al., 2005). Additionally, µ 
opioid receptor phosphorylation and desensitisation has been implicated in the 
development of opioid tolerance (Pitcher et al., 1998; Liu and Anand, 2001). Repeated 
exposure to µ opioid receptor agonists has been found to induce phosphorylation of the 
receptor by G protein-coupled receptor kinases (GRKs). The phosphorylated receptor is 
then bound by β-arrestin, a protein that is a member of the arrestin family, which 
subsequently leads to the uncoupling of the µ opioid receptor from G proteins. This 
induces a desensitisation of the receptor’s responsiveness to agonists (Ferguson et al., 
1996) and may be responsible for the appearance of tolerance. Protein kinase A (PKA) and 
protein kinase C (PKC), which are involved in the signal transduction pathways following 
µ opioid receptor activation, have also been linked to the appearance of analgesic 
tolerance. PKA and PKC inhibitors are found to prevent the development of tolerance to 
morphine in mice in vivo (Javed et al., 2004). In the present study, it would be interesting 
to assess the ability of these inhibitors to prevent the development of respiratory tolerance 
to fentanyl.  
 
From the extensive research, it is evident that there is still considerable uncertainty 
regarding the exact mechanisms responsible for the development of tolerance. It is likely 
that a complex set of cellular and molecular processes are involved. It is difficult to 
directly compare the findings from previous work with the results of the present study, 
given that there are many discrepancies including the type of opioid agonist administered, 
the dose administered, method of administration, duration of exposure, species and age of 
animals assessed. Moreover, most studies have investigated analgesic tolerance to µ opioid 
receptor agonists which might have a distinct mechanistic profile compared to respiratory 
tolerance development. These incongruities should therefore be taken into consideration 
when evaluating potential mechanisms of tolerance in the present study. In order to 
ascertain the mechanisms directly related to respiratory tolerance, investigations of µ 
opioid receptor regulation within respiratory-related brain areas e.g. the ventrolateral 
medulla could be assessed before and after fentanyl exposure. Since fentanyl is believed to 
induce respiratory frequency depression via direct actions on the preBötC (Gray et al., 
1999; Takeda et al., 2001; Mellen et al., 2003; Montandon et al., 2011), it is of particular 
interest to explore the effects of repeated exposure on the expression of µ opioid receptors 
within the preBötC. Radioligand binding or immunohistochemistry analyses of the µ 
opioid receptor could be undertaken. This would help to determine if the lack of fentanyl-
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induced respiratory depression is due to changes within the preBötC at the level of the 
receptor.   
 
The unforeseen development of tolerance to fentanyl-evoked respiratory depression has 
sparked new interest in the respiratory effects of repeated fentanyl exposure, particularly as 
a result of exposure during early postnatal life when the respiratory system undergoes 
significant maturational changes. Given the widespread use of opioid analgesic 
therapeutics in clinical practice, understanding the respiratory consequences of repeated 
exposure has an important clinical relevance and certainly warrants further investigation.   
 
3.7.2 Respiratory sensitivity to fentanyl was age-dependent 
 
Study 3 also investigated the respiratory depressive effects of fentanyl throughout postnatal 
development. To prevent the confounding respiratory effects of repeated fentanyl 
exposure, and thus allowing our hypothesis to be tested, each mouse was only studied on 
one postnatal day. As previously discussed, µ opioids including fentanyl are believed to 
induce respiratory frequency depression in vivo by direct actions on the preBötC (Gray et 
al., 1999; Takeda et al., 2001; Mellen et al., 2003; Montandon et al., 2011). It was 
therefore proposed that fentanyl could be utilised as a pharmacological tool to selectively 
depress the activity of the preBötC, but leave the opioid–insensitive RTN/pFRG 
unperturbed, thereby allowing for the dissociation of the functioning of these two 
postulated respiratory oscillators throughout postnatal life. Importantly, in all experiments, 
fentanyl did not induce hypothermia or sedation, indicating that the fentanyl dose 
administered (0.04 mg/kg) was sufficient to study the desired respiratory actions of the 
drug with minimal side effects. The acute respiratory effects of fentanyl were investigated 
from P1-P5, which represents a critical developmental time window that encompasses 
significant postnatal respiratory maturation (see study 1, section 3.3). Additionally, 
respiratory modulation by fentanyl was also assessed at P7, P10 and in adulthood (P30).  
 
When examining the effects of fentanyl on respiratory frequency, the data reveals that 
there was a trend towards an age-dependent increase in respiratory sensitivity to fentanyl 
after the postulated maturation step, as hypothesised. At P1 and P2 when respiratory 
patterns still exhibited significant immaturity, fentanyl did not elicit a depression of 
respiratory frequency. Conversely, when breathing exhibited a mature pattern from P3 
onwards, a respiratory frequency reduction was observed in response to fentanyl. Since a 
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significant postnatal maturation of respiratory activity occurs by approximately P3, it 
appears the increased respiratory susceptibility to fentanyl was related to postnatal 
maturation. This heightened respiratory sensitivity to the depressive actions of fentanyl 
post-maturation supports our hypothesis that the preBötC only functions as the dominant 
respiratory rhythm generator after the respiratory has undergone a step in maturity. A 
previous in vivo study investigating the effects of fentanyl on breathing patterns of rats 
during early life has also reported an increase in the magnitude of the respiratory frequency 
depressant actions of fentanyl with advancing postnatal age (Greer et al., 1995). However 
this study only investigated fentanyl’s respiratory actions at 3 postnatal ages (P1, P4 and 
P10), thus the age-dependent effects were not as thoroughly assessed compared with the 
present study. The results from study 3 are also congruent with the findings from previous 
in vivo studies that have explored the acute respiratory effects of riluzole throughout 
postnatal life in mice (Dr Leanne McKay, personal communication, SFN abstract 2009). 
Riluzole, which depresses the activity of the RTN/pFRG, was also found to have age-
dependent respiratory depressive actions. Riluzole was reported to induce the greatest 
magnitude of respiratory depression in early life (P1-P3) when the respiratory system is 
still immature, which is in direct contrast to the age-dependent respiratory effects of 
fentanyl. Taken together, the fentanyl and riluzole experiments suggest that the level of 
involvement of the RTN/pFRG and the preBötC in respiratory rhythm generation change 
with postnatal development, with the RTN/pFRG functioning as the dominant respiratory 
oscillator in early life when the respiratory system is immature, and the preBötC 
functioning as the principal respiratory oscillator driving breathing rhythm after the 
respiratory system has matured. To complement the work carried out in the whole animal, 
it would be advantageous to also examine the age-dependent changes in fentanyl mediated 
depression of respiratory frequency in vitro by utilising the brainstem-spinal cord 
preparation, which retains the activity of both the preBötC and the RTN/pFRG. Activity of 
the preBötC and the RTN/pFRG in addition to respiratory motor output could be recorded 
in response to fentanyl. 
 
Fentanyl-induced changes in Vt throughout postnatal development and through to 
adulthood were less clear and did not follow the same age-dependent pattern as seen with 
fentanyl-induced changes in respiratory frequency. Mice did not exhibit an enhanced 
susceptibility to fentanyl-induced Vt depression after the proposed maturation step. In this 
study, Vt was presented as a relative change from baseline given that the accuracy of 
absolute Vt values calculated from neonatal plethysmography is disputed (see section 3.4.3 
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for full discussion). Fentanyl induced a reduction in Vt from P1-P7, but the magnitude of 
depression was not affected by postnatal age during this time window and therefore was 
also not influenced by respiratory maturation. Surprisingly, at P10, fentanyl did not induce 
a notable Vt depression. In contrast to the young mice, fentanyl elicited an increase in Vt in 
the adult (P30) mice. At present, there is no detailed explanation for these differential Vt 
responses. Furthermore, the reason(s) why fentanyl’s age-dependent modulation of 
respiratory frequency differs from the modulation of Vt also remains to be elucidated. It is 
likely that the fentanyl-mediated neural mechanisms that account for changes in Vt are 
distinct from those responsible for respiratory frequency changes. It has been reported that 
systemically administered fentanyl acutely reduces the excitability of phrenic premotor 
neurons as well as depressing the intensity of phrenic nerve discharge in the anaesthetised 
cat (Lalley, 2003). This suggests that fentanyl may act to depress Vt by direct actions at the 
level of the phrenic spinal nerves. Similar to the effects of fentanyl in the young mice (P1-
P7) there are numerous studies that have reported a depression of Vt after µ opioid 
administration in awake rats (van den Hoogen and Colpaert, 1986; Greer et al., 1995; 
Manzke et al., 2003; Moss et al., 2006; Ren et al., 2006; Greer and Ren, 2009; Montandon 
et al., 2011). However comparable to the fentanyl-induced increase in Vt observed in the 
adult mice in the present study, an augmentation in Vt in response to fentanyl has been 
previously reported by Colman and Miller (2001) who studied both neonatal and adult 
mice. These authors did however report a gasping breathing pattern in response to fentanyl, 
which was not observed in the present study. Additionally in contrast to our findings they 
did not report a difference in Vt response between neonatal and adult rats. A fentanyl-
induced increase in Vt is reported to be mediated via actions at the µ1-opioid receptor 
subtype, whereas a fentanyl-induced depression of Vt is believed to be mediated through 
the µ2- opioid receptor (Colman and Miller, 2001). It is interesting to consider the 
possibility that the age-dependent Vt effects seen in this present study were due to fentanyl 
exhibiting differential actions on the µ opioid receptor subtypes, however this has never to 
our knowledge been investigated. Opioid-induced changes in Vt in the awake rodent have 
been reported as highly complex (van den Hoogen and Colpaert, 1986), which is in 
agreement with our data. The mechanisms underlying the Vt responses to fentanyl 
throughout postnatal development cannot be deduced from this study alone, but certainly 
warrants further investigation. It is imperative to highlight the high degree of variability 
observed in the Vt response between individual animals in each age group, particularly the 
adults (P30). This high variability in the data adds to the difficulty in interpreting the 
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results and suggests the sample size should be increased to allow more definitive 
conclusions to be drawn.  
 
Given that we were interested in the direct effects of fentanyl on the preBötC and therefore 
on respiratory rhythm, the respiratory frequency changes which are an in vivo measure of 
central respiratory rhythm generation, were the most important measure. Although the 
fentanyl modulation of Vt throughout postnatal life is difficult to interpret, we found a 
trend towards an increased susceptibility to respiratory frequency depression after 
respiratory maturation, which supports our hypothesis. 
 
3.7.3 Study limitations and points to consider 
 
When interpreting the respiratory effects of fentanyl in relation to postnatal age in study 3 
it is imperative that the control data is also acknowledged. At P3 and P4, respiratory 
frequency displayed a significant decrease following administration of the saline vehicle. 
The reason for this unexpected depression in respiratory frequency could be due to natural 
fluctuations in baseline respiratory activity throughout the experimental procedure. Mice 
were contained within the plethysmograph chamber for a considerable period of time 
following drug administration and it is therefore likely that the arousal state (i.e. 
wakefulness, REM and non-REM sleep) varied throughout the duration of the experiment. 
Given that arousal state significantly influences respiratory activity (Aserinsky, 1965; 
Remmers et al., 1978; Horner, 2008; Pagliardini et al., 2012; Pagliardini et al., 2013), 
fluctuations in arousal state could explain the changes in respiratory frequency observed in 
the control experiments. While it is difficult to accurately monitor the behavioural state of 
neonatal mice using typical electroencephalogram (EEG) techniques (Karlsson and 
Blumberg, 2002), future experiments could measure nuchal muscle EMG activity, where a 
reduction in activity indicates the presence of sleep (Durand et al., 2005). The invasive 
nature of this technique could however influence baseline breathing. Another factor that 
could affect respiratory patterns and should be taken into consideration when interpreting 
the respiratory frequency changes in the control data is the impact of maternal separation. 
Neonatal mice were separated from their mother for approximately 2 hours during the 
experimental protocol. It has been reported that neonatal maternal separation (NMS) 
induces a stress-related increase in respiratory instability in the rat (Gulemetova and 
Kinkead, 2011). It is possible that NMS evoked stress responses that could have 
contributed somewhat to the fluctuations in respiratory frequency throughout the 
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experiment in the P3 and P4 control mice. These potentially confounding variables do not 
however explain why a significant change in respiratory frequency in the control 
experiments was not observed at all ages. Nonetheless, the fact that respiratory frequency 
reductions were observed in the absence of a respiratory depressant drug should be 
considered when interpreting the respiratory effects of fentanyl throughout postnatal 
development. This is particularly important when assessing respiratory modulation by 
fentanyl at P4, where the magnitude of respiratory frequency depression was comparable 
to that observed after saline administration. Furthermore, given the high degree of 
variability in the data from both the control and fentanyl experiments, increasing the 
number of mice studied at each postnatal age is essential and would help to reveal clearer 
data trends and increase the validity of the data. It would also be advantageous to increase 
the range of postnatal ages studied, particularly from P6 onwards, which would allow a 
more comprehensive analysis of fentanyl-induced respiratory modulation throughout 
postnatal life.   
 
It is important to consider other possible explanations for the enhanced fentanyl-induced 
respiratory frequency depression seen post-maturation that might not be related to a switch 
in the dominant neuronal group generating the respiratory rhythm. It is unlikely that age-
dependent differences in enzyme degradation and therefore metabolism of fentanyl could 
account for the differential respiratory sensitivity to fentanyl, given that this process 
appears to be fully functional by birth (Thornton et al., 1998). Furthermore, penetration of 
fentanyl across the blood brain barrier is also comparable between neonatal and juvenile 
mice (Thornton et al., 1998), so differences in the level of drug reaching the preBötC 
would not account for differential respiratory responses to fentanyl. Changes in the number 
of functional µ opioid receptors within the brainstem throughout the maturation period 
could account for changes in respiratory sensitivity to fentanyl. However, the effects of 
postnatal development on the density of µ opioid receptors in the brainstem of the mouse 
have received very little attention, and there are no reports on changes specifically within 
the preBötC. Autoradiography studies using radioligand binding have revealed that the 
number of µ opioid receptors in the whole mouse brain increase with age and show the 
greatest increase within the first few weeks after birth  (Tavani et al., 1985). Furthermore 
the number of µ opioid receptors expressed throughout the medulla is also found to display 
an age-dependent increase in the rat, with a low level of expression found in early postnatal 
life (Xia and Haddad, 1991; Kivell et al., 2004). It has therefore been concluded that µ 
opioid receptors are developmentally regulated in the brainstem. Importantly however, if 
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this age related increase in µ opioid receptors numbers is observed at the level of the 
preBötC is unknown.  If there is a change in the density of µ opioid receptors within the 
preBötC then this could contribute in part to the age-related alteration in respiratory 
sensitivity to fentanyl observed in this present study and should be considered. 
Immunohistochemical analyses of µ opioid receptors expression within the preBötC 
throughout postnatal life could be undertaken to provide further insight into the influence 
of postnatal maturation on µ opioid receptor regulation.          
 
One caveat of using fentanyl to investigate the effects of perturbing the rhythmic activity 
of the preBötC is the fact that this drug induces global actions throughout the body. 
Fentanyl likely also targeted other respiratory and non-respiratory central and peripheral 
sites which may have impacted on the change in respiratory activity. Furthermore, fentanyl 
was administered via an i.p injection; therefore the level of drug that reached the preBötC 
could not be controlled for and may have differed between individual animals. This could 
partly account for the high level of variability in the data. These study limitations should be 
taken into consideration when interpreting the data.    
 
3.7.4 Summary 
 
Study 2 has provided invaluable insight into the development of respiratory tolerance 
induced by repeated fentanyl exposure during early postnatal life. These findings have 
generated interest in the potential long-term respiratory consequences of such repeated 
opioid exposure. By utilising fentanyl as a pharmacological tool to target the preBötC in 
vivo in study 3, we have increased the understanding of age-dependent effects of fentanyl 
induced respiratory modulation. The data lends support to the hypothesis that the preBötC 
acts as the dominant respiratory oscillator driving breathing rhythm after the respiratory 
system has undergone a significant maturation step. In order to determine if the 
RTN/pFRG functions as the dominant rhythm generator at birth and during the first few 
days of life, further investigation is required. Moreover, the data from study 3 has helped to 
shed some light on the influence of postnatal maturation on central respiratory control.  
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Chapter 4. 
Long-term respiratory effects of repeated fentanyl 
exposure in neonatal and juvenile mice 
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4.1 Introduction 
 
In the clinical setting, including the paediatric population, opioids are the most widely used 
and effective pharmacological agents for treating chronic and acute pain (Swarm et al., 
2001; Niesters et al., 2013). In addition, opioids are utilised extensively as sedatives and 
anaesthetics (Anand et al., 1990; Booker, 1999; Tobias, 1999). The µ opioid receptor 
agonist, fentanyl, is currently one of the most frequently utilised opioid drugs owing to its 
high potency, fast onset of action, relatively short-acting nature as well as the fact it is 
metabolised to a number of pharmacologically inert metabolites (Fitzgerald and Teitler, 
1993; Booker, 1999; Saarenmaa et al., 1999). Fentanyl treatment is often administered for 
continuous and prolonged time periods to provide effective pain relief or sedation (Arnold 
et al., 1991; Dellemijn et al., 1998; Tobias, 1999; Kornick et al., 2003; Brill, 2013). The 
most widely acknowledged and potentially fatal side effect of fentanyl, as well as other 
opioid therapeutics, is respiratory depression (Pattinson, 2008). In clinical practice, 
respiratory function is routinely monitored during the acute period following opioid 
administration (Niesters et al., 2013); however despite the profound respiratory depressive 
actions of this class of drug, the long-term respiratory consequences of repeated opioid 
treatment, particularly during neonatal and infant life, has never to our knowledge been 
investigated clinically or in pre-clinical animal studies. To date, most pre-clinical rodent 
studies investigating the long-term effects of repeated opioid exposure in early life have 
focused on the development of tolerance and reduced sensitivity to the analgesic properties 
of the drugs (Thornton and Smith, 1998). There are, however, no detailed investigations 
into long-term changes in the sensitivity to the respiratory depressive actions of opioids 
after repeated exposure in early life.  
 
Rhythmic breathing is a fundamental physiological process essential to mammalian life. As 
thoroughly detailed in chapter 3, at birth and during early postnatal life, respiratory 
patterns generated by the respiratory system in rodents are irregular and display a variable 
frequency (Mortola, 2001). Furthermore, breathing is also irregular in newborn humans 
(Fisher et al., 1982; Mortola, 1984). This immaturity of the respiratory system and 
consequential fragile breathing phenotype could make early postnatal life a vulnerable time 
period for mammals, in particular to the lasting effects of opioid respiratory manipulation. 
In mice, the respiratory system is hypothesised to undergo a maturational change between 
postnatal days 2 and 3, after which breathing increases in frequency, becomes less variable 
and exhibits a more robust rhythmic pattern (see study 1, chapter 3). The mechanism(s) 
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underlying this step in maturity and in particular the level of involvement of the preBötC 
remain to be ascertained.  
 
As extensively discussed in chapters 1 and 3, there is a wealth of evidence to suggest the 
preBötC is a critical site for respiratory rhythmogenesis in mammals and is necessary for 
driving the rhythmic contractions of the inspiratory musculature (Smith et al., 1991; Gray 
et al., 2001; Janczewski et al., 2002; Mellen et al., 2003; McKay et al., 2005; Janczewski 
and Feldman, 2006; McKay and Feldman, 2008; Tan et al., 2008). In vitro and in vivo 
studies have highlighted the critical role of the preBötC in mediating respiratory frequency 
depression induced by opioids (Gray et al., 1999; Takeda et al., 2001; Mellen et al., 2003; 
Montandon et al., 2011). As discussed in chapter 3, it is believed that fentanyl can be used 
as a pharmacological tool to target the preBötC in vivo. Previous studies have investigated 
the lasting respiratory effects of preBötC neuronal destruction in adult rats to gain a better 
understanding of its role in respiratory rhythm generation in vivo (Gray et al., 2001; 
McKay et al., 2005; McKay and Feldman, 2008). Fentanyl can be utilised to ascertain the 
long-term effects of a milder pharmacological depression of the preBötC to help further 
elucidate its role in respiratory rhythmogenesis in vivo.  
 
4.1.1 Study aims and rationale 
 
Study 2 detailed in chapter 3 revealed that repeated fentanyl exposure throughout early 
postnatal development induced an acute respiratory desensitisation to the drug. The aim of 
the studies described in this chapter was to expand on these findings and further investigate 
the long-term respiratory effects of repeated fentanyl exposure in the mouse. Owing to the 
immaturity of the respiratory system and the corresponding fragile nature of breathing 
patterns during neonatal life in mammals, it was of interest to investigate the long-term 
effects of fentanyl exposure during this vulnerable respiratory time period, which also 
encompasses the critical respiratory maturation step. To determine if the postnatal age of 
fentanyl-exposure influences long-term respiratory effects, fentanyl exposure during 
juvenile life which is regarded as being post-respiratory maturation, was also investigated. 
These studies were designed to give invaluable insight into the susceptibility of the 
respiratory system including that of the preBötC, to the effects of repeated opioid 
depression at various time periods in early life. From a clinical rationale, the studies 
detailed in this chapter may also provide novel insight into the potential long-term 
respiratory consequences of repeated or prolonged fentanyl exposure in human neonates 
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and infants, and to ascertain if there is a time period in early life that may be particularly 
vulnerable to respiratory depression. Given that long-term tolerance to the antinociceptive 
properties of fentanyl have been observed in juvenile rats chronically exposed to the drug 
(Thornton and Smith, 1998), it was of particular interest to determine if neonatal and 
juvenile repeated fentanyl exposure induces long-term changes in sensitivity to the acute 
respiratory depressive actions of fentanyl that can be seen later in life. 
 
Study 4: Investigation of the long-term respiratory effects of repeated 
fentanyl exposure in the neonatal mouse 
 
Aim: To determine if repeated fentanyl exposure during neonatal life induces long-term 
alterations in respiratory activity as well as the acute respiratory response to subsequent 
fentanyl exposure in mice in vivo. When mice reached adulthood their respiratory activity 
was assessed when they were awake and then when anaesthetised. The anaesthetised state 
not only allowed more detailed in vivo respiratory measurements to be obtained, but also 
permitted the examination of breathing in a depressed brain state.   
 
Study 5: Investigation of the long-term respiratory effects of repeated 
fentanyl exposure in the juvenile mouse 
 
Aim: To determine if repeated fentanyl exposure during juvenile life induces long-term 
changes in respiratory activity as well as the acute respiratory response to subsequent 
fentanyl exposure in mice in vivo. When the mice reached adulthood their respiratory 
activity was assessed when they were awake and then when anaesthetised.  
 
4.1.2 Hypotheses 
 
Study 4 
Owing to the fragility of breathing patterns in neonatal life, it was hypothesised that 
neonatal fentanyl exposure would induce long-term changes in respiratory activity. 
Furthermore, given that repeated fentanyl exposure in neonatal life induces an acute 
desensitisation to the respiratory depressive actions of the drug (study 2, chapter 3) it was 
hypothesised that this desensitisation would continue into adulthood.  
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Study 5 
Since breathing follows a more stable and rhythmic pattern in juvenile life, it was 
hypothesised that juvenile fentanyl exposure would induce less pronounced long-term 
changes in respiratory activity compared to neonatal exposure. It was also hypothesised 
that repeated juvenile fentanyl exposure would induce a long-term desensitisation to the 
respiratory depressive actions of fentanyl observed in adulthood.  
 
4.2 Methods 
 
4.2.1 Animals 
 
All experimental procedures were carried out under licence from the UK Home Office and 
performed in accordance with the Animals (Scientific Procedures) Act, 1986. Experiments 
detailed in this chapter were performed on male ICR mice. Female mice were not studied 
as they displayed a variable and unpredictable reaction to the urethane anaesthesia. All 
mice were bred at the Wellcome Surgical Institute animal research facility. A total of 42 
mice were used in study 4 and 32 mice in study 5. All mouse pups were housed with their 
mother until they reached weaning age (21 days old), after which they were housed 
according to their sex in groups of no more than six. Mice were maintained on a 12 hour 
light/dark cycle with food and water available ad libitum.  
 
4.2.2 Study design 
 
Both study 4 and study 5 were longitudinal in nature. Repeated exposure to fentanyl or a 
saline vehicle took place during neonatal life (P1-P5, study 4) or juvenile life (P9-P13, 
study 5). Repeated exposure was defined as a single i.p. injection of 0.04 mg/kg fentanyl 
per day for 5 consecutive days. In both study 4 and 5, monitoring of respiratory activity did 
not take place until mice reached adulthood (6 weeks old). Baseline respiratory activity 
was measured as well as the ventilatory response to an acute fentanyl challenge when mice 
were awake and then repeated under anaesthesia. A range of fentanyl doses were studied in 
adulthood to determine if pre-exposure to fentanyl influences future respiratory responses 
to the drug, and if these responses are dose dependent. A subgroup of mice from study 4 
followed a protocol designed to investigate chemosensory responses in the wakeful state 
and determine if repeated fentanyl exposure evokes lasting changes in chemosensory 
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functions. These chemosensory experiments were the only experiments undertaken in this 
group of mice. Schematic illustrations of the design of study 4 and study 5 are shown in 
Figure 4-1 and Figure 4-2, respectively. Full details of all experimental protocols are 
described in the subsequent method sections of this chapter.   
 
4.2.3 Repeated fentanyl exposure 
 
Study 4: Neonatal fentanyl exposure 
Neonatal mice were repeatedly administered fentanyl citrate (Janssen-Cilag, UK) from P1-
P5 (n=21). Each mouse pup received a single intraperitoneal (i.p) dose of 0.04 mg/kg 
(same dose as administered in study 2, detailed in chapter 3) on each postnatal day. Control 
mice (n=21) were administered an equivalent volume of physiological saline the vehicle 
used for fentanyl, throughout the same postnatal period.  
 
Study 5: Juvenile fentanyl exposure 
Juvenile mice were repeatedly administered fentanyl citrate (Janssen-Cilag, UK ) from P9-
P13 (n=16). Each mouse pup received a single i.p dose of 0.04 mg/kg on each postnatal 
day. Control mice (n=16) were administered an equivalent volume of physiological saline 
the vehicle used for fentanyl, throughout the same postnatal period.  
 
4.2.4 Definition of experimental groups 
 
Mice repeatedly exposed to fentanyl in neonatal life (P1-P5, study 4) are defined in this 
thesis as neonatal-exposed. The corresponding saline-exposed mice are referred to as 
controls. 
 
Mice repeatedly exposed to fentanyl in juvenile life (P9-P13, study 5) are defined in this 
thesis as juvenile-exposed. The corresponding saline-exposed mice are referred to as 
controls. 
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Figure 4-1. Experimental protocols undertaken in study 4. Mice repeated exposed to fentanyl in neonatal life are referred to as 
neonatal-exposed. Respiratory monitoring began when mice reached adulthood (6 weeks). Baseline respiratory measurements and an 
acute respiratory response to a single fentanyl challenge were measured when mice were awake and also when anaesthetised. A range of 
fentanyl doses were studied. Mice were assigned to one of 4 fentanyl doses in the plethysmography experiments (0.04, 0.06, 0.08 or 0.1 
mg/kg) as well as the anaesthetised experiments (0.01, 0.02, 0.04 or 0.06 mg/kg). In a subgroup of control and neonatal-exposed mice, 
only chemosensitivity experiments were carried out in adult life. 
 140 
 
 
 
 
 
 
 
 
Figure 4-2. Experimental protocols undertaken in study 5. Mice repeatedly exposed to fentanyl in juvenile life are referred to as 
juvenile-exposed. Respiratory monitoring began when mice reached adulthood (6 weeks). Baseline respiratory activity and the acute 
respiratory response to a single fentanyl challenge were measured when mice were awake and also when anaesthetised. A range of 
fentanyl doses were studied. Mice were assigned to one of 4 fentanyl doses in plethysmography (0.04, 0.06, 0.08 or 0.1 mg/kg) and in 
anaesthetised experiments (0.01, 0.02, 0.04 or 0.06 mg/kg).
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4.2.5 Respiratory recording in awake adult mice 
 
4.2.5.1 Baseline breathing and acute respiratory response to fentanyl challenge 
 
In both studies 4 and 5, when mice reached adulthood their resting respiratory activity 
(under normoxic conditions) as well as the acute respiratory response to fentanyl was 
examined. Resting breathing parameters were first recorded when mice were in a 
conscious state and freely behaving, using the non-invasive technique of whole-body 
plethysmography (see section 2.3). Before experimental sessions began, animals were 
given 45 minutes to habituate to the recording chamber. Between respiratory recordings, 
the recording chamber was supplied with humidified air (21% O2, balanced N2) at a rate of 
2 l/min. Three baseline respiratory recordings were taken (each recording was 2 minutes in 
duration), approximately 15 minutes apart. After measurement of resting, baseline 
respiration, the acute ventilatory response to a single fentanyl challenge was recorded. A 
range of fentanyl doses were examined, and each mouse was assigned to receive only one 
dose. Mice were removed from the recording chamber and injected (i.p) with a single 
fentanyl dose of 0.04, 0.06, 0.08 or 0.1 mg/kg, and after placement back into the chamber, 
their ensuing respiratory output was recorded at 5, 15, 30 and 45 minutes post-injection. 
Recording of respiration at each time point lasted 2 minutes. At the end of every 
respiratory recording, a calibration volume of 0.1 ml was injected into the recording 
chamber.    
 
4.2.5.2 Chemosensitivity experiments 
 
In study 4, the chemosensory responses of a subgroup of control (n=5) and neonatal-
exposed mice (n=5) were tested when they reached adulthood. This was the only 
experimental procedure undertaken on this group of mice. Respiratory parameters were 
measured under normoxic (21% O2), hypercapnic (3%, 5% and 8% CO2) and hypoxic 
(10% O2) conditions using whole-body plethysmography. Before experimental sessions 
began, animals were given 45 minutes to habituate to the recording chamber. Three 
baseline respiratory recordings were then taken approximately 15 minutes apart under 
normoxic conditions (air, 21% O2, balanced N2). The recording chamber was then filled 
with a 3% CO2 gas mixture (3% CO2, 21% O2, balanced N2) for 10 minutes at a rate of 2 
l/min. At the end of the 10 minute period, a 2 minute respiratory recording was taken. This 
protocol was then repeated for 5% CO2 (5% CO2, 21% O2, balanced N2) and 8% CO2 (8% 
 142 
 
CO2, 21% O2, balanced N2). Following exposure to the final hypercapnic stimuli, the 
recording chamber was flushed with air (2 l/min) and respiratory recordings were taken at 
2 minutes, 15 minutes and 30 minutes to assess post-hypercapnic recovery. The recording 
chamber was then filled with a hypoxic gas mixture (10% O2, balanced N2; 2 l/min) and 
respiratory recordings were taken at 5 minutes and 10 minutes during hypoxic exposure. 
The recording chamber was then flushed with air (2 l/min) and respiratory recordings were 
taken at 2 minutes, 15 minutes and 30 minutes post-hypoxia to measure respiratory 
recovery. At the end of every respiratory recording, which lasted 2 minutes, a calibration 
volume of 0.1 ml was injected into the recording chamber.       
 
4.2.6 Respiratory analysis in awake adult mice 
 
To measure respiratory variables, the plethysmography recordings were analysed using 
Spike 2 software (see section 2.5). Only periods of quiet resting breathing were analysed 
given that movement distorts the respiratory signal. Blinding to the identity of the 
experimental group was carried out during analysis. 
 
4.2.6.1 Baseline breathing and acute respiratory response to fentanyl challenge 
 
Baseline respiratory frequency, inspiratory duration, expiratory duration, Vt and Ve were 
analysed on a breath by breath basis (see chapter 2, section 2.5.1 for further details). All 
three baseline respiratory recordings were analysed and the data was compiled to generate 
a baseline value for each respiratory parameter. Respiratory frequency, Vt and Ve were 
also calculated at 5 minutes, 15 minutes, 30 minutes and 45 minutes post-fentanyl 
exposure to determine the acute effects of the challenge. Absolute changes in these 
parameters as well as relative changes (percentage change) from baseline are presented. 
 
4.2.6.2 Chemoresponses 
 
In the experiments assessing chemosensory responses in study 4, changes in respiratory 
frequency, Vt and Ve in response to hypercapnia and hypoxia as well as respiratory 
recovery from the stimuli were analysed using Spike 2 software (Cambridge Instruments, 
UK). 
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4.2.7 Statistical analysis of respiratory variables in awake adult mice  
 
All statistical analyses were performed using GraphPad Prism4 software. The following 
statistical analyses were carried out for both studies 4 and 5.  
 Unpaired t-tests were performed to compare baseline respiratory frequency, 
inspiratory duration, expiratory duration, Vt and Ve between control and repeatedly 
exposed mice.  
 For control and repeatedly-exposed mice, fentanyl-induced acute changes in 
respiratory frequency, Vt, and Ve across time were analysed using a 2-way 
ANOVA with Bonferroni’s post test.  
 
The following statistical analyses were carried out for the chemosensitivity experiments in 
study 4. 
 A comparison of respiratory variables (respiratory frequency, Vt, and Ve) between 
control and neonatal-exposed mice under each of the respiratory stimuli was 
performed using a 2-way ANOVA with Bonferroni’s post test. 
 
Differences were regarded as significant if p<0.05. All data are presented as mean ± SD. 
 
4.2.8 Respiratory recording in anaesthetised adult mice  
 
In addition to plethysmographic breathing measurements, baseline respiratory activity and 
the acute respiratory response to a fentanyl challenge was also examined under 
anaesthesia. Mice were anaesthetised with an i.p. injection of urethane (initial injection of 
1.5 g/kg followed by three 0.25 g/kg supplementary injections administered 5 minutes 
apart), transorally intubated and allowed to spontaneously breathe room air without 
ventilatory aid for the duration of the experimental procedure. Body temperature was 
monitored via a rectal probe and maintained between 36.5 and 37
°
C using a heat lamp. 
Respiratory airflow, genioglossus EMG activity (GGEMG) and abdominal muscle EMG 
activity (ABDEMG) were continually recorded for the duration of each experiment as 
previously described (chapter 2, section 2.6). It would have been desirable to obtain 
diaphragm EMG activity as this is the principal inspiratory muscle; however due to 
unforeseen technical issues, it was not possible to make this measurement (see discussion 
section 4.5.7 for further information). Animals were given 30 minutes to stabilise before 
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baseline respiratory activity was recorded continuously for 10 minutes. Following this 
control period, mice were injected i.p with a single dose of 0.01, 0.02, 0.04 or 0.06 mg/kg 
of fentanyl. Respiratory airflow and respiratory muscle EMG activity were monitored and 
recorded for 60 minutes post-fentanyl injection.  
 
4.2.9 Respiratory analysis in anaesthetised adult mice 
 
All respiratory variables were analysed on a breath by breath basis using Spike 2 software 
(Cambridge Instruments). Respiratory frequency, inspiratory duration, expiratory duration, 
Vt, Ve and GGEMG activity were analysed throughout the 10 minute baseline period (see 
chapter 2, section 2.6.4 for further details on calculation of these respiratory variables). 
The number of augmented breaths observed during the 10 minute period of baseline 
breathing was also quantified. An augmented breath is defined as an increased respiratory 
effort with a tidal volume >50% of a regular breath. Respiratory frequency, Vt, Ve and 
GGEMG activity were also analysed at 5 minute time points post-fentanyl injection until 30 
minutes, then at 45 minutes and 60 minutes post-injection. At each time point, a total of 30 
seconds of continuous recording was analysed. Blinding to the identity of the experimental 
group was carried out during analysis. 
 
4.2.10 Statistical analysis of respiratory variables in anaesthetised adult 
mice 
 
All statistical analyses were performed using GraphPad Prism4 software. All statistical 
tests described were performed for both studies 4 and 5.  
 Unpaired t-tests were performed to compare baseline respiratory frequency, 
inspiratory duration, expiratory duration, Vt, Ve and GGEMG activity between 
control and repeatedly exposed mice. A Mann Whitney test was performed to 
compare the number of augmented breaths observed during baseline breathing 
between control and repeatedly exposed mice.  
 To compare fentanyl-induced acute changes in respiratory frequency, Vt, Ve and 
GGEMG activity across time between control and repeatedly exposed mice, a 2-way 
ANOVA with Bonferroni’s post test was used.  
 
Differences were regarded as significant if p<0.05. All data are presented as mean ± SD. 
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4.3 Results of study 4: Investigation of the long-term respiratory 
effects of repeated fentanyl exposure in the neonatal mouse 
 
Results from study 4 are presented in section 4.3  
 
4.3.1 Animal body weights 
 
There was no significant difference in the average body weights of neonatal-exposed and 
control mice during the drug exposure period from P1-P5 or when they reached adulthood 
(p>0.05, 2-way ANOVA, Table 4-1).  
 
  
  
 Weight (g) 
Postnatal Age Control Neonatal-Exposed 
P1 1.6±0.3 1.8±0.3 
P2 2.0±0.5 2.2±0.2 
P3 2.8±0.4 2.7±0.3 
P4 3.3±0.4 3.1±0.5 
P5 3.9±0.3 3.7±0.7 
Adult 36.4±4.7 38.9±3.2 
 
Table 4-1. Average body weights of control and neonatal-exposed mice. 
Body weight was measured throughout the repeated drug exposure period (P1-
P5) and on reaching adulthood. Data presented as mean±SD. No significant 
difference in body weight between the two experimental groups at all ages, 2-way 
ANOVA.
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4.3.2 Baseline respiratory parameters of awake adult mice 
 
In the wakeful state, adult mice (6 weeks old) which were neonatal-exposed had a 
significantly lower baseline respiratory frequency compared to control mice (150±8 bpm 
vs 180±6 bpm, p<0.05, Figure 4-3A), owing to the fact that neonatal-exposed mice 
exhibited a significantly longer inspiratory duration (0.16±0.01 s vs 0.12±0.01 s, p<0.05, 
Figure 4-3B). Expiratory duration was comparable between the two experimental groups 
(neonatal-exposed: 0.26±0.02 s; control: 0.23±0.01 s p>0.05, Figure 4-3C), as was Vt 
(neonatal-exposed: 12±1 µl/g; control: 13±1 µl/g, p>0.05, Figure 4-3D). Due to the 
significantly lower respiratory frequency, neonatal-exposed mice also displayed a 
significantly lower baseline Ve compared to control mice (1797±149 µl/g/min vs 2223±98 
µl/g/min, p<0.05, Figure 4-3E). It should be noted that no obvious respiratory 
abnormalities or ataxic breathing patterns were observed in any of the control or neonatal-
exposed mice. The changes in the respiratory phenotype appeared to be mild. 
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Figure 4-3. Baseline respiratory parameters of adult control and neonatal-exposed mice during wakefulness. Control mice, n=16; 
neonatal-exposed, n=16. Each data point on the scatter plots represents an individual animal. Line denotes the mean. * p<0.05, Student ’s 
unpaired t-test. 
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4.3.3 Acute fentanyl challenge in awake mice 
 
Both control and neonatal-exposed mice were subjected to a fentanyl challenge in 
adulthood. The acute respiratory response to the fentanyl challenge was first measured in 
the wakeful state. A range of fentanyl doses (0.04 mg/kg-0.1 mg/kg) were investigated and 
mice were assigned to receive only one dose. 
 
4.3.3.1 Respiratory Frequency 
 
In the control groups, all 4 fentanyl doses evoked a continual reduction in respiratory 
frequency from baseline, with the greatest reduction evident at 30 minutes post-injection 
(Figure 4-4). Respiratory frequency was significantly lower at 30 minutes post 0.04, 0.06 
and 0.1 mg/kg fentanyl challenge compared to baseline (0.04 mg/kg: 147±17 bpm vs 
baseline: 193±27 bpm, p<0.05, Figure 4-4A; 0.06 mg/kg: 137±10 bpm vs baseline: 174±11 
bpm, p<0.05, Figure 4-4B; 0.1 mg/kg: 136±18 bpm vs baseline: 171±18 bpm, p<0.05, 
Figure 4-4D). Respiratory frequency showed a clear trend towards a reduction from 
baseline at 30 minutes post 0.08 mg/kg fentanyl in the control group (baseline: 181±32 
bpm vs 30 mins post-fentanyl: 134±50 bpm, p>0.05, Figure 4-4C). For all doses of 
fentanyl, respiratory frequency returned to baseline values by 45 minutes post injection in 
the control groups (Figure 4-4A-D). 
 
In contrast to the control mice, even at the highest dose, a fentanyl challenge failed to 
induce a depression of respiratory frequency in neonatal-exposed mice. No significant 
reduction in respiratory frequency from baseline was found at any of the time points 
examined for any of the fentanyl doses injected (p>0.05, Figure 4-4A-D). Interestingly, at 
5 minutes post-fentanyl insult, the neonatal-exposed mice displayed an unexpected 
increase in respiratory frequency. This was found to be statistically significant after 0.06 
mg/kg and 0.01 mg/kg fentanyl challenge (p<0.05, Figure 4-4B and D). This augmented 
respiratory frequency was not exhibited by the control mice. When looking at the 
percentage change in respiratory frequency from baseline in response to fentanyl (Figure 4-
5), it is evident that the neonatal-exposed mice displayed marked differences in their acute 
respiratory response to all doses of fentanyl compared to control mice. These data reiterate 
the changes in absolute respiratory frequency values shown in Figure 4-4 and clearly 
illustrates the differential frequency response to fentanyl between control and neonatal-
exposed mice.  At 30 minutes post-fentanyl, control mice showed a clear reduction in 
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respiratory frequency from baseline (0.04 mg/kg: 23±2% reduction, 0.06 mg/kg: 21±4% 
reduction, 0.08 mg/kg: 27±16% reduction, 0.1 mg/kg: 20±10% reduction, Figure 4-5), 
which was not seen in the neonatal-exposed mice (0.04 mg/kg: 8±9% reduction, 0.06 
mg/kg: 5±13% reduction, 0.08 mg/kg: 1±1% increase, 0.1 mg/kg: 10±18% increase, Figure 
4-5). At 5 minutes post fentanyl injection, the increase in respiratory frequency exhibited 
by the neonatal-exposed mice ranged from 14±11% to 49±30% depending on the dose of 
fentanyl administered (Figure 4-5). This increase was not dose related. 
 
4.3.3.2 Tidal volume 
 
In the control group, fentanyl at all doses did not induce any significant changes in Vt at 
any of the time points post-injection (p>0.05 Figure 4-6). At 5 minutes post 0.04 and 0.06 
mg/kg fentanyl, there was a trend towards an increase in Vt from baseline (0.04 mg/kg: 
15±2 µl/g vs baseline: 13±2 µl/g, p>0.05 Figure 4-6A; 0.06 mg/kg: 17±3 µl/g vs baseline: 
13±3 µl/g, p>0.05, Figure 4-6B). At 15 minutes post injection of 0.1 mg/kg fentanyl there 
was also a trend towards an increase in Vt from baseline (17±2 µl/g vs baseline: 14±5 µl/g, 
p>0.05 Figure 4-6D). Administration of 0.04 mg/kg and 0.1 mg/kg fentanyl to the 
neonatal-exposed mice evoked a significant increase in Vt at 5 minutes and 15 minutes 
post-injection (p<0.05, Figure 4-6A and D). Administration of 0.06 mg/kg fentanyl to the 
neonatal-exposed mice induced a significant increase in Vt from baseline seen at 5 minutes 
post-fentanyl (p<0.05, Figure 4-6B). There was a trend towards an increase in Vt at 5 
minutes after 0.08 mg/kg fentanyl administration in the neonatal-exposed mice (p>0.05, 
Figure 4-6C). Figure 4-7 illustrates the Vt response to fentanyl as a percentage change 
from baseline. From this figure, it is apparent that the neonatal-exposed mice exhibited a 
large percentage increase in Vt from baseline in response to fentanyl, particularly at the 5 
minute time point following the fentanyl challenge (0.04 mg/kg: 57±30% increase, 0.06 
mg/kg: 77±34% increase, 0.1 mg/kg: 74±20% increase, Figure 4-7A, B and D).  The Vt 
increase was not as pronounced following 0.08 mg/kg fentanyl (Figure 4-7C). Whilst Vt 
increases in response to fentanyl were seen in the control mice at 5, 15 and 30 minutes 
after injection, the magnitude was smaller than that displayed by the neonatal-exposed 
mice (Figure4-7A-D).  
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4.3.3.3 Minute ventilation 
 
Fentanyl given at a dose of 0.04 mg/kg and 0.06 mg/kg, induced a significant increase in 
Ve observed at 5 minutes post-administration in the control mice (0.04 mg/kg: 2358±1453 
µl/g/min vs 3185±183 µl/g/min; 0.06 mg/kg: 2134±485 µl/g/min vs 3207±1070 µl/g/min 
for baseline vs 5 mins post-fentanyl respectively, p<0.05, Figure 4-8A and B). This 
increase is likely due to the trend towards the increased Vt at this time point (Figure 4-6).  
There was no significant change in Ve at any of the other time points studied (p>0.05, 
Figure 4-8A and B). In the control mice, Ve remained unchanged at all time points 
following 0.08 mg/kg and 0.1 mg/kg fentanyl challenge (Figure 4-8C and D). Owing to the 
increases in both respiratory frequency and Vt in response to fentanyl, the Ve of the 
neonatal-exposed mice showed a significant increase 5 minutes after injection of 0.04 
mg/kg, 0.06 mg/kg and 0.1 mg/kg fentanyl (p<0.05, Figure 4-8A,B and D). There was a 
trend toward an increase in Ve in response to 0.08 mg/kg fentanyl at 5 minutes post-
injection (p>0.05, Figure 4-8C). In the neonatal-exposed group, Ve was comparable with 
baseline values at 10, 15 and 45 minutes post-injection, except in the group administered 
0.1 mg/kg, where Ve remained significantly elevated up to 15 minutes post-fentanyl. When 
observing the percentage changes in Ve in response to all doses of fentanyl, it is evident 
that when compared to the control group, neonatal-exposed mice exhibited a greater 
fentanyl-induced increase in Ve at 5 minutes following administration (Figure 4-9).   
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Figure 4-4. Changes in respiratory frequency in response to a single fentanyl challenge in control and neonatal-exposed mice 
when awake. Acute response to 0.04 mg/kg fentanyl (A), 0.06 mg/kg fentanyl (B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). 
Control mice; n=4, neonatal-exposed; n=4 for all 4 fentanyl groups. Data presented as mean±SD. * denotes a significant difference 
(p<0.05) from baseline, 2-way ANOVA with Bonferroni’s post test. 
0.04mg/kg fentanyl
Control Neonatal-Exposed
0
50
100
150
200
250
Baseline
5mins post-fentanyl
15mins post-fentanyl
30mins post-fentanyl
45mins post-fentanyl
R
e
s
p
ir
a
to
ry
 F
re
q
u
e
n
c
y
 (
b
p
m
)
0.06mg/kg fentanyl
Control Neonatal-Exposed
0
50
100
150
200
250
R
e
s
p
ir
a
to
ry
 F
re
q
u
e
n
c
y
 (
b
p
m
)
0.08mg/kg fentanyl
Control Neonatal-Exposed
0
50
100
150
200
250
R
e
s
p
ir
a
to
ry
 F
re
q
u
e
n
c
y
 (
b
p
m
)
0.1mg/kg fentanyl
Control Neonatal-Exposed
0
50
100
150
200
250
R
e
s
p
ir
a
to
ry
 F
re
q
u
e
n
c
y
 (
b
p
m
)
A B
C D
*
*
**
*
*
 152 
 
 
 
 
 
 
 
Figure 4-5. Percentage change in respiratory frequency in response to a single fentanyl challenge in control and neonatal-
exposed mice when awake. Data shown as a percentage change from baseline. Acute response to 0.04 mg/kg fentanyl (A), 0.06 mg/kg 
fentanyl (B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). Control mice; n=4, neonatal-exposed; n=4 for all 4 fentanyl groups. Data 
presented as mean±SD.
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Figure 4-6. Changes in tidal volume (Vt) in response to a single fentanyl challenge in control and neonatal-exposed mice when 
awake. Acute Vt response to 0.04 mg/kg fentanyl (A), 0.06 mg/kg fentanyl (B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). Control 
mice; n=4, neonatal-exposed; n=4 for all 4 fentanyl groups. Data presented as mean±SD. * denotes a significant difference (p<0.05) from 
baseline, 2-way ANOVA with Bonferroni’s post test. 
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Figure 4-7. Percentage change in tidal volume (Vt) in response to a single fentanyl challenge in control and neonatal-exposed 
mice when awake. Data shown as a percentage change from baseline. Acute response to 0.04 mg/kg fentanyl (A), 0.06 mg/kg fentanyl 
(B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). Control mice; n=4, neonatal-exposed; n=4 for all 4 fentanyl groups. Data presented 
as mean±SD.
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Figure 4-8. Changes in minute ventilation (Ve) in response to a single fentanyl challenge in control and neonatal-exposed mice 
when awake. Acute Ve response to 0.04 mg/kg fentanyl (A), 0.06 mg/kg fentanyl (B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). 
Control mice; n=4, neonatal-exposed; n=4 for all 4 fentanyl groups. Data presented as mean±SD. * denotes a significant difference 
(p<0.05) from baseline, 2-way ANOVA with Bonferroni’s post test. 
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Figure 4-9. Percentage change in minute ventilation (Ve) in response to a single fentanyl challenge in control and neonatal-
exposed mice when awake. Data shown as a percentage change from baseline. Acute Ve response to 0.04 mg/kg fentanyl (A), 0.06 
mg/kg fentanyl (B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). Control mice; n=4, neonatal-exposed; n=4 for all 4 fentanyl groups. 
Data presented as mean±SD. 
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4.3.3.4 Plethysmography respiratory traces 
 
Baseline breathing and the differential acute respiratory response to a fentanyl challenge 
exhibited between the control and neonatal-exposed mice can be clearly seen from Figure 
4-10, which shows example plethysmography respiratory traces before and after 
administration of the lowest dose of 0.04 mg/kg fentanyl (A) and the highest dose of 0.1 
mg/kg fentanyl (B). It is clear that both groups of mice displayed rhythmic baseline 
breathing with no respiratory disturbances or irregularities. From the respiratory traces it is 
also apparent that the neonatal-exposed mice had a lower baseline respiratory frequency 
compared to the control mice (Figure 4-10A and B). It is evident that fentanyl, at both 
doses, induced a reduction in respiratory frequency and caused an increase in Vt at 30 
minutes following administration in the control mice. However, the traces taken from the 
neonatal-exposed mice show that in contrast to the control mice, fentanyl at both doses 
failed to induce a respiratory depression from baseline, but rather evoked an increase in 
both respiratory frequency and Vt at 5 minutes after the challenge.  
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Figure 4-10. Representative respiratory traces before and after fentanyl challenge in control and neonatal-exposed mice. The 
effects of 0.04 mg/kg (A) and 0.1 mg/kg fentanyl (B) are shown. It is evident that fentanyl at both doses did not induce respiratory 
depression in the neonatal-exposed mice.  
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4.3.4 Chemosensitivity 
 
In a subgroup of neonatal-exposed (n=5) and control mice (n=5), chemosensory responses 
were assessed in adult life when the mice were in the wakeful state. Both groups of mice 
displayed similar chemosensory responses to hypercapnia and hypoxia and exhibited a 
comparable respiratory recovery from the stimuli (Figure 4-11). No significant difference 
in the respiratory parameters under each of the chemosensory stimuli was found between 
the experimental groups (p>0.05, Figure 4-11 A-C). Both groups of mice displayed an 
increase in respiratory frequency, Vt, and therefore Ve in response to the increasing 
intensity of hypercapnic stimuli (3%, 5% and 8% CO2). When normoxia was re-
established, respiratory frequency, Vt and Ve returned to baseline values by 15 minutes 
and were still maintained within baseline levels 30 minutes following hypercapnia. After 5 
minutes exposure to hypoxia (10% O2), respiratory frequency of both control and neonatal-
exposed mice increased but began to show a trend towards a decrease by 10 minutes of 
exposure. Vt did not change in response to either 5 minutes or 10 minutes of hypoxia 
exposure in both experimental groups. Ve increased after 5 minutes exposure to hypoxia 
and then started to decrease by 10 minutes exposure in both control and neonatal-exposed. 
These changes in Ve were due to the corresponding hypoxia-induced changes in 
respiratory frequency. At the 2 minute recovery period (under normoxia) following 
hypoxia, both groups of mice exhibited a respiratory frequency, Vt and Ve comparable to 
baseline values, which was maintained up to 30 minutes following hypoxic exposure.  
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Figure 4-11. Respiratory responses of control and neonatal-exposed mice to hypercapnic and hypoxic stimuli in the wakeful 
state. Respiratory frequency (A) tidal volume (B) and minute ventilation (C) were measured under each respiratory stimulus. Control: n=5; 
neonatal-exposed: n=5. No significant difference in the respiratory parameters under each respiratory stimulus was found between the 
experimental groups, p>0.05, 2-way ANOVA. Data presented as mean±SD.
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4.3.5 Baseline respiratory parameters of adult mice under anaesthesia 
 
After respiratory monitoring in the conscious state, a more detailed respiratory analysis 
was carried out in anaesthetised mouse preparations. When under anaesthesia, the baseline 
respiratory frequency was comparable between the two experimental groups (neonatal-
exposed: 165±10 bpm, control: 181±9 bpm, p>0.05, Figure 4-12A). In accordance with 
this, both groups exhibited a similar inspiratory duration (neonatal-exposed: 0.14±0.001 s; 
control: 0.15±0.004 s, p>0.05, Figure 4-12B) and expiratory duration (neonatal-exposed: 
0.25±0.03 s; control: 0.20±0.02 s, p>0.05, Figure 4-12C). Under anaesthesia, the neonatal-
exposed mice had a significantly lower baseline Vt compared to control mice (4±0.2 µl/g 
vs 5±0.1 µl/g, p<0.05, Figure 4-12D). As a result of the significantly lower Vt, the 
neonatal-exposed mice also displayed a significantly lower Ve than the control group 
(663±59 µl/g/min vs 863±45 µl/g/min, p<0.05, Figure 4-12E).  Interestingly, both groups 
of mice displayed a reduced baseline Vt compared with the values observed during 
wakefulness (wakefulness; neonatal-exposed: 12±1 µl/g, control: 13±1 µl/g, Figure 4-3D). 
No significant difference in baseline GGEMG amplitude was found between the 
experimental groups (neonatal-exposed: 0.15±0.03 a.u; control: 0.18±0.13 a.u; p>0.05, 
Figure 4-12F). It is important to highlight that in all experimental mice, the GG muscle 
displayed a rhythmic, inspiratory-related mode of activity (Figure 4-13).  
 
From the outset of study 4, one of the aims was to gain a measure of baseline expiratory 
muscle function to determine if this differed between the two experimental groups. The 
abdominal muscles have been previously reported to exhibit expiratory-related activity in 
urethane-anaesthetised rats (Pagliardini et al., 2012) thus their activity was recorded in this 
study. However, rhythmic expiratory ABDEMG activity (i.e. muscle firing concurrently with 
expiratory airflow in the absence of GGEMG activity) was found in only two of the mice 
studied (1 control and 1 neonatal-exposed), and in these mice the rhythmic activity 
appeared suddenly and was of short duration (approximately 2 minutes). In all 
experimental mice, abdominal muscle activity was predominantly sporadic in nature and 
did not appear to be respiratory-modulated. For this reason, no quantitative analysis of 
abdominal muscle activity was performed. Examples of non-respiratory related and 
expiratory-modulated ABDEMG activity observed in study 4 are illustrated in Figure 4-13. 
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Figure 4-12. Baseline respiratory parameters of adult control and neonatal-exposed mice under anaesthesia. Control mice, n=16; 
Neonatal-exposed, n=16. Each data point on the scatter plots represents an individual animal. Line denotes the mean.  * p<0.05, Student’s 
unpaired t-test. 
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Figure 4-13. Examples of baseline GGEMG and ABDEMG activity. In all 
experimental mice, the GG showed an inspiratory-modulated pattern of activity (A 
and B). Sporadic, non-expiratory related ABD muscle activity was exhibited by all 
urethane-anaesthetised mice (A). Rhythmic, expiratory-modulated abdominal 
activity was found in only 2 experimental mice (B). This ABD rhythmic EMG 
bursting was synchronised with the expiratory phase of breathing. It was, however, 
present for only a short duration.  
 
4.3.6 Augmented breaths 
 
The number of large amplitude, augmented breaths (illustrated in Figure 4-14A) present 
during 10 minutes of continuous baseline breathing under anaesthesia was quantified for 
control and neonatal-exposed mice. Neonatal-exposed mice on average exhibited a 
significantly greater number of augmented breaths compared to the control animals 
(10.1±12.5 augmented breaths/10 mins vs 0.8±1.4 augmented breaths/10 mins, p<0.05, 
Figure 4-14B). It is important to note that the number of augmented breaths exhibited by 
the neonatal-exposed mice was variable. Out of the 16 control mice, 5 mice exhibited 
augmented breaths (31.3%), whereas 12 out of 16 neonatal-exposed mice displayed 
augmented breaths (75.0%).  
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Figure 4-14. Number of augmented breaths exhibited by control and 
neonatal-exposed mice under anaesthesia. An augmented breath is defined as 
an increased respiratory effort, with a tidal volume >50% of a regular breath. The 
number of augmented breaths observed during 10 minutes of baseline breathing 
was quantified. A: a representative airflow trace from a neonatal-exposed mouse 
illustrating the presence of augmented breaths during baseline breathing. 
Augmented breaths appear as spikes in the compressed airflow trace on top. The 
area demarcated by the blue box is expanded and show in the trace below. B: 
neonatal-exposed mice (n=16) exhibited a significantly greater number of 
augmented breaths during baseline breathing (10 minutes) compared to control 
mice (n=16).* p<0.05, Mann Whitney test. Data presented as mean ±SD. 
 
 
 
 
 
 
 
 
 
31
3
31
3
0.25ml 
10s 
Control Neonatal-Exposed
0
5
10
15
20
25
N
u
m
b
e
r 
o
f 
a
u
g
m
e
n
te
d
 b
re
a
th
s
/1
0
 m
in
s
1s 
A B 
Augmented breath 
Augmented breaths 
* 
 165 
 
4.3.7 Acute fentanyl challenge in anaesthetised mice 
 
When mice were under anaesthesia, fentanyl was found to induce a quicker and more 
pronounced respiratory depression compared to the effects when awake. For this reason the 
range of doses investigated was decreased. The doses administered ranged from 0.01 
mg/kg-0.06 mg/kg. Mice were assigned only one dose. All neonatal-exposed mice 
displayed a complete respiratory failure in response to fentanyl that occurred at varying 
time points post-injection, therefore the absolute values for each of the respiratory 
parameters were not averaged at each time point as this would result in the data being 
skewed. Thus the percentage changes from baseline are shown. 
 
4.3.7.1 Respiratory frequency 
 
Fentanyl at all doses induced a depression of respiratory frequency in the control group 
(Figure 4-15). A reduction in respiratory frequency was seen as early as 5 minutes 
following fentanyl injection (0.01 mg/kg: 12±2% reduction; 0.02 mg/kg: 18±6% reduction; 
0.04 mg/kg: 33±28% reduction; 0.06 mg/kg: 40±27% reduction, Figure 4-15A-D). 
Although the respiratory frequency never returned to baseline levels, all control mice 
continued to spontaneously breathe for the duration of the experiment, i.e. up to 60 minutes 
post-fentanyl challenge. With the neonatal-exposed mice, fentanyl evoked a profound 
depression of the respiratory frequency that was of a significantly greater magnitude 
compared with the control mice, and resulted in a respiratory arrest in 100% of the mice 
(Figure 4-15, p<0.05). This fentanyl-induced respiratory failure was observed at all 
fentanyl doses. Respiratory arrest was identified as a complete cessation of airflow and 
genioglossus muscle activity and is indicated on the plots when the data line reaches a 
value of zero (Figure 4-15A-D). When respiratory arrest was identified, artificial 
ventilation was provided, however spontaneous breathing never returned in any of the 
neonatal-exposed mice. The average latency for complete suppression of respiration varied 
depending on the dose of fentanyl administered, and was variable between individual mice, 
but by 30 minutes post-injection all of the neonatal-exposed mice exhibited complete 
respiratory depression. At the highest dose of 0.06 mg/kg, fentanyl induced respiratory 
failure within 5 minutes following the acute challenge (Figure 4-15D). Given that 0.06 
mg/kg fentanyl induced such a rapid respiratory failure, only 2 neonatal-exposed mice 
were studied in this group. The high variability in the average data from the neonatal-
exposed mice, highlighted by the large error bars, is attributed to the fact than mice entered 
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respiratory failure at varying times post-injection. It is very interesting to highlight the fact 
that anaesthetised neonatal-exposed mice displayed a striking difference in their response 
to fentanyl when compared to the wakeful state, where fentanyl did not induce a 
respiratory frequency depression.  
 
4.3.7.2 Tidal volume and minute ventilation 
 
Fentanyl at all doses induced a reduction in Vt from baseline in the control mice (Figure 4-
16), which was evident at 5 minutes post-fentanyl (0.01 mg/kg: 5±4% reduction; 0.02 
mg/kg: 11±19% reduction; 0.04 mg/kg: 15±13% reduction; 0.06 mg/kg: 12±7% reduction, 
Figure 4-16A-D). Post-injection, Vt never reached baseline values except in the group of 
mice administered 0.02 mg/kg fentanyl, where Vt returned to baseline levels by 60 minutes 
following administration. Similar to respiratory frequency effects, fentanyl at all doses, 
evoked a significantly greater depression of Vt in the neonatal-exposed mice (Figure 4-16 
p<0.05), inducing a complete suppression. As a result of the combined effects on 
respiratory frequency and Vt, neonatal-exposed mice also exhibited a complete failure in 
Ve in response to all doses of fentanyl, which was not observed in the control mice (Figure 
4-17).  
 
4.3.7.3 Genioglossus activity 
 
The effect of an acute fentanyl insult on the GGEMG activity was also measured. Fentanyl 
did not appear to induce a marked depression of the amplitude of the GG activity in the 
control mice at any of the time points following fentanyl administration. This was observed 
for all of the doses of fentanyl studied (Figure 4-18A-D). It should be noted that there was 
a high degree of variability in the response of the GG muscle to fentanyl between 
individual control mice. Some mice displayed an increase in the amplitude of EMG 
bursting; others displayed a decrease and most showed no change. In the neonatal-exposed 
mice, all fentanyl doses induced a complete suppression of the GGEMG (Figure 4-18A-D). 
The failure in the GG muscle output occurred at the same time as the ventilatory arrest. 
Not all neonatal-mice displayed a gradual decline in GG muscle function after fentanyl 
injection; some displayed an increase in activity just prior to ventilatory failure which 
seemed to be irrespective of the fentanyl dose. The reduction in the amplitude of the 
GGEMG activity after a 0.01 mg/kg and 0.02 mg/kg fentanyl challenge was significantly 
greater than the control mice. Due to the high level of variability in the data, no statistically 
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significant difference was found in the GGEMG response between control and neonatal-
exposed animals after injection of 0.04 mg/kg and 0.06 mg/kg fentanyl (p>0.05). 
Considering the fact that complete suppression of the muscle activity was induced in the 
neonatal-exposed mice and not in the control animals, the findings were evidently 
biologically significant. In both the control and neonatal-exposed mice, the genioglossus 
fired simultaneously with the inspiratory phase i.e. it was inspiratory-modulated (Figure 4-
19), and thus the rate of muscle bursting was always identical to the respiratory frequency. 
Fentanyl therefore always depressed the frequency of genioglossus firing to the same 
extent as the respiratory frequency.  
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Figure 4-15. Changes in respiratory frequency in response to a fentanyl challenge in control and neonatal-exposed mice under 
anaesthesia. Data shows the change in respiratory frequency as a percentage of baseline, where baseline represents 100%. Acute effects 
of 0.01 mg/kg (A) 0.02 mg/kg (B) 0.04 mg/kg (C) and 0.06 mg/kg fentanyl (D). When values reached 0% of baseline this represents 
respiratory failure, seen in all neonatal-exposed mice in response to all doses of fentanyl. This response was not exhibited by the control 
animals. Data presented as mean±SD. *denotes a significant difference between the experimental groups (p<0.05), 2-way ANOVA with 
Bonferroni’s post test. 
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Figure 4-16. Changes in tidal volume (Vt) in response to a fentanyl challenge in control and neonatal-exposed mice under 
anaesthesia. Data shows the change in Vt as a percentage of baseline, where baseline represents 100%. Acute effects of 0.01 mg/kg (A) 
0.02 mg/kg (B) 0.04 mg/kg (C) and 0.06 mg/kg fentanyl (D). When values reached 0% of baseline this represents respiratory failure, seen 
in all neonatal-exposed mice in response to all doses of fentanyl. This response was not exhibited by the control animals. Data presented 
as mean±SD. *denotes a significant difference between the experimental groups (p<0.05), 2-way ANOVA with Bonferroni’s post test. 
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Figure 4-17. Changes in minute ventilation (Ve) in response to a fentanyl challenge in control and neonatal-exposed mice under 
anaesthesia. Data shows the change in Ve as a percentage of baseline, where baseline represents 100%. Acute effects of 0.01 mg/kg (A) 
0.02 mg/kg (B) 0.04 mg/kg (C) and 0.06 mg/kg fentanyl (D). When values reached 0% of baseline this represents respiratory failure, seen 
in all neonatal-exposed mice in response to all doses of fentanyl. This response was not exhibited by the control animals. Data presented 
as mean±SD. *denotes a significant difference between the experimental groups (p<0.05), 2-way ANOVA with Bonferroni’s post test. 
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Figure 4-18. Changes in genioglossus amplitude in response to a fentanyl challenge in control and neonatal-exposed mice under 
anaesthesia. Data shows the change in GG amplitude as a percentage of baseline, where baseline represents 100%. Acute effects of 0.01 
mg/kg (A) 0.02 mg/kg (B) 0.04 mg/kg (C) and 0.06 mg/kg fentanyl (D). When values reached 0% of baseline this represents respiratory 
failure, seen in all neonatal-exposed mice in response to all doses of fentanyl. This response was not exhibited by the control animals. Data 
presented as mean±SD. *denotes a significant difference between the experimental groups (p<0.05), 2-way ANOVA with Bonferroni’s post 
test.
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4.3.7.4 Physiological traces from anaesthetised preparations 
 
The striking difference in the acute respiratory response to a fentanyl challenge between 
the control and neonatal-exposed mice under anaesthesia is clearly illustrated from Figure 
4-19 and Figure 4-20. Representative airflow and GGEMG traces, continually sampled for 
the duration of the experiment are shown, highlighting the acute respiratory response to 
0.02 mg/kg fentanyl in a control mouse (Figure 4-19) and a neonatal-exposed mouse 
(Figure 4-20). Fentanyl induced a depression of respiratory activity in the control mouse; 
however despite this depression and the fact that the respiratory frequency and tidal 
volume never returned to baseline levels, the mouse continued to spontaneously breathe for 
the full course of the experiment, i.e. up to 60 minutes following the fentanyl challenge 
(Figure 4-19). Conversely, the neonatal-exposed mouse suffered a complete respiratory 
arrest, i.e. a failure of respiratory airflow and GG muscle activity, in response to an acute 
0.02 mg/kg fentanyl challenge. There was a continual decline in respiratory frequency and 
tidal volume. By 14 minutes post-fentanyl administration, respiratory activity was very 
weak and a complete cessation of airflow i.e. a fatal apnoea and respiratory muscular 
activity quickly followed (Figure 4-20). Artificial ventilation failed to evoke spontaneous 
breathing. This fentanyl-induced respiratory arrest occurred in all 16 neonatal-exposed 
mice in response to all four fentanyl doses investigated. The exact time at which the arrest 
occurred following fentanyl did however differ between experimental mice.  
 
It is evident from both Figures 4-19 and 4-20 that the GG muscle was inspiratory 
modulated i.e. fired concomitantly with the inspiratory phase of respiration, and the 
frequency of muscle firing was always identical to the respiratory frequency. While 
fentanyl induced a variable effect on the amplitude of the GGEMG signal, it always 
depressed the rate of firing in both control and neonatal-exposed mice (Figure 4-19 and 4-
20). 
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Figure 4-19. Representative airflow and GGEMG trace taken from a control mouse administered 0.02 mg/kg fentanyl under 
anaesthesia. Airflow, raw and integrated GGEMG traces are shown. The areas demarcated by the blue dashed lines are expanded and 
shown in the traces below. 0.02 mg/kg fentanyl evoked a depression of respiratory activity, but did not induce a respiratory arrest. 
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Figure 4-20. Representative airflow and GGEMG trace taken from a neonatal-exposed mouse administered 0.02 mg/kg fentanyl 
under anaesthesia. Airflow, raw and integrated GGEMG traces are shown.  The areas demarcated by the blue dashed lines are expanded 
and shown in the traces below. 0.02 mg/kg fentanyl evoked a complete suppression of respiratory activity by 14 minutes post-injection.   
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4.4 Results of study 5: Investigation of the long-term respiratory 
effects of repeated fentanyl exposure in the juvenile mouse 
 
Study 5 differs for study 4 in that mice were exposed to fentanyl at a later stage in 
postnatal life, from P9-P13. Results from study 5 are presented in section 4.4   
 
4.4.1 Animal body weights 
 
There was no significant difference in the average body weights of control and juvenile-
exposed mice during the repeated drug exposure period from P9-P13 or when they reached 
adulthood (p>0.05, 2-way ANOVA, Table 4-2).  
 
 
 Weight (g) 
Postnatal Age Control Juvenile-Exposed 
P9 5.4±1.9 6.0±1.3 
P10 5.8±1.9 6.4±1.4 
P11 6.2±1.8 6.7±1.4 
P12 6.5±1.8 7.0±1.4 
P13 6.9±1.8 7.3±1.5 
Adult 33.4±2.9 35.2±4.0 
 
Table 4-2. Average body weights of control and juvenile-exposed mice. Body 
weight was measured throughout the repeated drug exposure period (P9-P13) and 
on reaching adulthood. Data presented as mean±SD. No significant difference in 
body weight between the two experimental groups at all ages.
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4.4.2 Baseline respiratory parameters of awake adult mice 
 
In the wakeful state, adult mice (6 weeks old) which were juvenile-exposed showed a trend 
towards a lower baseline respiratory frequency compared to control mice (161±6 bpm vs 
182±9 bpm, p>0.05, Figure 4-21A). While inspiratory duration was comparable between 
the two groups (juvenile-exposed: 0.13±0.003 s vs control: 0.13±0.01 s, p>0.05, Figure 4-
21B), there was a trend towards a longer expiratory duration in the juvenile-exposed mice 
(juvenile-exposed: 0.25±0.01 s vs control: 0.22±0.01 s; p>0.05, Figure 4-21C) which 
would account for the lower respiratory frequency exhibited. No significant difference in 
Vt was found between the experimental groups (juvenile-exposed: 11±1 µl/g vs control: 
12±1 µl/g, p>0.05, Figure 4-21D). Due to the trend towards a lower respiratory frequency, 
juvenile-exposed mice displayed a significantly lower baseline Ve compared to control 
mice (1829±69 µl/g/min vs 2262±179 µl/g/min, p<0.05, Figure 4-21E). It is important to 
highlight that no obvious respiratory anomalies or ataxic breathing patterns were observed 
in any of the juvenile-exposed mice; all mice displayed a rhythmic and stable respiratory 
pattern.  
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Figure 4-21. Baseline respiratory parameters of adult control and juvenile-exposed mice during wakefulness. Control mice, n=16; 
juvenile-exposed, n=16. Each data point on the scatter plots represents an individual animal. Line denotes the mean. *p<0.05, Student’s 
unpaired t-test. 
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4.4.3 Acute fentanyl challenge in awake mice 
 
The same range of fentanyl doses detailed in study 4 (0.04 mg/kg-0.1 mg/kg) were 
investigated, and each mouse was administered only one dose. 
 
4.4.3.1 Respiratory frequency 
 
In the control groups, all 4 fentanyl doses induced a continual reduction in respiratory 
frequency from baseline that was greatest at 30 minutes post-injection (Figure 4-22). 
Respiratory frequency was significantly lower at 30 minutes post 0.04, 0.06 and 0.08 
mg/kg fentanyl challenge compared to baseline (0.04 mg/kg: 131±30 bpm vs baseline: 
180±13 bpm, p<0.05, Figure 4-22A; 0.06 mg/kg: 112±20 bpm vs baseline: 184±41 bpm, 
p<0.05, Figure 4-22B; 0.08 mg/kg: 130±14 bpm vs baseline: 180±46 bpm, p<0.05, Figure 
4-22C). Respiratory frequency showed a clear trend towards a reduction at 30 minutes post 
0.1 mg/kg fentanyl challenge in the control group (30 minutes post-challenge: 153±15 bpm 
vs baseline: 185±46 bpm, Figure 4-22D). Respiratory frequency had returned to baseline 
values by 45 minutes post-fentanyl injection in the control mice (Figure 4-22A-D, p>0.05). 
 
Incongruent to the respiratory response observed in the control mice, even at the highest 
dose, a fentanyl challenge failed to induce a depression of respiratory frequency in 
juvenile-exposed mice. No significant reduction from baseline respiratory frequency was 
found at any of the time points examined for any of the fentanyl doses injected (p>0.05, 
Figure 4-22A-D). Interesting to highlight, at 5 minutes post-fentanyl challenge, juvenile-
exposed mice exhibited an unexpected increase in respiratory frequency.  This increase 
was only found to be statistically significant following administration of 0.04 mg/kg and 
0.06 mg/kg fentanyl (p<0.05, Figure 4-22A-B); however there was a trend towards an 
increase post 0.08 mg/kg and 0.1 mg/kg fentanyl challenge (p>0.05, Figure 4-22C+D). 
This increase in respiratory frequency was not exhibited by the control mice. When 
looking at the changes in respiratory frequency in response to fentanyl as a percentage 
change from baseline (Figure 4-23), it is apparent that the control and juvenile-exposed 
mice displayed a clear disparity in their acute respiratory response. This was seen for all 
the doses of fentanyl studied. These data reinforce the data illustrated in Figure 4-22 and 
clearly highlights the discrepancy in the respiratory frequency response to fentanyl 
between control and juvenile-exposed mice. At 30 minutes post-fentanyl, control mice 
showed a clear reduction in respiratory frequency from baseline (0.04 mg/kg: 28±11% 
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reduction, 0.06 mg/kg: 38±7% reduction, 0.08 mg/kg: 27±11% reduction, 0.1 mg/kg: 
20±10 reduction, Figure 4-23A-D), which was not seen in the juvenile-exposed mice (0.04 
mg/kg: 2±15% increase, 0.06 mg/kg: 12±25% increase, 0.08 mg/kg: 2±25% reduction, 0.1 
mg/kg: 8±11% reduction, Figure 4-23A-D). In the juvenile-exposed mice, the increase in 
respiratory frequency at 5 minutes post-fentanyl ranged from 18±29% to 45±20% from 
baseline, depending on the dose of fentanyl administered (Figure 4-23A-D). This increase 
did not appear to be associated with an increase in fentanyl dose. 
 
4.4.3.2 Tidal volume 
 
In the control group, Vt increased following administration of 0.04 mg/kg, seen at 15 
minutes, although not significant (baseline: 13±2 µl/g; 15 mins post-fentanyl: 16±3 µl/g, 
p>0.05, Figure 4-24A). Vt significantly increased at 5 minutes, 15 minutes and 30 minutes 
post 0.06 mg/kg fentanyl challenge (baseline: 14±3 µl/g; 5 mins: 18±2 µl/g, 15 mins: 18±2 
µl/g, 30 mins: 18±2 µl/g, p<0.05, Figure 4-24B). A slight increase in Vt was seen at 5 
minutes and 15 minutes after 0.08 mg/kg fentanyl injection (baseline: 11±2 µl/g; 5 mins: 
14±2 µl/g; 15 mins: 15±3 µl/g, p>0.05, Figure 4-24C). A dose of 0.1 mg/kg fentanyl did 
not induce any changes in Vt at any time point (p>0.05, Figure 4-24D). 
 
The juvenile-exposed mice exhibited similar Vt increases in response to fentanyl as the 
control mice. Administration of 0.04 mg/kg fentanyl evoked an increase in Vt at 5 minutes, 
15 minutes and 30 minutes post-injection (baseline: 12±1 µl/g; 5 mins: 16±4 µl/g, 15 mins: 
17±2 µl/g, 30 mins: 16±2 µl/g, Figure 4-24A). The increase was however only found to be 
statistically significant at the 15 minute time point. An injection of 0.06 mg/kg fentanyl 
induced an increase in Vt from baseline seen at 5 minutes and 15 minutes post-fentanyl 
(baseline: 11±3 µl/g; 5 mins: 14±4 µl/g, 15 mins: 14±1 µl/g, p>0.05, Figure 4-24B). A 
dose of 0.08 mg/kg evoked an increase in Vt, seen at 5, 15 and 30 minutes following 
administration (baseline: 12±2 µl/g; 5 mins: 17±2 µl/g, 15 mins: 14±1 µl/g, 30 mins: 17±1 
µl/g, Figure 4-24D). The highest dose of 0.1 mg/kg fentanyl also caused an increase in Vt 
at 5 minutes and 15 minutes following injection (baseline: 10±1 µl/g; 5 mins: 15±4 µl/g, 
15 mins: 15±3 µl/g, p>0.05, Figure 4-24D). Figure 4-25 illustrates the Vt response to 
fentanyl as a percentage change from baseline. From this figure, it is apparent that both 
control and juvenile-exposed mice exhibited an increase in Vt in response to fentanyl at 5 
minutes, 15 minutes and 30 minutes following the fentanyl challenge at all doses.  The 
changes in Vt induced by fentanyl were variable within both the control and juvenile-
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exposed groups. There did not appear to be a dose dependent effect of fentanyl at any of 
the doses investigated. 
 
4.4.3.3 Minute ventilation 
 
In the control mice, fentanyl at all doses did not evoke any significant changes in Ve from 
baseline (p>0.05, Figure 4-26A-D). This is due to the combined effect of a lowered 
respiratory frequency and increased Vt in response to fentanyl, thereby resulting in no 
overall alteration in Ve.  As a result of the increases in both respiratory frequency and Vt in 
response to fentanyl, Ve was increased post –fentanyl in the juvenile-exposed mice (Figure 
4-26A-D). Following 0.04 mg/kg fentanyl injection, there was a significant increase in Ve 
at 5 minutes and 15 minutes (baseline: 1803±134 µl/g/min; 5 mins: 3564±1481 µl/g/min, 
15 mins: 3010±631 µl/g, p<0.05, Figure 4-26A). Ve increased significantly from baseline 
at 5 minutes post 0.06 mg/kg fentanyl (baseline: 1688±352 µl/g/min; 5 mins: 3360±1609 
µl/g/min, p<0.05, Figure 4-26B) and 0.08 mg/kg fentanyl (baseline: 2084±303 µl/g/min; 5 
mins: 3606±1140 µl/g/min p<0.05, Figure 4-26C). Juvenile-exposed mice also displayed a 
trend towards an increase in Ve at 5 minutes and 15 minutes following 0.1 mg/kg fentanyl 
(baseline: 1741±155 µl/g/min; 5 mins: 2964±1265 µl/g/min; 15 mins: 2562±531 µl/g/min, 
p>0.05, Figure 4-26D).  In the juvenile-exposed mice, Ve returned to baseline values by 45 
minutes post-injection of all fentanyl doses. When observing the percentage changes in Ve 
in response to all doses of fentanyl, it is apparent that, when compared to control mice, 
juvenile-exposed mice exhibited a greater fentanyl-induced increase in Ve, particularly at 5 
and 10 minutes following administration (Figure 4-27A-D).   
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Figure 4-22. Changes in respiratory frequency in response to a single fentanyl challenge in control and juvenile-exposed mice 
when awake. Acute response to 0.04 mg/kg fentanyl (A), 0.06 mg/kg fentanyl (B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). 
Control mice; n=4, juvenile-exposed; n=4 for all 4 fentanyl groups. Data presented as mean±SD. * denotes a significant difference (p<0.05) 
from baseline, 2-way ANOVA with Bonferroni’s post test. 
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Figure 4-23. Percentage change in respiratory frequency in response to a single fentanyl challenge in control and juvenile-
exposed mice when awake. Data shown as a percentage change from baseline. Acute response to 0.04 mg/kg fentanyl (A),     0.06 
mg/kg fentanyl (B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). Control mice; n=4, juvenile-exposed; n=4 for all 4 fentanyl groups. 
Data presented as mean±SD.
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Figure 4-24. Changes in tidal volume (Vt) in response to a single fentanyl challenge in control and juvenile-exposed mice when 
awake. Acute Vt response to 0.04 mg/kg fentanyl (A), 0.06 mg/kg fentanyl (B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). Control 
mice; n=4, juvenile-exposed; n=4 for all 4 fentanyl groups. Data presented as mean±SD. * denotes a significant difference (p<0.05) from 
baseline, 2-way ANOVA with Bonferroni’s post test. 
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Figure 4-25. Percentage change in tidal volume (Vt) in response to a single fentanyl challenge in control and juvenile-exposed 
mice when awake. Data shown as a percentage change from baseline. Acute response to 0.04 mg/kg fentanyl (A), 0.06 mg/kg fentanyl 
(B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). Control mice; n=4, juvenile-exposed; n=4 for all 4 fentanyl groups. Data presented 
as mean±SD.
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Figure 4-26. Changes in minute ventilation (Ve) in response to a single fentanyl challenge in control and juvenile-exposed mice 
when awake. Acute Ve response to 0.04 mg/kg fentanyl (A), 0.06 mg/kg fentanyl (B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). 
Control mice; n=4, juvenile-exposed; n=4 for all 4 fentanyl groups. Data presented as mean±SD. * denotes a significant difference (p<0.05) 
from baseline, 2-way ANOVA with Bonferroni’s post test. 
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Figure 4-27. Percentage change in minute ventilation (Ve) in response to a single fentanyl challenge in control and juvenile-
exposed mice when awake. Data shown as a percentage change from baseline. Acute Ve response to 0.04 mg/kg fentanyl (A), 0.06 
mg/kg fentanyl (B), 0.08 mg/kg fentanyl (C) and 0.1 mg/kg fentanyl (D). Control mice; n=4, juvenile-exposed; n=4 for all 4 fentanyl groups. 
Data presented as mean±SD. 
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4.4.3.4 Plethysmography Respiratory Traces 
 
Baseline breathing and the differences in the acute ventilatory response to a fentanyl 
challenge between the control and juvenile-exposed mice during wakefulness are clearly 
illustrated in Figure 4-28, which shows example plethysmographic respiratory traces taken 
before and after administration of the lowest dose of 0.04 mg/kg fentanyl (A) and the 
highest dose of 0.1 mg/kg fentanyl (B). In terms of the baseline breathing, it is clear that 
both groups of mice exhibited rhythmic breathing with no evident respiratory 
abnormalities. The representative plethysmography traces also show the juvenile-exposed 
mice had a lower baseline respiratory frequency compared with the control mice (Figure 4-
28A and B). It is apparent that fentanyl, at both doses, evoked a depression of respiratory 
frequency and induced an increase in Vt at 30 minutes following administration, in the 
control mice. On the contrary, the juvenile-exposed mice did not display any respiratory 
depression post-fentanyl insult at either dose. The increase in both respiratory frequency 
and Vt at 5 minutes after both fentanyl doses is also clearly highlighted from the traces.  
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Figure 4-28. Representative respiratory traces before and after a fentanyl challenge taken from control and juvenile-exposed 
mice. The effects of 0.04 mg/kg (A) and 0.1 mg/kg fentanyl (B) are shown. It is apparent that the control and juvenile-exposed mice 
exhibited a different respiratory response to fentanyl. Fentanyl did not induce a depression of respiratory activity in the juvenile-exposed 
mice at either dose.  
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4.4.4 Baseline respiratory parameters of adult mice under anaesthesia 
 
After recording of respiratory activity when mice were in the conscious state, a more 
detailed respiratory analysis was carried out in anaesthetised mouse preparations. When 
under anaesthesia, adult mice (weeks old) that were juvenile-exposed exhibited a 
significantly higher baseline respiratory frequency compared to control mice (224±32 bpm 
vs 184±30 bpm, p<0.05, Figure 4-29A). This was due to juvenile-exposed mice having a 
significantly shorter inspiratory duration (0.13±0.01 s vs 0.15±0.01 s, p<0.05, Figure 4-
29B) and expiratory duration (0.14±0.04 s vs 0.19±0.06 s, p<0.05, Figure 4-29C). Under 
anaesthesia, the juvenile-exposed mice exhibited a significantly lower baseline Vt 
compared to control mice (4.7±0.7 µl/g vs 5.2±0.6 µl/g, p<0.05, Figure 4-29D). The 
combination of a reduced Vt and increased respiratory frequency resulted in the minute 
ventilation of the juvenile-exposed mice to remain unchanged and comparable to that of 
the control mice (1058±205 µl/g/min vs 966±183 µl/g/min, p>0.05, Figure 4-29E). As 
observed in study 4, both control and juvenile-exposed mice had a lower baseline Vt under 
anaesthesia compared with the wakeful state (awake juvenile-exposed: 11±1 µl/g; awake 
control: 12±1 µl/g, Figure 4-21D). No significant difference in GGEMG amplitude was 
found between the experimental groups (juvenile-exposed: 0.24±0.16 a.u vs control: 
0.22±0.15 a.u, p>0.05, Figure 4-29F).The GG muscle always displayed a rhythmic pattern 
of activity, and was strongly inspiratory-related in all experimental mice. As also discussed 
in section 4.3.5, expiratory-modulated ABD muscle activity was not found in any of the 
experimental mice in study 5 and therefore no analysis of this muscle activity was 
performed. All abdominal muscle activity recorded was sporadic in nature (Figure 4-13). 
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Figure 4-29. Baseline respiratory parameters of adult control and juvenile-exposed mice under anaesthesia. Control mice, n=16; 
Juvenile-exposed, n=16. Each data point on the scatter plots represents an individual animal. Line denotes the mean. * p<0.05, Student ’s 
unpaired t-test. 
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4.4.5 Augmented breaths 
 
As in study 4, the number of augmented breaths (illustrated in Figure 4-14A) observed 
during 10 minutes of continuous baseline breathing under anaesthesia was quantified for 
control and juvenile-exposed mice. Only a small number of mice in each experimental 
group exhibited augmented breaths. In the control group, 5 out of 16 mice (31.3%) 
displayed augmented breaths and 2 out of 16 juvenile-exposed mice (12.5%) exhibited 
them. Both control and juvenile-exposed mice exhibited a low occurrence of augmented 
breaths per 10 minutes and the average number exhibited was not significantly different 
between the groups (juvenile-exposed: 0.3±0.9 augmented breaths/10 mins vs control: 
1.6±4.3 augmented breaths/10 mins, p>0.05, Figure 4-30). 
 
 
 
       
 
 
 
 
 
 
 
 
 
 
Figure 4-30. Number of augmented breaths exhibited by control and juvenile-
exposed mice under anaesthesia. The number of augmented breaths observed 
during 10 minutes of baseline breathing was quantified. There was no significant 
difference (p>0.05) in number of augmented breaths exhibited between control 
(n=16) and juvenile-exposed mice (n=16), Mann-Whitney test. Data presented as 
mean±SD.  
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4.4.6 Acute fentanyl challenge in anaesthetised mice 
 
The same range of fentanyl doses investigated in the adult anaesthetised mouse 
preparations in study 4 were also examined in study 5 i.e. 0.01 mg/kg-0.06 mg/kg fentanyl. 
Mice were administered only 1 dose. 
 
4.4.6.1 Respiratory frequency 
 
Fentanyl at all doses induced a similar depression of respiratory frequency in both control 
and juvenile-exposed mice (Figure 4-31). There was no significant difference in the acute 
respiratory response to fentanyl at any time point following fentanyl administration 
between the two groups of mice. In both control and juvenile-exposed mice, a reduction in 
respiratory frequency was seen as early as 5 minutes following fentanyl challenge (all 
doses, Figure 4-31A-D). Although the respiratory frequency never returned to baseline 
levels within the 60 minutes following all doses of fentanyl, all control and juvenile-
exposed mice continued to spontaneously breathe for the duration of the experiment, with 
the exception of one juvenile-exposed mouse in the 0.06 mg/kg fentanyl group. With this 
mouse, an injection of 0.06 mg/kg induced respiratory failure within 20 minutes post-
insult. As a result of this loss of respiratory activity, the variability in the data was high for 
the 0.06 mg/kg fentanyl group (Figure 4-31D). It is important to highlight the fact that 
when under anaesthesia, the juvenile-exposed mice showed a different respiratory response 
to fentanyl compared to when they were awake. Fentanyl at the range of doses studied 
induced a reduction in respiratory frequency which was not observed in the wakeful state.   
 
4.4.6.2 Tidal volume and minute ventilation 
 
Fentanyl at all doses induced a similar reduction in Vt in control and juvenile-exposed 
mice (Figure 4-32). There was no significant difference in the acute fentanyl-induced Vt 
depression at any time point following fentanyl administration between the two groups of 
mice. The suppression of Vt was evident at 5 minutes following all four doses of fentanyl. 
Within the 60 minutes recording period following fentanyl, Vt never reached baseline 
levels except in the juvenile-exposed mice administered 0.02 mg/kg fentanyl, where Vt 
returned to baseline levels by 30 minutes following administration (30 minutes post-
fentanyl: 1±14% reduction from baseline, Figure 4-32B). As a result of the combined 
reduction in respiratory frequency and Vt following all doses of fentanyl, control and 
 193 
 
juvenile-exposed mice also displayed a reduction in Ve (Figure 4-33). There was no 
significant difference in the fentanyl-induced reduction of Ve at any time point following 
the fentanyl challenge between the two experimental groups (Figure 4-33A-D).   
 
4.4.6.3 Genioglossus activity 
 
The effect of an acute fentanyl insult on the GGEMG activity was measured. There was no 
significant difference in the GGEMG response to fentanyl between the control and juvenile-
exposed mice at all of doses studied (p>0.05, Figure 4-34A-D). On average, fentanyl did 
not depress the amplitude of the GG activity in the control mice or the juvenile-exposed 
mice. This was observed for all four doses of fentanyl studied (Figure 4-34A-D). Both 
groups of mice did however display a high degree of variability in the GGEMG response to 
fentanyl. Some mice displayed an increase in the amplitude of EMG bursting whereas 
others displayed a decrease or no change. The response was not affected by the dose 
administered. In both groups of mice, the genioglossus displayed an inspiratory-modulated 
pattern of activity (see Figure 4-35 and 4-36 for illustration), and therefore the frequency 
of muscle bursting was always identical to the respiratory frequency. The frequency of GG 
muscle firing was therefore always reduced to the same extent as the respiratory frequency 
in response to fentanyl (Figure 4-31). 
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Figure 4-31. Changes in respiratory frequency in response to a fentanyl challenge in control and juvenile-exposed mice under 
anaesthesia. Changes in respiratory frequency presented as a percentage of baseline, where baseline represents 100%. Acute effects of 
0.01 mg/kg (A) 0.02 mg/kg (B) 0.04 mg/kg (C) and 0.06 mg/kg fentanyl (D). Data presented as mean±SD.  
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Figure 4-32. Changes in tidal volume (Vt) in response to a fentanyl challenge in control and juvenile-exposed mice under 
anaesthesia. Changes in Vt presented as a percentage of baseline, where baseline represents 100%. Acute effects of 0.01 mg/kg (A) 0.02 
mg/kg (B) 0.04 mg/kg (C) and 0.06 mg/kg fentanyl (D). Data presented as mean±SD.. 
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Figure 4-33. Changes in minute ventilation (Ve) in response to a fentanyl challenge in control and juvenile-exposed mice under 
anaesthesia. Changes in Ve presented as a percentage of baseline, where baseline represents 100%. Acute effects of 0.01 mg/kg (A) 
0.02 mg/kg (B) 0.04 mg/kg (C) and 0.06 mg/kg fentanyl (D). Data presented as mean±SD. 
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Figure 4-34. Changes in GG amplitude in response to a fentanyl challenge in control and juvenile-exposed mice under 
anaesthesia. Changes in GG amplitude presented as a percentage of baseline, where baseline represents 100%. Acute effects of 0.01 
mg/kg (A) 0.02 mg/kg (B) 0.04 mg/kg (C) and 0.06 mg/kg fentanyl (D). Data presented as mean±SD. 
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4.4.6.4 Physiological traces from anaesthetised preparations 
 
The acute respiratory response to a fentanyl challenge exhibited by the control and 
juvenile-exposed mice under anaesthesia is illustrated in Figure 4-35 and 4-36 respectively. 
Shown are example airflow and GGEMG traces that were continually sampled for the 
duration of the experiment, highlighting the ventilatory effects of 0.02 mg/kg fentanyl. 
From the airflow traces it can be seen that the juvenile-exposed mouse had a higher 
baseline respiratory frequency compared to the control mouse (Figure 4-35 and 4-36). 
Fentanyl induced a respiratory depression in both mice. A reduction in respiratory 
frequency, Vt and GGEMG amplitude and frequency was observed and can be clearly seen 
at 5 minutes following the fentanyl challenge in both groups of mice. At 60 minutes 
following fentanyl administration, the control mouse still displayed a depressed respiratory 
activity compared to baseline levels (Figure 4-35), whereas the respiratory parameters had 
returned to baseline value by 60 minutes in the juvenile-exposed mouse (Figure 4-36). 
Importantly, both the juvenile-exposed and control mouse maintained spontaneous 
respiratory output after the fentanyl challenge and throughout the course of the experiment. 
This finding was consistent for all fentanyl doses studied for both groups of mice.
 199 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-35. Representative airflow and GGEMG trace taken from a control mouse administered 0.02 mg/kg fentanyl under 
anaesthesia. Airflow, raw and integrated GGEMG traces are shown. The areas demarcated by the blue dashed lines are expanded and 
shown in the traces below. 0.02 mg/kg fentanyl evoked a depression of respiratory activity, but did not induce a respiratory arrest. 
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Figure 4-36. Representative airflow and GGEMG trace taken from a juvenile-exposed mouse administered 0.02 mg/kg fentanyl 
under anaesthesia. Airflow, raw and integrated GGEMG traces are shown. The areas demarcated by the blue dashed lines are expanded 
and shown in the traces below. 0.02 mg/kg fentanyl evoked a depression of respiratory activity, but did not induce a respiratory arrest. 
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4.5 Discussion  
 
The studies described in this chapter are the first to assess the long-term respiratory 
consequences of neonatal and juvenile repeated fentanyl exposure in mice. Neonatal life 
encompasses a critical maturation of respiratory activity and is therefore an interesting time 
period to target with the respiratory depressant drug fentanyl. Exposing mice to fentanyl 
during neonatal life induced long-term respiratory alterations as was hypothesised. In 
particular this exposure evoked a notable change in the acute respiratory response to future 
fentanyl challenges, which interestingly was state-dependent. The juvenile exposure 
studies were complementary experiments to assess if the long-standing respiratory 
alterations were in fact a developmental phenomenon. Juvenile fentanyl exposure also 
resulted in a lasting change to respiratory activity; however the striking long-term 
alteration in the acute respiratory response to fentanyl induced by neonatal exposure was 
not observed.   
 
4.5.1 Wakeful state: resting breathing 
 
4.5.1.1 Neonatal fentanyl exposure induced lasting changes in resting breathing 
during wakefulness  
 
When neonatal-exposed mice reached adulthood they exhibited a reduced resting 
respiratory frequency and therefore an overall reduction in resting ventilation in the 
wakeful state. The slower respiratory frequency was a result of a longer inspiratory phase. 
Given that fentanyl was systemically administered and would therefore have widespread 
effects throughout the body, the mechanism(s) by which fentanyl acts to induce these 
lasting respiratory changes cannot be elucidated from this study. A previous in vivo study 
in adult rats established that systemically administered fentanyl fully mediates respiratory 
frequency depression by exclusively depressing NK1R-expressing preBötC neurons 
(Montandon et al., 2011). In this study, fentanyl-induced slowing of respiratory frequency 
was completely prevented by local bilateral application of naloxone into the preBötC, 
therefore it was concluded that the preBötC is the critical brain site where fentanyl acts to 
suppress respiratory rate (Montandon et al., 2011). Furthermore, systemic application of 
fentanyl to the decerebrate cat slows the rhythm of phrenic nerve discharge, suggesting a 
direct effect on the respiratory rhythm generator (Lalley, 2003). Based on these findings, it 
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is postulated that in this present study, the long-term reduction of baseline respiratory 
frequency and thus the ventilatory profile could be due fully or in part to the depressive 
actions of fentanyl on the preBötC during neonatal life. This hypothesised repeated 
preBötC depression may have induced long-term changes in the rhythm generating 
properties of the neurons. Since it is widely accepted that inspiratory rhythmogenic drive 
originates from the preBötC (Smith et al., 1991; Gray et al., 1999), the fact that the 
neonatal-exposed mice had an altered inspiratory duration also supports our hypothesis that 
neonatal fentanyl exposure has affected preBötC functioning. However, it is imperative to 
highlight the fact that the central respiratory system is comprised of a complex network of 
functionally interacting neurons, and in the behaving animal the preBötC functions as part 
of a larger network. It is therefore very difficult to determine fentanyl’s long-term effects 
on individual neural groups in vivo. Affecting one component of the respiratory network 
could have an indirect impact on various other components, and in the whole animal 
system these potential complex network effects cannot be ascertained. In accordance with 
this theory, it is possible that alterations in respiratory frequency could reflect changes in 
neural groups that shape or relay the output of the preBötC as opposed to rhythm 
generation per se. There is evidence that opioids target the Kölliker-Fuse and parabrachial 
nuclei of the pons to affect respiratory output (Lalley, 2006). These nuclei have 
connections with the VRG in the ventrolateral medulla (Jiang et al., 2004) and 
computational modelling studies suggest these areas regulate the output from the pre-
Bötzinger complex (Rybak et al., 2004). It is therefore a possibility that long-term changes 
in the functioning of these respiratory nuclei also contribute to the altered respiratory 
frequency in neonatal-exposed mice. Despite the depression in the baseline respiratory 
frequency, repeated neonatal fentanyl exposure did not predispose mice to respiratory 
pattern disturbances in adult life when in the wakeful state. All neonatal-exposed mice 
displayed a regular and rhythmic respiratory pattern at rest. This suggests that in the 
wakeful state, the ability of the preBötC to generate a reliable and robust respiratory output 
is unaffected by repeated neonatal fentanyl exposure.  
 
4.5.1.2 Neonatal fentanyl exposure does not alter respiratory response to 
hypercapnia or hypoxia 
 
It is firmly believed that stimulation of breathing by decreases in the partial pressure of O2 
and increases in partial pressure of CO2 in the blood is fundamental to rhythmic breathing, 
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and failure of this vital process can lead to disordered breathing (Loeschcke, 1982; 
Dubreuil et al., 2008; Dubreuil et al., 2009), therefore it was of interest to determine if 
repeated neonatal fentanyl exposure induced lasting effects on chemosensory responses. 
Neonatal-exposed mice and control mice exhibited the same ventilatory response to both 
hypercapnic and hypoxic stimuli, and showed a comparable respiratory recovery following 
the chemosensory stimuli. Hypercapnia evoked a typical ventilatory stimulation and 
hypoxia induced the characteristic biphasic response, with an initial increase in ventilation 
followed by a secondary decline. This suggests that neonatal fentanyl exposure did not 
elicit lasting changes to central or peripheral chemosensory functions. Congruent with this 
finding is work by Berkenbosch and colleagues (Berkenbosch et al., 1997), who conducted 
an in vivo study showing that morphine, a µ opioid receptor agonist, does not acutely 
influence the hypoxic ventilatory response in the cat when administered intravenously 
which is likely due to the fact that morphine exerts a weak effect on the activity of the 
carotid body (McQueen and Ribeiro, 1980), which is known to express the µ opioid 
receptor (Lundberg et al., 1979). It is therefore likely that fentanyl exposure in neonatal life 
did not elicit long term changes in the O2 sensitivity of the carotid body or the relaying of 
chemoafferent information to the CNS. There is a wealth of evidence to suggest that the 
RTN/pFRG contributes to the central chemoreflex and may function as the principal 
central chemosensory site in the adult rodent (Mulkey et al., 2004; Guyenet et al., 2005; 
Takakura et al., 2008; Marina et al., 2010) as well as the neonatal rodent (Dubreuil et al., 
2008; Onimaru et al., 2008). Previous studies have shown that µ opioid receptor agonists 
do not depress the neural activity of the RTN/pFRG in vitro (Takeda et al., 2001; 
Janczewski et al., 2002; Mellen et al., 2003), thus it was hypothesised that fentanyl 
application would not induce any perturbation to RTN/pFRG function in vivo. It is 
probable that the function of the RTN/pFRG was unaffected by fentanyl exposure in early 
neonatal life, thus central chemoreception remained unperturbed. In support of this theory, 
an in vivo study using rats has demonstrated that intravenous administration of morphine 
induces a respiratory depression but does not alter the CO2 responsiveness of RTN neurons 
(Mulkey et al., 2004). Serotonergic raphe neurons are also proposed to play a role in 
mediating CO2 chemosensitivity (Hodges and Richerson, 2010). From our results, it can 
therefore be speculated that repeated neonatal fentanyl exposure does not affect the long 
term functioning of this neuronal group. The presence of normal chemoresponses also 
suggests that CNS processing of peripheral chemoafferent input as well as 
neurotransmission of chemosensory signals to the rhythm generator were unaltered in 
neonatal-exposed mice. Regardless of the sites involved or the mechanisms of central and 
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peripheral chemoreception, these data indicate that fentanyl exposure in neonatal life does 
not induce any lasting effects on the function of the chemosensory centres under resting 
conditions in the wakeful state.   
 
4.5.1.3 Juvenile fentanyl exposure did not induce lasting changes in resting 
breathing during wakefulness 
 
In the wakeful state, the baseline respiratory activity of the juvenile-exposed mice 
generally appeared unaltered. Juvenile-exposed mice did exhibit a statistically significant 
reduction in ventilation due to a trend towards a lowered respiratory frequency, but these 
changes were very subtle and therefore too much emphasis should not be placed on the 
biological significance. Furthermore, similar to neonatal exposure, juvenile fentanyl 
exposure did not induce any long-term respiratory anomalies; all mice displayed a 
rhythmic respiratory pattern. Taken together, these results highlight that juvenile fentanyl 
exposure did not evoke any marked lasting changes in resting respiratory activity during 
wakefulness and when compared to neonatal fentanyl exposure, the changes are more 
subtle. This suggests that the preBötC was capable of generating a eupneic respiratory 
rhythm at rest in the wakeful state and therefore was unlikely to exhibit notable alterations 
in its functioning. Chemosensory functions of juvenile-exposed mice during wakefulness 
were not tested in the present study. We demonstrated that ventilatory responses to 
hypercapnia and hypoxia were normal in neonatal-exposed mice and considering juvenile-
exposed mice also displayed normal, rhythmic breathing at rest it is unlikely that they 
would have presented with altered chemosensory functions 
 
4.5.2 Wakeful state: acute respiratory response to fentanyl 
 
4.5.2.1 Neonatal-exposed mice exhibited a reduced sensitivity to fentanyl during 
wakefulness 
 
In the control mice, first exposure to fentanyl in adulthood induced the expected 
attenuation of respiratory frequency. Although non-significant, Vt was slightly augmented 
in response to fentanyl, similar to the response observed in the adult mice of study 3 
(investigation of the susceptibility of postnatal breathing patterns to fentanyl: a single 
exposure study) described in chapter 3 (see section 3.6.4). A fentanyl-induced increase in 
Vt has been previously reported by Colman and Miller (2001) who studied the effects of 
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fentanyl on neonatal and adult rats. However they observed a gasping-like breathing 
pattern in response to fentanyl, which was not observed in this study. Conversely, there are 
numerous studies that have reported a profound depression of Vt after opioid 
administration in awake rats (van den Hoogen and Colpaert, 1986; Greer et al., 1995; 
Manzke et al., 2003; Moss et al., 2006; Ren et al., 2006; Greer and Ren, 2009; Montandon 
et al., 2011), whereas one study in the awake adult rat found no change in Vt in response to 
a greater i.p dose of fentanyl than investigated in this present study (Chevillard et al., 
2009). The reasons for these differences are not known. Opioid-induced changes in Vt in 
the awake rodent have been reported as complex and can be highly dependent on the dose 
administered (van den Hoogen and Colpaert, 1986). A wide range of fentanyl doses have 
been investigated in the previous studies which could account for the different Vt 
responses. Furthermore, variations in the route of administration may also explain the 
divergent results among these studies. It was also apparent that fentanyl did not induce 
dose-dependent respiratory effects in the control mice as anticipated and as documented in 
previous studies in the rat (Greer et al., 1995). An increasing fentanyl dose did not alter the 
magnitude of the respiratory effects. The reason for this remains elusive. Much of the work 
examining the effects of fentanyl has been conducted in the rat. The lack of dose-
dependent fentanyl actions found in this study could be attributable to the species used or 
more specifically the strain of mouse (ICR). Further studies conducted in various mouse 
strains would help to determine if this is the case.        
 
In the wakeful state, the respiratory response to fentanyl in adulthood was altered in the 
neonatal-exposed mice. Repeated neonatal fentanyl exposure appeared to induce a long-
term desensitisation to the acute respiratory depressive actions of subsequent fentanyl. It is 
possible that the mice developed a respiratory tolerance to fentanyl. Tolerance is generally 
defined as an attenuated physiological response to a pharmacological agent at a dose that 
should induce an effect. Mice pre-exposed to fentanyl in neonatal life no longer exhibited 
the typical respiratory frequency depression when they were exposed to fentanyl again in 
adulthood. Interestingly, this reduced respiratory depression was found in response to a 
wide range of fentanyl doses (0.04 mg/kg-0.1 mg/kg). This desensitisation to fentanyl 
occurs rapidly and within days of the repeated exposure as shown from study 2 detailed in 
chapter 3. The longitudinal study described here confirms that the reduced sensitivity to 
fentanyl’s respiratory depressive actions is maintained into adulthood. The mechanism(s) 
underlying this long-term respiratory tolerance during wakefulness cannot be determined 
from this study alone. Repeated or long-term exposure to agonists that act on µ opioid 
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receptors are known to induce tolerance to the analgesic actions of the drugs; however 
studies examining the effects on the respiratory actions are scarce. A number of studies 
have investigated and postulated potential mechanisms of opioid tolerance that involve µ 
opioid receptor regulation as thoroughly discussed in chapter 3, section 3.7.1. It is possible 
that these hypothesised mechanisms could also explain this long-term tolerance to 
respiratory depression observed after neonatal exposure. It is imperative to highlight that 
this tolerance is no longer observed in the anaesthetised state, suggesting the mechanism(s) 
of tolerance is not permanent but can be altered or even reversed depending on the state of 
the animal.  
 
Not only did the neonatal-exposed mice lack respiratory depression during wakefulness 
they also displayed a surprising increase in ventilation at 5 minutes following the acute 
fentanyl challenge, which was not observed by the control mice. This ventilatory increase 
was due to a combined increase in respiratory frequency and Vt. A possible explanation for 
this observation is repeated exposure to fentanyl during neonatal life may have predisposed 
the mice to increased anxiety in adulthood thereby augmenting their sensitivity to stressful 
events. There is evidence to suggest repeated opioid exposure in rats induces 
glucocorticoid-dependent changes in the expression of Fos transcription factors within 
stress-related brain areas including the central amygdala and the hypothalamic 
paraventricular nucleus, which could alter the stress-responsive system (Garcia-Perez et 
al., 2012). Furthermore, dependence and withdrawal symptoms have been reported in 
neonatal rats chronically administered fentanyl (Thornton and Smith 1997; Thornton and 
Smith, 1998), which in turn could alter anxiety levels. To determine if mice exhibited 
heightened anxiety, baseline and post-injection levels of serum corticosterone, a known 
stress marker, could be measured (Ren et al., 2012b), where elevated levels would indicate 
increased anxiety. If the neonatal-exposed mice were in fact more stressed later in adult 
life, they would be highly sensitive to noxious stimuli including the i.p fentanyl injection. 
Furthermore, removing the animal from the recording chamber in order to administer the 
drug would also induce a stress response. The respiratory stimulation after the fentanyl 
challenge could therefore represent an injection-induced hyperventilation, which could in 
turn counteract the respiratory depressive effects of fentanyl. This could mean the reduced 
fentanyl depression does not actually signify tolerance, but rather a masking of the 
respiratory depression response. Thus, the method of administration utilised in these 
studies may not be optimal. An osmotic mini pump could represent an alternative method 
of drug delivery for future studies that would not induce an injection stress response. It is 
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also possible that if tolerance has in fact developed, fentanyl would not induce the same 
magnitude of respiratory depression that would otherwise counteract the injection-induced 
respiratory increase, and hence in the neonatal-exposed mice respiratory stimulation 
following the injection is evident. We also cannot rule out the possibility that fentanyl 
itself induced a stimulation in ventilation in the neonatal-exposed mice. A potential method 
to determine if the increase in ventilation is due to an injection-induced stress response as 
opposed to a pharmacological effect of fentanyl would be to pre-treat mice with naloxone 
(µ opioid receptor antagonist) prior to fentanyl administration. If the ventilatory increase is 
naloxone-insensitive and hence fentanyl-insensitive, then it is likely a result of the 
injection itself. Additionally an increase in ventilation in response to a vehicle injection 
would also suggest the injection is responsible.   
 
4.5.2.2 Juvenile-exposed mice exhibited a reduced sensitivity to fentanyl during 
wakefulness 
 
Repeated juvenile fentanyl exposure also evoked a long-term tolerance to the acute 
respiratory depressive actions of subsequent fentanyl, which was observed in the wakeful 
state. Identical to the respiratory response to fentanyl exhibited by neonatal-exposed mice, 
juvenile-exposed mice did not display the typical respiratory frequency depression when 
exposed again to fentanyl in adulthood. Again, fentanyl failed to induce respiratory 
depression at a wide range of doses. Furthermore, juvenile-exposed mice displayed an 
augmentation in ventilation directly after fentanyl administration that was also exhibited by 
the neonatal-exposed animals. Considering the similarity in the long-term altered fentanyl 
responsiveness seen in the wakeful state, it is highly likely that the mechanisms underlying 
these changes are similar in both the neonatal and juvenile-exposed mice. See section 
4.5.2.1 above for discussion on the possible explanations for the altered respiratory 
response.   
 
Taken together, the neonatal and juvenile exposure studies suggest that repeated fentanyl 
exposure early in life induces a long-term reduction in the sensitivity to the respiratory 
depressive actions of the drug observed during wakefulness. Given that the same 
respiratory response to fentanyl is seen in both neonatal and juvenile-exposed animals, the 
long-term change in the responsiveness to the drug in the wakeful state appear to occur 
independently of the age of exposure.   
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4.5.3 Anaesthetised state: resting breathing 
 
Mice were anaesthetised with urethane to allow more detailed respiratory measurements to 
be performed as well as enabling respiratory activity to be assessed in a more depressed 
brain state. Urethane is an atypical general anaesthetic in that it does not potentiate 
GABAergic neurotransmission or reduce glutamatergic neurotransmission, but rather 
hyperpolarises cortical neurons by modulating a resting potassium conductance 
(Antkowiak, 2001; Thompson and Wafford, 2001; Hara and Harris, 2002; Sceniak and 
Maciver, 2006). Urethane was the anaesthetic of choice owing to its reported long duration 
of action and minimal depressive effects on the cardiovascular and respiratory system 
(Maggi and Meli, 1986). 
 
4.5.3.1 Neonatal fentanyl exposure induced lasting changes in resting breathing 
under anaesthesia 
 
Under anaesthesia, whilst respiratory frequency was unaffected, compared with 
wakefulness, all control and neonatal-exposed mice displayed a lower tidal volume and 
therefore lower minute ventilation when anaesthetised, suggesting that urethane induced a 
selective depressive action on tidal volume resulting in a more depressed and vulnerable 
breathing state. When under anaesthesia, the neonatal-exposed mice no longer exhibited a 
lower respiratory frequency compared with the control mice; however they displayed a 
lower tidal volume and therefore reduced minute ventilation. It has been reported that 
systemically administered fentanyl acutely reduces the excitability of phrenic premotor 
neurons as well as depressing the frequency and intensity of phrenic nerve discharge in the 
adult anaesthetised cat (Lalley, 2003). Accordingly, it can be speculated that repeated 
neonatal fentanyl exposure may have induced a long-term depression of phrenic nerve 
activity and hence also reduced the contraction of the diaphragm and depth of breathing 
that only becomes apparent in the anaesthetised state. This would account for the lasting 
reduction in tidal volume and consequential lowered ventilatory profile. In vivo recording 
of the phrenic nerve discharge in the anaesthetised adult mice could be investigated in 
future studies to determine if there are lasting alterations in its motor output.  
 
The activity of the GG, an upper airway muscle with an inspiratory-modulated activity 
profile, was assessed. The GG is believed to maintain upper airway patency. In humans, a 
reduction in GG activity during sleep has been implicated in obstructive sleep apnoea 
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(Sauerland and Harper, 1976; Remmers et al., 1978). Furthermore, fentanyl has been found 
to evoke inhibitory actions on hypoglossal premotor neurons (Montandon et al., 2011) and 
hypoglossal motor pools (motoneurons that innervate the GG) thereby inducing a 
depression of the GG muscle activity (Hajiha et al., 2009). Accordingly, the effects of 
repeated neonatal fentanyl exposure on the long-term activity of this muscle were 
investigated in this present study. Under baseline conditions, neonatal-exposed mice did 
not exhibit any change in the amplitude of GG bursting, nor in the activation profile of the 
muscle. In all experimental mice in study 4 (control and neonatal-exposed), the GG muscle 
fired rhythmically and in synchrony with the inspiratory phase, suggesting early neonatal 
fentanyl exposure does not induce any lasting detrimental effects on the function of this 
inspiratory muscle. Previous studies have shown that GG activity is depressed during rapid 
eye movement (REM) and non-REM (nREM) sleep in rats (Pagliardini et al., 2012). It 
would be advantageous to undertake sleep/wake studies where EEG electrodes are 
implanted into the cortex to determine the sleep state of the rodent. GG muscle activity 
could be measured under various sleep states to determine if this previously reported state 
dependent depression of the GG is altered or augmented by repeated neonatal fentanyl 
exposure. 
 
ABD muscles have been demonstrated to exhibit an expiratory pattern of firing in rodents, 
and are defined as the main expiratory muscles in mammals (Pagliardini et al., 2011; 
Pagliardini et al., 2012). To gain an index of expiratory muscle activity and the effects of 
repeated fentanyl exposure on the functioning of expiratory muscles, ABD muscle EMG 
was recorded. It was found however that ABD muscle expiratory-modulated activity was 
not present in the majority of the experimental mice. Instead, ABD muscle activity was 
consistently tonic in nature and not synchronised with any phase of respiration. This is 
congruent with findings from two previous in vivo studies where ABDEMG activity was 
measured in urethane-anaesthetised rats and mice and it was found that approximately half 
of the animals displayed tonic ABD muscle activity throughout the experiment (Pagliardini 
et al., 2012; Pagliardini et al., 2013). In our study, 2 mice (one control and one neonatal-
exposed) did intermittently display expiratory-related, rhythmic ABD muscle activity, 
which appeared suddenly but was short-lived. The source of this expiratory activity is not 
known, nor is its exact function. It is hypothesised that ABD expiratory activity is present 
during active expiration when there is an increased respiratory drive (e.g. during exercise), 
and contraction of the abdominal muscles act to force more air out of the lungs thereby 
aiding ventilation (West, 2007). In rodents, ABD expiratory activity can be evoked or 
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augmented by chemosensory stimulation (Iizuka and Fregosi, 2007; Marina et al., 2010; 
Abbott et al., 2011), focal excitation of the RTN/pFRG (Pagliardini et al., 2011) and during 
REM sleep states (Pagliardini et al., 2012; Pagliardini et al., 2013). It is probable that 
expiratory activity was predominantly inactive in the current study as mice were under 
normal resting conditions so expiration was likely in a passive state. Pagliardini and 
colleagues (Pagliardini et al., 2012; Pagliardini et al., 2013) demonstrated that urethane-
anaesthetised rats and mice undergo sleep-like brain state alternations that can influence 
expiratory-related ABD muscle activity. They found that REM-like brain states induce or 
potentiate ABD expiratory muscle activation through unknown mechanisms. It is possible 
that the urethane-anaesthetised mice in the present study underwent similar brain-state 
changes that could have influenced ABD muscle recruitment and induced the sudden 
expiratory activation seen in the two mice; however this does not explain why it was 
completely absent in the majority of the mice. Irrespective of the underlying source or 
functional significance of respiratory-related ABD muscle activity; these results do suggest 
that fentanyl exposure in neonatal life does not influence the respiratory activity of this 
muscle under the conditions assessed.  
 
An interesting respiratory characteristic exhibited by neonatal-exposed mice when under 
anaesthesia and air breathing was spontaneous augmented breaths. More specifically, 
augmented breaths in this study are defined as large amplitude inspiratory efforts, where 
the tidal volume is 50% greater than that of a regular breath. Augmented breaths were not 
common in the control mice. Conversely, a large proportion of neonatal-exposed mice 
displayed spontaneous augmented breaths during baseline breathing, and many exhibited a 
high occurrence of these breaths. The precise physiological function and neural correlates 
of augmented breaths in vivo are not known. Augmented breaths are similar to sighs which 
have been widely reported in rodent in vivo and human studies. Sighs are generally defined 
as spontaneous large amplitude breaths followed by a post-sigh pause (Bartlett, 1971; 
Marshall and Metcalfe, 1988; Hoch et al., 1998; Voituron et al., 2010; Pagliardini et al., 
2012). The augmented breaths observed in this study were not followed by an expiratory 
pause and therefore cannot strictly be defined as sighs; however they are sigh-like 
behaviours. Sighs are believed to be an essential component of the respiratory system that 
function to increase lung compliance, maintain functional residual capacity, prevent 
alveolar atelectasis (Glogowska et al., 1972) and improve alveolar oxygenation (Patroniti 
et al., 2002). Augmented breaths are commonly induced by hypoxic stimuli in rodents 
(Bell et al., 2011; Pagliardini et al., 2012) and local cyanide stimulation of the carotid 
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bodies evokes sighing behaviour in cats (Glogowska et al., 1972). Taken together, these 
data suggest that augmented breaths may be induced by an activation of the peripheral 
chemoreceptors under hypoxic conditions. It is possible that when under anaesthesia, the 
neonatal-exposed mice were hypoxaemic (reduced arterial partial pressure of O2), and 
consequently exhibited a high frequency of augmented breaths through peripheral 
chemoreceptor stimulation, in an attempt to increase blood oxygenation. The reduced 
baseline Vt observed in the anaesthetised neonatal-exposed mice will have contributed to a 
poorer ventilation and potentially the increased generation of augmented breathing patterns 
to counteract this. It would have been beneficial to monitor the blood gas status of a 
subgroup of these mice throughout the experimental procedure via blood sampling, to 
determine if mice were hypoxaemic. A non-invasive pulse oximeter positioned on the tail 
to measure blood O2 saturation levels could also be employed (Ren et al., 2012a). In 
addition, assessment of chemosensory function under anaesthesia would have helped to 
ascertain if peripheral and central chemoreception was altered, which would affect blood 
gas homeostasis and potentially contribute to the frequent appearance of these sigh-like 
behaviours. Previous in vivo studies using a mouse model of Rett Syndrome have 
demonstrated that Rett mutant mice display a disordered respiratory phenotype that is 
characterised by an increased occurrence of sighing (Robinson et al., 2012). The frequent 
occurrence of augmented sigh-like breaths displayed by the neonatal-exposed mice in this 
present study may therefore be indicative of an unstable and fragile breathing state, and 
could potentially signify inadequate ventilatory function. In vitro studies using reduced 
brainstem slice preparations from embryonic and neonatal rodents have demonstrated that 
in addition to eupneic bursting, the preBötC can generate sigh-like respiratory output in the 
absence of peripheral chemosensory inputs (Lieske et al., 2000; Lieske and Ramirez, 
2006b, a; Chapuis et al., 2014). This suggests that the preBötC alone may be sufficient for 
the generation of augmented breaths and may represent their central origin. It is therefore 
intriguing to speculate that the high frequency of augmented breaths under anaesthesia 
could be an indication of an altered preBötC function in the neonatal-exposed mice, which 
generates an unstable respiratory pattern. Additionally, sighs have been postulated to play 
an important role in resetting the neurorespiratory control system (Baldwin et al., 2004). It 
can therefore also be hypothesised that the increased frequency of augmented breaths may 
be an attempt to reset respiratory rhythm generation, and improve respiratory control. 
Since no abnormal breathing characteristics, including sighs, were noted during 
wakefulness, it is conceivable that neonatal fentanyl exposure predisposes mice to 
respiratory defects that are only observed when mice are in a more depressed and 
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vulnerable state e.g. under anaesthesia. This finding is supported by a previous clinical 
study that reported normal respiratory activity during wakefulness but sleep-disordered 
breathing in adult patients receiving prolonged opioid therapy (Farney et al., 2003). 
  
4.5.3.2 Juvenile fentanyl exposure induced lasting changes in resting breathing 
under anaesthesia 
 
Similar to the neonatal-exposed mice, when under urethane anaesthesia, juvenile-exposed 
mice displayed a reduced baseline Vt. However in contrast to the neonatal-exposed 
animals, juvenile-exposed mice also exhibited an increased respiratory frequency. This in 
turn maintained their minute ventilation. This increase in respiratory frequency could 
represent a compensatory mechanism to overcome the lowered Vt, thereby maintaining a 
normal ventilatory profile. The reason why this heightened baseline respiratory frequency 
was not observed in the neonatal-exposed mice is unknown. This could signify that 
exposing mice to fentanyl in neonatal life may induce detrimental changes in respiratory 
control in the mature system that could prevent compensatory changes in respiratory 
activity. Juvenile-exposed mice did not exhibit any long-term change in either the 
amplitude of the GG bursting or the activation profile of the muscle, which consistently 
showed inspiratory-related activity in all experimental mice. This suggests juvenile 
fentanyl exposure, akin to neonatal exposure, does not induce any lasting effects on the 
function of this inspiratory muscle. In terms of ABD muscle activity, this was found to be 
tonic in nature and did not display an expiratory-modulated mode of activation in either 
control or juvenile-exposed mice. This is congruent with the findings from the neonatal 
exposure study (see section 4.5.3.1 for discussion), and suggests juvenile-exposed mice 
also exhibited passive expiration under anaesthesia and repeated juvenile fentanyl exposure 
does not alter this. 
 
In contrast to the neonatal-exposed mice, juvenile-exposed mice did not exhibit a high 
frequency of augmented, sigh-like breaths during baseline breathing under anaesthesia. If 
these breaths are an indication of hypoxaemia and therefore unstable ventilation as 
previously discussed, then the data from study 4 and study 5 suggests that repeated 
fentanyl exposure in neonatal life may induce more pronounced long-term detrimental 
respiratory effects compared to juvenile exposure. Unlike neonatal-exposed mice, the 
anaesthetised juvenile-exposed mice did not exhibit a reduced baseline minute ventilation 
due to their enhanced respiratory frequency and were therefore unlikely to have blood gas 
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values outside the physiological range. This would suggest that there was no requirement 
for the high occurrence of augmented breaths to improve blood oxygenation. As discussed 
with regards to the neonatal exposure study, it would also be advantageous to measure the 
partial pressure of O2 and CO2 in the blood of a subgroup of juvenile-exposed mice to 
confirm blood gas homeostasis is in fact maintained throughout the experimental 
procedures. Again, if our speculation that a high occurrence of augmented breaths is 
indicative of altered function at the level of the preBötC, the low occurrence in the 
juvenile-exposed mice could imply that juvenile exposure does not induce the same lasting 
effects on preBötC activity as exposure during the neonatal period.   
 
4.5.4 Anaesthetised state: acute respiratory response to fentanyl 
 
4.5.4.1 Neonatal-exposed mice exhibited a heightened sensitivity to fentanyl under 
anaesthesia 
 
When neonatal-exposed mice were under anaesthesia they exhibited a strikingly different 
respiratory response to fentanyl compared with wakefulness. The mice no longer exhibited 
a reduced respiratory responsiveness to fentanyl, but rather displayed an enhanced 
sensitivity. Fentanyl, even at the lowest dose studied, induced a complete arrest of 
respiratory activity in all neonatal-exposed animals. This respiratory failure was not 
observed in any of the control mice. The loss of coordinated, rhythmic respiratory 
musculature movements and the development of persistent apnoea would have been fatal if 
mice were not artificially ventilated. The respiratory depression was so profound that 
artificial ventilation failed to restore spontaneous breathing. Here we have demonstrated 
that a non-destructive, pharmacological depression of the respiratory system with fentanyl 
during the early postnatal period can induce a heightened sensitivity to future respiratory 
challenges, but only when mice are anaesthetised. The mechanisms underlying these state-
dependent fentanyl effects can only be hypothesised at present. 
 
From the outset of the study, the initial aim was to examine the same fentanyl dose when 
mice were awake and anaesthetised; however it was clear that in both control and neonatal-
exposed mice, anaesthesia represented a particularly vulnerable state for fentanyl-induced 
respiratory depression. The doses examined under anaesthesia were consequently lowered. 
This finding is in agreement with data reported by Montandon and colleagues (Montandon 
et al., 2011), who found that the magnitude of opioid-induced respiratory depression after 
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direct bilateral application to the preBötC in adult rats was correlated with the level of 
cortical activation as determined by EEG monitoring. Brain states with depressed cortical 
activity such as those under anaesthesia and non-REM sleep were most vulnerable to the 
depressive actions of opioids. This finding lends support to our data and fits with the 
theory that wakefulness can provide ample excitatory drive to the central respiratory 
system to help overcome depressed respiratory activity (Phillipson and Bowes, 1986). This 
concept of state-dependent respiratory depression and loss of cortical drive under 
anaesthesia can help to explain the hypersensitivity to fentanyl. Once again we speculate 
alterations in the rhythm generating capacity of the preBötC in these neonatal-exposed 
mice. µ opioid receptor agonists depress the neural activity of the preBötC in vitro (Takeda 
et al., 2001; Mellen et al., 2003; Montandon et al., 2011) and in vivo the preBötC is found 
to be the critical brain site where fentanyl acts to depress respiratory frequency 
(Montandon et al., 2011). Given that in this current study a subsequent fentanyl challenge 
caused a failure in the generation of a robust and rhythmic respiratory output under 
anaesthesia, it can be postulated that these effects are due to alterations at the level of the 
preBötC. It is possible that repeated fentanyl exposure in early life induces long-term 
neural alterations in the preBötC, making it more sensitive to the effects of future fentanyl. 
This proposed dysfunction may only become apparent when there is a loss of cortical drive 
to the central respiratory system and when the preBötC neural activity is further depressed. 
It should be noted however that increased preBötC sensitivity to opioids does not 
necessarily mean the rhythm generating function has been altered. Another point to 
consider is the reduced Vt and the presence of augmented breaths during baseline 
breathing, which as previously discussed could indicate respiratory instability in neonatal-
exposed mice under anaesthesia. This already vulnerable baseline breathing state may be 
more sensitive to depressive agents and thus could also be attributable to the respiratory 
failure evoked by fentanyl. The finding that destruction of NK1R-expressing preBötC 
neurons induces breathing disturbances that are first observed in sleep in adult rats (McKay 
et al., 2005) together with the finding that respiratory instability is marked in nREM sleep 
in CCHS patients (Shea, 1997), is consistent with the idea that respiratory abnormalities 
and vulnerabilities to perturbations tend to initially manifest in depressed states, and is also 
congruent with the data reported here. Sleep represents a depressed brain state that 
significantly influences respiratory activity (Pagliardini et al., 2012). Given that opioids are 
widely used to manage post-operative pain together with the fact that patients tend to spend 
a substantial portion of time asleep following surgery (Caplan et al., 1989; Gourlay et al., 
1990; Viscusi et al., 2004), it would be beneficial to examine the response to fentanyl 
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during sleep in the mice, which would provide further translational value to the study. It 
would be interesting to determine if similar findings are observed under sleep. Since 
wakefulness can clearly overcome or compensate for defects in components of the 
respiratory system, studying respiratory activity during wakefulness alone could mask 
respiratory disturbances. For a comprehensive respiratory analysis, it is imperative that 
respiration activity is analysed under various brain sates.  
 
It is important to highlight that the specific actions of urethane on the central respiratory 
system and its individual components including the preBötC have not been identified. 
Further investigation is required to determine if urethane exerts increased depressive 
actions in the neonatal-exposed mice or induces more adverse effects that could contribute 
to the increased responsiveness to fentanyl. As discussed above in section 4.5.2.1, the 
neonatal-exposed mice may have exhibited exaggerated stress-responses when in the 
wakeful state that could have counteracted the depressive effects of fentanyl. Under 
anaesthesia stress responses are abolished which could also explain why fentanyl induced a 
clear respiratory depression and may represent the true response to fentanyl.   
 
Fentanyl has been shown to induce acute hypoxemia in rats (Chen et al., 1996; Chevillard 
et al., 2009). Furthermore, work by Moss and colleagues (Moss et al., 2006) has revealed 
that recurrent hypoxic exposure in juvenile rats, which renders them hypoxemic, induces 
an increased respiratory sensitivity to subsequent fentanyl exposure in adulthood. The 
authors suggest that this increased sensitivity is due to hypoxemia producing a repeated 
release of endogenous opiates that could in turn activate µ opioid receptors and sensitise 
them to subsequent opioid administration. If repeated fentanyl exposure in neonatal life 
induces recurrent hypoxemia then this mechanism of increased endogenous opiate release 
and consequential sensitisation of the µ opioid receptors within the preBötC could underlie 
the increased respiratory responsiveness to future fentanyl application in adult life under 
anaesthesia. Repeated hypoxemia in early life may therefore induce a detrimental impact 
on the respiratory system.   
 
4.5.4.2 Juvenile-exposed mice did not exhibit an altered sensitivity to fentanyl 
under anaesthesia 
 
When juvenile-exposed mice were anaesthetised they exhibited a different respiratory 
response to fentanyl compared with wakefulness. Fentanyl induced a significant 
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respiratory depression which was not observed during wakefulness. This once again 
highlights the concept of state-dependent respiratory depression (see section 4.5.4.1) and 
suggests the mechanisms of respiratory depression may change depending on the arousal 
state. The loss of stress-related responses under anaesthesia as discussed above (section 
4.5.4.1) could also account for the depressed respiratory activity only observed under 
anaesthesia. The respiratory depression evoked by fentanyl under anaesthesia was of the 
same magnitude as that seen in the control mice, suggesting fentanyl exposure in juvenile 
life does not alter the response to subsequent fentanyl challenges under anaesthesia. 
Importantly, the profound suppression of respiratory activity and eventual respiratory 
failure seen in the neonatal-exposed mice in response to fentanyl was not exhibited by the 
juvenile-exposed mice (with the exception of one mouse). The low occurrence of 
augmented breaths and the fact they exhibited unaltered minute ventilation suggests the 
juvenile-exposed mice had a more stable breathing phenotype under anaesthesia compared 
to the neonatal-exposed mice, therefore making them less susceptible to fentanyl’s 
depressive actions. Whether neonatal and juvenile-exposed mice exhibited differences in 
central respiratory control including preBötC functioning that could account for this 
differential fentanyl response remains to be elucidated. 
 
It is clear that the striking difference in the respiratory response to fentanyl between the 
neonatal and juvenile-exposed mice only became apparent when the mice were in the 
anaesthetised state. In terms of respiratory function and fentanyl effects during 
wakefulness, there were only subtle differences between the two groups of mice. Studying 
breathing in the wakeful state alone would have drawn a different interpretation. This 
highlights the complexity of opioid respiratory depression and the fact that in order to gain 
a full analysis of opioid depression and its effects on respiratory control, respiratory 
activity must be explored under varying behavioural states. Taken together, the neonatal 
and juvenile exposure studies suggest that the postnatal age of fentanyl-exposure 
influences long-term respiratory effects. It appears that repeated neonatal fentanyl 
exposure is more detrimental to respiratory control. 
 
4.5.5 Neonatal life is vulnerable to repeated fentanyl exposure 
 
Only the neonatal-exposed mice displayed a depressed baseline ventilation and high rate of 
augmented breaths under anaesthesia coupled with an enhanced sensitivity to fentanyl that 
resulted in respiratory arrest. This strongly suggests that neonatal life represents a time 
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period that is particularly vulnerable to the lasting effects of opioid depression. The 
reason(s) behind this age-dependent difference cannot be elucidated at present; however 
we can offer some speculation. `  
 
The increased vulnerability of neonatal mice to the long-term respiratory effects of 
repeated fentanyl exposure is unlikely due to age-dependent differences in blood brain 
barrier integrity that could influence the level of drug that reaches and acts on the brain. 
Previous studies have demonstrated that the degree of fentanyl penetration across the blood 
brain barrier is similar between neonatal and juvenile rats, given that the concentration of 
fentanyl in brain tissue following administration was comparable at all ages (Thornton and 
Smith, 1997). Furthermore, fentanyl is highly lipophilic and readily crosses the blood brain 
barrier (Bragg et al., 1995), so age is unlikely to affect this. It would however be 
advantageous to measure fentanyl levels in the brain tissue of the neonatal and juvenile 
mice of this study to confirm similar drug penetration. It is also unlikely that repeated 
fentanyl exposure hampered the feeding ability of the neonatal mice, which could have 
indirectly impacted the respiratory system, given that the body weights of the mice during 
the exposure period and on reaching adulthood were not affected by fentanyl 
administration. 
 
Previous studies have investigated the long-term consequences of the perinatal 
environment on respiratory control in rodents, and in accordance with the data presented in 
this chapter have found that exposure to various environmental stimuli in the neonatal 
period including hypoxia, hypercapnia, caffeine and stressful events can induce lasting 
changes in ventilatory control (Okubo and Mortola, 1988; Bavis and Kilgore, 2001; Bavis 
et al., 2004; Montandon et al., 2006; Gulemetova and Kinkead, 2011). Together with our 
findings, this is congruent with the idea that manipulations to the developing respiratory 
system can have profound, lasting changes in respiratory activity. It is widely 
acknowledged that the central respiratory system has a large capacity for plasticity, and 
constantly adapts to the internal and external environment of the organism. Our data 
suggests that fentanyl exposure in neonatal life induces developmental plasticity, which in 
terms of respiratory control has been defined as long-term changes in the mature 
respiratory system that are induced by experiences that occur during a critical 
developmental time period, whereas the same experiences after this critical time window 
evoke little or no lasting changes (Carroll, 2003; Bavis and Mitchell, 2008). This theory is 
strengthened by the fact that juvenile exposure to fentanyl did not elicit the same profound 
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long-term respiratory changes, suggesting the first five days of life in the mouse represents 
a critical developmental time period highly susceptible to opioid-induced developmental 
plasticity. The reasons behind this developmental susceptibility can only be hypothesised. 
In mammals there is a surge of endogenous opiates at birth (Jansen and Chernick, 1983) 
that have been proposed to depress preBötC function (Feldman and Del Negro, 2006; 
Janczewski and Feldman, 2006). The exogenous application of fentanyl coupled with the 
endogenous perinatal opiate surge could exert a significant depression on the preBötC in 
the neonatal mice and may be partly or fully accountable for the more pronounced long-
term respiratory effects compared with juvenile-exposure. In addition, breathing exhibits 
an irregular and fragile pattern immediately after birth. Given that a critical postnatal 
maturation of breathing occurs within the first 3-5 days of life in the mouse (see chapter 3 
for full details), it is possible that neonatal fentanyl exposure interferes with this maturation 
process thereby inducing profound long-term respiratory consequences and altered 
respiratory responsiveness to future fentanyl challenges that persist into adulthood. This 
would explain why juvenile exposure did not induce such profound respiratory changes, 
since juvenile mice would have exhibited a mature breathing pattern at the time of 
exposure. An immature respiratory system is perhaps highly susceptible to repeated 
perturbations. From our studies we cannot deduce if fentanyl exposure during all 5 
postnatal days (P1-P5) is essential for the lasting respiratory effects, or if there is a more 
narrow critical time window. Repeating the studies with slight variations in the exposure 
time frame would help to ascertain the exact critical developmental time period. The 
results from both neonatal and juvenile exposure studies have highlighted the potential 
long-term health consequences of developmental plasticity in respiratory control. 
  
4.5.6 Future experimental studies 
 
It is imperative to highlight the fact that the fundamental mechanisms by which repeated 
fentanyl exposure evokes the long-term respiratory effects can only be speculated at 
present. The studies described in this chapter have examined the long-term physiological 
effects at the system level. Whether fentanyl induces its long-term effects by specific 
actions on single neural groups or via more complex network effects remains elusive. 
Fentanyl was administered systemically and likely targeted respiratory and non-respiratory 
brain areas, as well as peripheral sites, which could have contributed directly or indirectly 
to the respiratory changes seen in adult life. This study design is clinically relevant. 
However to unravel the underlying mechanisms of repeated opioid exposure and its 
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respiratory consequences, further studies must be undertaken in more reduced in vitro 
preparations. Whether repeated neonatal fentanyl exposure induces long-term defects or 
alterations in preBötC functioning that continue into adulthood as postulated based on the 
studies described in this chapter, certainly warrants further investigation. This hypothesised 
opioid-induced abnormality in preBötC functioning could be further investigated by 
directly recording the inspiratory activity of preBötC neurons in medullary slice or en bloc 
hindbrain preparations using electrophysiology or calcium imaging techniques. These 
preparations are however most viable in young neonatal tissue (Fong et al., 2008). The 
working heart-brainstem in situ preparation could be employed in the adult mouse. This 
preparation has the advantage of an intact circulatory system as well as having a more 
intact respiratory network including peripheral chemoreception and cardiorespiratory 
reflexes (Paton, 1996b, a). From this preparation central respiratory motor output (phrenic 
and hypoglossal nerve discharge) can be monitored and recorded in addition to 
extracellular recordings of the preBötC neurons (Paton, 1996b, a). Employing this 
experimental preparation would enable the lasting central respiratory effects of fentanyl 
exposure to be more comprehensively investigated in the adult mouse.  
 
Another future research direction could be to establish the brain regions acutely affected by 
fentanyl in adulthood and determine if neonatal and juvenile repeated fentanyl exposure 
alters this. A quantitative 2-deoxyglucose (2-DG) autoradiography study could be 
employed to explore the complex neuropharmacological effects of fentanyl. The 2-DG 
technique uses a radiolabelled analogue of glucose and works on the principle that cerebral 
metabolism is closely linked to glucose utilisation (Wree, 1990). Studying the fate of the 
injected radiolabelled glucose analogue can give indications of the functional activity of 
individual neural structures and hence can show the functional effect of fentanyl on 
discrete brain regions. This study would help to delineate the acute effects of fentanyl on 
the brain and identify if repeated fentanyl exposure in neonatal or juvenile life elicits long-
term changes in fentanyl’s actions that could explain the physiological changes described 
in the present studies of this chapter. Furthermore, the influence of anaesthesia on 
fentanyl’s activity in the brain could be investigated, which would further aid in the 
understanding of state-dependent respiratory depression. 
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4.5.7 Limitations and technical issues 
 
It was very difficult to design these pre-clinical studies to be fully clinically relevant given 
the heterogeneous nature of opioid treatment in clinical practice. For one, the route of 
administration of fentanyl in the studies described in this chapter differs from that seen in 
the clinical setting. Mice received bolus intraperitoneal fentanyl injections over several 
days, whereas fentanyl is often given to patients by continuous intravenous infusion or 
transdermal application (Dellemijn et al., 1998; Kornick et al., 2003). These routes of 
administration are not feasible in mouse pups. It is therefore very difficult to replicate the 
doses administered clinically as these vary depending on the route of administration. In 
addition, the duration of opioid treatment administered in the clinic can differ significantly 
depending on both its therapeutic purpose and on the individual patient and their 
physiological response to the treatment. These limitations should be considered when 
interpreting the clinical relevance of the data. 
 
In addition to recording GG muscle activity, the original objective was to also measure 
EMG activity of the diaphragm, given that it is the principal inspiratory muscle. There was 
however technical issues that prevented recording. Initially, wire EMG electrodes were 
sutured into the diaphragm muscle; however insertion of the electrodes through the thin 
muscle wall created a small hole that allowed air to enter the pleural cavity consequently 
inducing a pneumothorax. This in turn had a detrimental impact on respiration. In a further 
attempt to measure diaphragm activity, hooked needle EMG electrodes were also inserted 
into the muscle. Although they did not damage the diaphragm, it was difficult to keep them 
secured in place to allow continual and reliable EMG measurements. The use of smaller 
gauge EMG wire electrodes that induce less damage to the diaphragm and remain securely 
in contact with the muscle could overcome the problem. To enable sufficient diaphragm 
EMG recordings for future respiratory studies in the mouse, it is fundamental that the 
experimental technique is optimised. 
 
4.5.8 Summary 
 
For the first time we have shown that repeated exposure to fentanyl during early life in the 
mouse induces lasting respiratory alterations including a remarkable respiratory 
hypersensitivity to fentanyl under anaesthesia (see Table 4-3 for summary of main 
findings). Given the widespread application of opioids in clinical practice and their potent 
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respiratory depressive actions, understanding long-term detrimental respiratory effects of 
opioid exposure is invaluable. If these findings translate to the clinical setting then long-
term neonatal opioid therapy in humans could predispose a patient to respiratory 
abnormalities later in life that may manifest initially in depressed behavioural states e.g. 
during sleep. Furthermore, repeated neonatal opioid exposure could induce a dangerous 
hypersensitivity to the respiratory depressive actions of opioid drugs in depressed 
behavioural states, thus limiting their therapeutic usefulness. In conclusion these studies 
have generated novel data yielding invaluable insight into the vulnerabilities of the 
immature mammalian respiratory system to opioid-induced depression. Moreover these 
studies have aided in the understanding of state-dependent respiratory modulation and 
depression, whilst laying a solid foundation for future studies examining the impact of 
repeated fentanyl exposure on respiratory control.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4-3. Summary of the long-term respiratory effects of repeated 
fentanyl exposure in the neonatal and juvenile mouse.   
 
•No change in the respiratory 
sensitivity to fentanyl
•Fentanyl induced typical respiratory 
depression but did not evoke a 
respiratory arrest
•Hypersensitivity to the respiratory 
depressive effects of fentanyl
•Fentanyl evoked a respiratory arrest 
Long-term changes in 
respiratory response to 
fentanyl under anaesthesia
•Increased respiratory frequency
•Reduced inspiratory duration
•Reduced tidal volume
•Unaltered minute ventilation
•Unaltered genioglossus activity
•Unaltered respiratory frequency
•Unaltered inspiratory and expiratory 
duration
•Reduced tidal volume
•Reduced minute ventilation
•Unaltered genioglossus activity
•Increased frequency of augmented 
breaths
Long-term changes in 
baseline breathing under 
anaesthesia
•Reduced sensitivity to the respiratory 
depressive effects of fentanyl
•Reduced sensitivity to the respiratory 
depressive effects of fentanyl
Long-term changes in 
respiratory response to 
fentanyl during wakefulness
•Unaltered respiratory frequency
•Unaltered inspiratory and expiratory 
duration
•Unaltered tidal volume
•Subtle reduction in minute ventilation
•Reduced respiratory frequency
•Increased duration of inspiration
•Unaltered tidal volume
•Reduced minute ventilation
Long-term changes in 
baseline breathing during 
wakefulness
Repeated fentanyl exposure 
in the juvenile mouse
Repeated fentanyl exposure 
in the neonatal mouse
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Chapter 5. 
Long-term respiratory effects of repeated fentanyl 
exposure in the neonatal mouse: Immunohistochemical 
analysis of the ventral respiratory column 
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5.1 Introduction  
 
From study 4 discussed in chapter 4, it was shown for the first time that repeated exposure 
to fentanyl during neonatal life in the mouse induces lasting alterations in resting 
ventilation and evokes a striking change in the response to future administrations of 
fentanyl, with a reduced sensitivity to fentanyl exhibited when awake but a 
hypersensitivity displayed when anaesthetised. Understanding the processes underlying 
these long-term respiratory changes is of clinical significance as opioids are utilised widely 
in clinical practice (Swarm et al., 2001; Niesters et al., 2013). However, at present, these 
underlying mechanism(s) remain elusive. Given that fentanyl is known to reduce 
respiratory frequency in vivo by acting on and depressing the activity of NK1R-expessing 
preBötC neurons (Montandon et al., 2011), it is possible that repeated fentanyl exposure 
induces a long-term change in preBötC function which may be due to lasting histological 
changes to the preBötC e.g. changes in NK1R expression. Histological alterations could be 
responsible for the long-term respiratory effects exhibited by the neonatal-exposed mice. 
The central respiratory system is comprised of a complex network of functionally 
interacting neurons, so it is not known if repeated depression of the preBötC by fentanyl 
induces indirect effects on other respiratory nuclei. Furthermore, fentanyl’s actions are 
widespread and not limited to the preBötC; therefore anatomical alterations in other 
respiratory and non-respiratory related brain regions could also contribute to the long term 
respiratory changes exhibited by neonatal-exposed mice. Since fentanyl acts on the µ 
opioid receptor to induce its pharmacological effects, it is possible that changes at the 
receptor level within respiratory-related brain areas, including that of the preBötC, are 
responsible for the long-term change in both resting respiratory activity and the respiratory 
responsiveness to fentanyl exhibited by the neonatal-exposed mice. In support of this 
theory, alterations in µ opioid receptor regulation and therefore receptor density throughout 
the brain have been implicated in the development of tolerance and reduced sensitivity to 
opioids following repeated exposure (Bhargava and Gulati, 1990; Yoburn et al., 1993; 
Bernstein and Welch, 1998; Stafford et al., 2001). As discussed in section 3.7.1 in chapter 
3, there is considerable debate concerning the exact receptor changes induced by repeated 
opioid exposure as well as the physiological significance of these changes. From the wide 
range of in vivo studies that have been conducted, there are incongruities in the observed 
changes in receptor density following repeated opioid exposure, with both upregulation 
and downregulation of the µ opioid receptor reported (see section 3.7.1 for full discussion). 
To date there have been no studies carried out which have investigated if repeated opioid 
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exposure induces long-lasting changes in µ opioid receptor regulation. Additionally, the 
long-term effect of repeated opioid exposure on the expression of the µ opioid receptor 
within specific respiratory-related brain regions has never been reported. The ventral 
respiratory column (VRC) is a region of the ventrolateral medulla containing some of the 
principal respiratory neurons including the preBötC. Elucidating potential histological 
changes within  the VRC could be vital in understanding the long-lasting and remarkable 
change in the susceptibility to the respiratory depressive actions of fentanyl observed in the 
neonatal-exposed mice described in study 4 (chapter 4).  
 
5.1.1 Study 6 aims and rationale 
 
The aim of study 6 described in this chapter was to determine if repeated exposure to 
fentanyl during neonatal life in the mouse induces long-lasting changes in receptor 
expression within a region of the VRC, using immunohistochemistry (IHC). The preBötC 
and the RTN/pFRG are two important respiratory neural groups implicated in respiratory 
control (Smith et al., 1991; Onimaru and Homma, 2003); therefore examining histological 
changes within these regions was of greatest interest. Given that fentanyl acts on the µ 
opioid receptor to evoke its effects, it was of particular interest to determine the effect of 
repeated fentanyl exposure on µ opioid receptor expression throughout the VRC, 
particularly within the region of the preBötC, which is reported to express a high level of 
the µ opioid receptor (Gray et al., 1999). Since both preBötC and RTN/pFRG neurons 
express the NK1R (Gray et al., 1999; Guyenet and Wang, 2001; Wang et al., 2001a; 
Guyenet et al., 2002; Onimaru et al., 2008; Pagliardini et al., 2008), the long-term effect of 
fentanyl exposure on NK1R expression throughout the VRC was also examined. Phox2b is 
a selective marker for the RTN/pFRG (Stornetta et al., 2006; Kang et al., 2007; Onimaru et 
al., 2008) therefore its expression within the VRC was also assessed. Study 6 was designed 
to elucidate some of the potential mechanisms underlying the long-term changes in 
baseline respiratory behaviour as well as the lasting altered respiratory response to fentanyl 
displayed by neonatal-exposed mice from study 4. It was hypothesised that neonatal-
exposed mice would exhibit long-lasting changes in µ opioid receptor expression within 
the region of the VRC corresponding to the preBötC. 
 
Given that repeated fentanyl exposure during juvenile life in the mouse also evoked long-
term respiratory effects as reported from study 5 (detailed in chapter 4) it was also of 
interest to determine if juvenile exposure induces long-lasting changes in receptor 
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expression within the VRC. This work was designed to complement and follow on from 
study 5. However, due to a number of technical issues no data were generated. This will be 
discussed in full in section 5.4.5. 
 
5.2 Methods 
 
5.2.1 Animals 
 
All experimental procedures were carried out under licence from the UK Home Office and 
performed in accordance with the Animals (Scientific Procedures) Act, 1986. Experiments 
detailed in this chapter were performed on male ICR mice. All mice were bred at the 
Wellcome Surgical Institute animal research facility and a total of 9 mice were studied. All  
mouse pups were housed with their mother until they reached weaning age (approximately 
21 days old), after which they were housed in groups of no more than six. Mice were 
maintained on a 12 hour light/dark cycle with food and water available ad libitum.    
 
5.2.2 Chronic fentanyl exposure 
 
Neonatal mice were repeatedly administered fentanyl citrate (Janssen-Cilag, UK) from P1-
P5 (n=5). They received a single intraperitoneal (i.p) dose of 0.04 mg/kg on each postnatal 
day. This was the same dose as administered to neonatal mice in study 4, detailed in 
chapter 4. Control mice (n=4) were administered an equivalent volume of physiological 
saline from P1-P5. Mice repeatedly exposed to fentanyl in neonatal life are referred to as 
neonatal-exposed.  
 
5.2.3 Perfusion fixation and cryostat sectioning 
 
When mice reached adulthood (6 weeks old) their brains were perfused to allow for 
detailed histological analyses of the VRC. Mice were administered a lethal i.p injection of 
pentobarbital (0.1ml) and on abolition of the hindlimb reflex were transcardially perfused 
with 4% paraformaldehyde (see chapter 2, section 2.7 for full details of perfusion fixation 
protocol). The brainstem was removed and post-fixed for 4 hours in the same fixative 
solution. 40 micrometer coronal medullary sections were cut at -21°C using a cryostat. 
Sections were collected sequentially into 48 well plates containing 0.3M PBS and then 
split into 4 groups to allow for different immunostaining within each group (see chapter 2, 
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Figure 2-7 for illustration).  Neurons were immunostained for NK1R in groups 1 and 3, µ 
opioid receptor in group 2 and Phox2b transcription factor in group 4. 
 
5.2.4 Antibody combinations 
 
All immunohistochemistry protocols were carried out on free floating brainstem sections. 
Neonatal-exposed and control tissue were always processed simultaneously for direct 
comparisons. For full details of the immunostaining protocol see chapter 2, section 2.9.1.  
 
5.2.4.1 NK1R immunostaining 
 
NK1R expression was detected using a rabbit anti-NK1R primary antibody (1:5000; 
Sigma-Aldrich, UK) and a biotinylated donkey anti-rabbit secondary antibody (1:500; 
Vector Laboratories, UK). A tyramide signal amplification step was carried out using 
tyramide conjugated to tetramethylrhodamine (1:50, Perkin Elmer Inc, UK).  
 
5.2.4.2 µ opioid receptor immunostaining 
 
Mu opioid receptor expression was detected using a rabbit anti-µ opioid receptor primary 
antibody (1:5000; Immunostar, UK) and a biotinylated donkey anti-rabbit secondary 
antibody (1:500; Vector Laboratories, UK). A tyramide signal amplification step was 
carried out using tyramide conjugated to tetramethylrhodamine (1:50, Perkin Elmer Inc, 
UK).  
 
5.2.4.3 Phox2b immunostaining 
 
Phox2b expression was detected using a rabbit anti-Phox2b primary antibody (1:500; gift 
from C.Goridis, ENS, France) and a donkey anti-rabbit secondary antibody conjugated to 
Alexa-488 (1:500; Stratech-Jackson Immunoresearch). Phox2b staining proved to be 
variable so quantification was not carried out (discussed in section 5.4.4). 
 
All sections were also stained for VGLUT2 and choline acetyltransferase (ChAT) enzyme. 
VGLUT2 is a marker for both preBötC and RTN/pFRG neurons and ChAT is expressed in 
motor neurons and helps to delineate the facial motor nucleus (one of the reference 
landmarks used in the method of cell counting). However the immunostaining for these 
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markers did not work and will be discussed in section 5.4.4. To stain for VGLUT2, a 
guinea pig anti-VGLUT2 primary antibody (1:1000, Millipore, UK) and a donkey anti-
guinea pig secondary antibody conjugated to dylight-649 (1:500, Stratech-Jackson 
Immunoresearch) were used. To stain for ChAT, a goat anti-ChAT primary antibody 
(1:1000, Sigma-Aldrich, UK) and a donkey anti-goat secondary antibody conjugated to 
either Alexa-488 or Rhodamine Red (1:500, Stratech-Jackson, Immunoresearch) were 
used. 
    
5.2.5 Immunofluorescent imaging and quantification  
 
NK1R, µ opioid receptor and Phox2b immunopositive cells were imaged and analysed 
throughout a section of the VRC extending from the preBötC to the RTN/pFRG, using an 
epifluorescent microscope (Axioscop, Zeiss, UK). Coronal sections were first examined 
under the epifluorescent microscope to identify the ones that contained the chosen 
reference landmarks, between which the cell counts took place. The first caudal landmark 
was the rostral border of the lateral reticular nucleus (LRN), where this neuronal group no 
longer exists as a single outline but rather exhibits a medial and lateral portion. This 
section was identified as the zero reference point and cells counts were performed in the 
consecutive sections. The second rostral landmark was the rostral portion of the facial 
motor nucleus and the section containing this landmark was the last to be analysed. Within 
this rostrocaudal extent of the ventrolateral medulla, NK1R-immunopositive and µ opioid 
receptor immunopositive cells were counted bilaterally (illustrated in Figure 5-1). Within 
the VRC, the preBötC is reported to be located ventral to the subcompact formation of the 
NA (scNA) (Gray et al., 1999). It was however difficult to determine the exact location and 
boundaries of the preBötC based on the NK1R and the µ opioid receptor staining in the 
mouse (discussed in section 5.4.4). As a result of this, NK1R and µ opioid receptor 
immunopositive cells were counted within a box (600 x 400 µm) that was large enough to 
encompass an extensive area below the NA to ensure the preBötC was contained. In the 
first four consecutive sections following the LRN landmark, NK1R and µ opioid receptor 
immunopositive cells were counted within the box, which was positioned so that the 
middle of its dorsal portion touched the ventral border of the NA (see Figure 5-2 for 
illustration). The first three sections are believed to contain the preBötC and the fourth 
section is believed to contain the Bötzinger complex (Franklin and Paxinos, 2008). The 
RTN/pFRG is reported to extend rostrocaudally along the entire length of the facial motor 
nucleus (Onimaru and Homma, 2003; Stornetta et al., 2006; Onimaru et al., 2008). In the 
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next three consecutive sections containing the facial motor nucleus, NK1R and µ opioid 
receptor expressing cells were also quantified. In these three sections, cells were counted in 
the area directly ventral to the facial motor nucleus and through to the ventral medullary 
surface (see Figure 5-3 for illustration) which encompasses the RTN/pFRG neurons. All 
sections were identified by their distance from the LRN and the last section examined was 
1120 µm rostral from the LRN.  
 
All sections examined were 160 µm apart to prevent duplicate counting of cells. The 
NK1R and µ opioid receptor are membrane bound receptors. A cell was only counted as 
being NK1R or µ opioid receptor immunopositive if there was clear immunostaining that 
outlined the somatic membrane i.e. there was a complete cell boundary and the soma was 
at least 10 µm in diameter. Bilateral cell counts were performed manually using 
Axiovision software (Carl Zeiss, UK). In addition, Phox2b immunopositive cells were 
qualitatively assessed throughout the same region of the VRC as described for the NK1R 
and µ opioid receptor; however no cells counts were performed. A cell was deemed 
Phox2b immunoreactive if staining clearly outlined the cell nucleus.  
 
5.2.6 Statistical analysis 
 
All statistical analyses were performed using GraphPad Prism 4 software. The number of 
NK1R and µ opioid receptor immunopositive cells found throughout the VRC was 
compared between control and neonatal-exposed mice using a 2-way ANOVA with 
Bonferroni’s post test. Differences were regarded as significant if p<0.05. All data are 
presented as mean ± SD. 
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Figure 5-1. The rostrocaudal extent of the ventral respiratory column (VRC) 
analysed. A: Schematic illustration showing the region of the VRC analysed i.e. 
between the rostral aspect of the lateral reticular nucleus and the rostral portion of 
the facial motor nucleus. B: Immunofluorescent image showing NK1R expression 
in a coronal section that contained the rostral aspect of the lateral reticular 
nucleus, which was deemed the zero reference point after which cell counts 
began. Note the lack of NK1R immunostaining which highlights the medial and 
lateral rostral tips of the lateral reticular nucleus (circled in white). C: 
Immunofluorescent image showing NK1R expression in a coronal section that 
contained the rostral end of the facial motor nucleus which was the last section 
within the VRC analysed. Scale bar=100µm. Abbreviations: Amb, nucleus 
ambiguus; BC, Bötzinger complex; cVRG, caudal ventral respiratory group, K-F, 
Köllicker-Fuse nucleus; LRt, lateral reticular nucleus; NTS, nucleus tractus 
solitarius; PB, parabrachial complex; preBötC, preBötzinger complex; RTN/pFRG, 
retrotrapezoid nucleus/parafacial respiratory group; rVRG, rostral ventral 
respiratory group; VII, facial motor nucleus. 
preBӧtC
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Figure 5-2. Method of cell counting within the region of the VRC containing the preBötC. A: Schematic illustration of a coronal 
medullary section showing the position of the box (600x400µm) within which cell counts took place. The box was positioned so that the 
middle of its dorsal portion touched the ventral border of the NA. This method of cell counting was applied to the first four consecutive 
sections following the section that contained the LRN. B: Schematic illustration of a coronal hemisection showing the estimated location of 
the preBötC, ventral to the subcompact formation of the NA (scNA). 
preBӧtC  
B A 
D 
L 
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Figure 5-3. Method of cell counting within the region of the RTN/pFRG. 
Schematic illustration of a coronal medullary section showing the region below the 
facial motor nucleus analysed which is believed to encompass the RTN/pFRG. 
Cells were counted in the region directly ventral to the facial motor nucleus and 
through to the ventral medullary surface as highlighted by the red outline. This 
method of cell counting was carried out in all three coronal sections containing the 
facial motor nucleus. sp5: spinal trigeminal nucleus, Pr: prepositus nucleus, py: 
pyramidal tract, VII: facial motor nucleus.    
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5.3 Results 
 
5.3.1 NK1R expression throughout the VRC 
 
The NK1R is a neuronal marker for both the preBötC and the RTN/pFRG (Gray et al., 
1999; Guyenet and Wang, 2001; Wang et al., 2001a; Guyenet et al., 2002; Onimaru et al., 
2008; Pagliardini et al., 2008). The number of NK1R expressing cells found throughout the 
VRC of control and neonatal-exposed mice was compared. In both groups of mice, NK1R 
expressing cells showed a similar rostrocaudal distribution and were present throughout the 
entire section of the VRC that was analysed i.e. from the section 160 µm rostral to the 
LRN through to the section 1120 µm rostral to the LRN (Figure 5-6). According to the 
mouse brain atlas by Franklin and Paxinos, the preBötC extends rostrally from 
approximately 160 µm to 600 µm from the LRN (Franklin and Paxinos, 2008). NK1R 
expressing cells were found within this rostrocaudal extent of the VRC in both control and 
neonatal-exposed mice (Figure 5-6) and were observed in the region below the subcompact 
formation of the NA, believed to represent the preBötC as illustrated in Figure 5-4. It is 
evident that NK1R immunoreactivity outlined the somatic membranes of cells (Figure 5-
4). With reference to the mouse brain atlas (Franklin and Paxinos, 2008), the RTN/pFRG 
begins at 800 µm rostral from the LRN and extends rostrally to a distance of 1120 µm 
from the LRN and is located below the facial motor nucleus. NK1R immunopositive cells 
of the RTN/pFRG of both control and neonatal-exposed mice are shown in Figure 5-5. 
NK1R expressing cells were present directly ventral to the facial motor nucleus and in 
close proximity to the ventral medullary surface. NK1R expression was also found within 
the facial motor nucleus, which facilitated the anatomical delineation of this landmark 
nucleus.  
 
Quantification of NK1R immunopositive cells within the region of the preBötC 
demonstrated a similar distribution pattern in both the control and neonatal-exposed mice 
(Figure 5-6). The position and size of the counting box (600 x 400 µm) ensured that the all 
of the NK1R immunopositive cells in the region estimated to be the preBötC were covered. 
In all sections containing the preBötC, NK1R immunopositive cells were present. The 
greatest number of NK1R immunopositive cells were found in the section located 480 µm 
rostral to the LRN in both control and neonatal-exposed mice. Neonatal-exposed mice did 
however exhibit significantly less NK1R expressing cells in this section when compared 
with control animals (neonatal-exposed: 17.2 ± 6.5 NK1R immunopositive cells vs control: 
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27.8 ± 3.8 NK1R immunopositive cells, p<0.05, Figure 5-6). Compared to control mice, 
neonatal-exposed mice also showed a trend towards having less NK1R expressing cells 
within the other sections that contained the preBötC (160 µm and 320 µm rostral to the 
LRN), however this was not found to be significant (p>0.05).  
 
In both control and neonatal-exposed mice, NK1R immunopositive cells were present in 
the region of the BC (estimated to be located in the section 640 µm rostral to the LRN, 
Figure 5-6). There was a slight trend towards the neonatal-exposed mice exhibiting fewer 
NK1R immunopositive cells within the BC, but this was not significant (neonatal-exposed: 
8.2 ± 1.8 NK1R immunopositive cells vs control: 14.8 ± 8.3 NK1R immunopositive cells, 
p>0.05, Figure 5-6). 
 
NK1R expressing cells were found within the region of the RTN/pFRG in both control and 
neonatal-exposed mice (located in sections 800, 960 and 1120 µm rostral to the LRN, 
Figure 5-6). In these three sections, cells were counted in the area ventral to the facial 
motor nucleus and through to the ventral medullary surface. There was no significant 
difference in the number of NK1R expressing cells found within the RTN/pFRG between 
the two groups of mice. 
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Figure 5-4. Fluorescent images showing NK1R expressing cells within the preBötC of control (A) and neonatal-exposed (B) mice. 
In both control and neonatal-exposed mice, NK1R expressing cells were found within the preBötC. Arrows show NK1R immunopositive 
somas. The coronal sections imaged were 480 µm rostral to the LRN and cells shown were located ventral to the subcompact formation of 
the nucleus ambiguus. Scale bar = 20 µm. Images were acquired using an epifluorescent microscope. 
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Figure 5-5. Fluorescent images showing NK1R expressing cells within the RTN/pFRG of control (A) and neonatal-exposed (B) 
mice. In both control and neonatal-exposed mice, NK1R expressing cells were found within the RTN/pFRG. Arrows show NK1R 
immunopositive cells of the RTN/pFRG. The cells of the facial motor nucleus also expressed the NK1R. The coronal sections imaged were 
960 µm rostral to the LRN. Scale bar = 20 µm. Images were acquired using an epifluorescent microscope. VII: facial motor nucleus 
(delineated by dotted line).
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Figure 5-6. Number of NK1R immunopositive cells throughout the VRC in 
control and neonatal-exposed mice. Bilateral cell counts were performed. 
Sections were identified by their rostral distance from the LRN. The preBötC is 
estimated to lie between 160 µm to 600 µm from the LRN, the BC is reported to 
extend from 600 µm to 800 µm from the LRN and the RTN/pFRG is estimated to 
lie between 800 µm to 1120 µm rostral to the LRN (with reference to Franklin and 
Paxinos adult mouse brain atlas). Control mice exhibited a significantly greater 
number of NK1R immunopositive cells in the section located 480 µm rostral to the 
LRN, which is believed to contain the preBötC. Control mice, n=4; neonatal-
exposed, n=5. Data presented as mean±SD. * denotes a significant difference 
(p<0.05) between experimental groups, 2-way ANOVA with Bonferroni’s post test. 
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5.3.2 µ opioid receptor expression throughout the VRC  
 
The distribution and number of µ opioid receptor expressing cells found throughout the 
VRC of control and neonatal-exposed mice was compared. Within the region of the 
preBötC, a large number of µ opioid receptor expressing cells were present in the control 
mice (Figure 5-7A). It is evident from the immunofluorescent images that µ opioid 
receptor immunoreactivity outlined the somatic membranes of cells (Figure 5-7A). 
Interestingly, in the neonatal-exposed mice there was a striking reduction in the number of 
cells expressing the µ opioid receptor within the region of the preBötC which is clearly 
illustrated in Figure 5-7B. In accordance with previous studies (Gray et al., 1999), when 
examining µ opioid receptor immunostaining within the region of the RTN/pFRG, it is 
apparent from Figure 5-8 that the cells within this neuronal group did not express the 
receptor. This was the case for both control and neonatal-exposed mice. Although not 
quantified, a cluster of µ opioid receptor expressing cells was found within the facial motor 
nucleus in the control mice (Figure 5-8A+B). However in the neonatal-exposed animals 
there were very few µ opioid receptor expressing cells found in the facial motor nucleus 
(Figure 5-8C+D). Interestingly, the few µ opioid receptor immunopositive cells that were 
present were weakly stained.  
 
Quantification revealed that within the VRC, µ opioid receptor immunopositive cells were 
present in the highest levels within the preBötC in the control mice (Figure 5-9). The 
greatest number of µ opioid receptor immunopositive cells were found in the section 
located 480 µm rostral to the LRN (74.7 ± 26.3 µ opioid receptor immunopositive cells). 
The cells within the BC also expressed the µ opioid receptor in the control group (67.0 ± 
27.1 µ opioid receptor immunopositive cells). Interestingly, the neonatal-exposed mice 
exhibited significantly less µ opioid receptor immunopositive cells throughout the preBötC 
(sections 160 µm through to 480 µm rostral to the LRN) and the BC (section 640 µm 
rostral to LRN) compared to control mice (-160 µm: 4.4 ± 6.6 vs 55.7 ± 10.6; -320 µm: 5.8 
± 4.4 vs 57.3 ± 12.7; -480 µm: 6.8 ± 12.0 vs 74.7 ± 26.3; -640 µm: 1.8 ± 3.0 vs 67.0 ± 27.1 
µ opioid receptor immunopositive cells for neonatal-exposed vs control respectively, 
p<0.05, Figure 5-9). In both experimental groups, µ opioid receptor immunopositive cells 
were not found within the RTN/pFRG (i.e. no immunopositive cells found in sections 800 
µm, 990 µm and 1120 µm from the LRN, Figure 5-9). 
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Figure 5-7. Fluorescent images showing µ opioid receptor expressing cells within the preBötC of control (A) and neonatal-
exposed (B) mice. A: In control mice, there was a large number of µ-OR expressing cells found within the region of the preBötC. B: 
Neonatal-exposed mice exhibited a substantial reduction in the number of µ-OR expressing cells within the preBötC. Arrows show example 
of µ-OR immunopositive cell. The coronal sections imaged were 480 µm rostral to the LRN and cells shown were located ventral to the 
subcompact formation of the nucleus ambiguus. Scale bar = 20 µm. Images were acquired using an epifluorescent microscope. µ-OR: µ 
opioid receptor. 
Control
µ-ORA B µ-OR
Neonatal-Exposed
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Figure 5-8. Fluorescent images showing a lack of µ opioid receptor 
expressing cells within the RTN/pFRG of control and neonatal-exposed 
mice. Higher magnification images of the RTN/pFRG in A and C are shown in B 
and D respectively. In control and neonatal-exposed mice there were no µ-OR 
expressing cells found within the region of the RTN/pFRG. The region ventral to 
the facial motor nucleus (VII) through to the ventral medullary surface contained 
no staining. In control mice, cells within the VII expressed high levels of the µ-OR 
(A and B). However the level of µ-OR immunostaining in the VII was greatly 
reduced in neonatal-exposed mice (C and D). The few µ-OR expressing cells that 
were present appeared to be weakly stained (shown by arrows). The coronal 
sections imaged were 960 µm rostral to the LRN. Scale bar = 50 µm in images A 
and C and 20 µm in images B and D. The area of the VII is delineated by the 
dotted line. Images were acquired using an epifluorescent microscope. µ-OR: µ 
opioid receptor. 
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Figure 5-9. Number of µ opioid receptor immunopositive cells throughout the 
VRC in control and neonatal-exposed mice. Cells were counted bilaterally. 
Sections were identified by their rostral distance from the LRN. The preBötC is 
estimated to lie between 160 µm to 600 µm from the LRN, the BC is reported to 
extend from 600 µm to 800 µm from the LRN and the RTN/pFRG is estimated to 
lie between 800 µm to 1120 µm rostral to the LRN (with reference to Franklin and 
Paxinos adult mouse brain atlas). µ opioid receptor immunopositive cells were 
found throughout the preBötC and BC in high numbers in control mice. Neonatal-
exposed mice exhibited a significantly lower number of µ opioid receptor 
immunopositive cells within both the preBötC and the BC. µ opioid receptor 
immunopositive cells were not found within the RTN/pFRG in control or neonatal-
exposed mice. Control mice, n=4; neonatal-exposed, n=5. Data presented as 
mean±SD. * denotes a significant difference (p<0.05) between experimental 
groups, 2-way ANOVA with Bonferroni’s post test. 
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5.3.3 µ opioid receptor expression outside the VRC 
 
Given that neonatal-exposed mice displayed a significantly reduced number of µ opioid 
receptor immunopositive cells throughout an extensive area of the VRC, it was of interest 
to determine if this was also found outside the VRC. µ opioid receptor expression levels 
within the hypoglossal nucleus, a region located in the dorsomedial medulla, close to the 
ventrolateral portion of the central canal, was qualitatively assessed. The hypoglossal 
nucleus has been reported to express the µ opioid receptor (Xia and Haddad, 1991; Kivell 
et al., 2004). Both control and neonatal-exposed mice expressed a high level of µ opioid 
receptor immunopositive cells within the hypoglossal nucleus (Figure 5-10). This 
confirmed that the reduction in µ opioid receptor expressing cells exhibited by the 
neonatal-exposed mice was not a global effect throughout the medulla.   
 
 
 
Figure 5-10. Fluorescent images showing µ opioid receptor expressing cells 
within the hypoglossal nucleus of control and neonatal-exposed mice. The 
hypoglossal nucleus (XII) is located in the dorsomedial medulla, below the central 
canal. Higher magnification images of the XII in A and C are shown in B and D 
respectively. The region of the XII is demarcated by the dotted line. A dense 
cluster of µ-OR immunopositive cells were found in the XII of control and neonatal-
exposed mice. Scale bar = 100 µm in images A and C and 20 µm in images B and 
D. Images were acquired using an epifluorescent microscope. µ-OR: µ opioid 
receptor. 
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5.3.4 Phox2b expression throughout the VRC 
 
Phox2b transcription factor is a known marker of RTN/pFRG neurons in both neonatal and 
adult rodents (Stornetta et al., 2006; Kang et al., 2007; Onimaru et al., 2008). The presence 
of Phox2b expressing cells throughout the VRC (from the preBötC to the RTN/pFRG) was 
assessed in control and neonatal-exposed mice, with a particular interest in the expression 
within the RTN/pFRG. The quality of the Phox2b staining was however variable between 
individual brains from both experimental groups. As a result, no quantification was carried 
out. When the VRC was qualitatively assessed, no Phox2b immunoreactive cells were 
found within the region of the preBötC or the BC in both experimental groups. There was a 
small number of Phox2b expressing cells found in the region of the RTN/pFRG. These 
cells were located directly ventral to the facial motor nucleus and on the ventral medullary 
edge in both control and neonatal-exposed mice (Figure 5-11).      
 
 
 
 
Figure 5-11. Fluorescent images showing Phox2b expressing cells within the 
RTN/pFRG of control (A) and neonatal-exposed (B) mice. In both control and 
neonatal-exposed mice, Phox2b expressing cells were found within the 
RTN/pFRG, in the region directly ventral to the VII (delineated by dotted line) and 
on the ventral medullary edge. Arrows show Phox2b immunopositive cells (nuclear 
staining). The coronal sections imaged were 960µm rostral to the LRN. Scale bar 
= 20µm. Images were acquired using an epifluorescent microscope.  
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5.4 Discussion 
 
The aim of study 6 was to ascertain if repeated exposure to fentanyl during neonatal life in 
the mouse induces long-lasting histological changes within a section of the VRC 
comprising the preBötC and the RTN/pFRG. This was an attempt to unravel some of the 
fundamental mechanisms that may underlie the long term respiratory effects observed in 
the in vivo physiology experiments carried out in study 4 (chapter 4). The number of 
NK1R and µ opioid receptor immunopositive cells found through the VRC were counted 
and compared between control and neonatal-exposed mice. The distribution of NK1R 
expressing cells throughout the VRC was comparable between control and neonatal-
exposed mice with a high level of expression found through the whole region examined. 
Neonatal-exposed mice did however exhibit significantly less NK1R expressing cells in a 
region believed to be the preBötC. The most striking consequence of neonatal fentanyl 
exposure was its long-term effect on µ opioid receptor expression throughout the VRC. 
Neonatal-exposed mice exhibited a dramatic reduction in the number of µ opioid receptor 
expressing cells in the preBötC and the region of the BC. This reduced level of µ opioid 
receptor expression within the preBötC could be fully or partially attributable to the 
respiratory effects reported in the neonatal-exposed mice from study 4, particularly the 
altered respiratory responsiveness to fentanyl observed in adulthood.  
 
5.4.1 Neonatal-exposed mice exhibited a reduction in NK1R expression 
within the preBötC 
 
NK1R expressing cells were present throughout the entire region of the VRC analysed in 
both control and neonatal-exposed mice. This finding is congruent with previous studies 
which have reported that NK1R immunoreactivity can be used as a marker for preBötC 
and RTN/pFRG neurons (Gray et al., 1999; Guyenet and Wang, 2001; Wang et al., 2001a; 
Guyenet et al., 2002; Onimaru et al., 2008; Pagliardini et al., 2008). It is important to 
highlight the fact that the exact rostrocaudal extent and anatomical boundaries of each of 
the respiratory groups (preBötC, BC and RTN/pFRG) has not been thoroughly investigated 
or identified in the adult mouse, with the majority of the work performed in the rat (Gray et 
al., 1999; Guyenet and Wang, 2001; Wang et al., 2001a). Their estimated positions were 
based on the adult mouse brain atlas by Franklin and Paxinos (Franklin and Paxinos, 
2008). The method of analysing the area of the VRC that is estimated to encompassed the 
preBötC was comparable to that employed by Wang and colleagues (2001), who used 
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similar reference landmarks in the adult rat (Wang et al., 2001a). They reported that the 
region estimated to comprise the preBötC contained a higher number of NK1R expressing 
cells compared to the areas located directly rostral and caudal. The distribution pattern of 
NK1R expressing cells was similar in the present study for both control and neonatal-
exposed mice. It is important to note that from NK1R expression alone it was difficult to 
anatomically delineate the area of the preBötC with great certainty. However, the large size 
of the counting box used (600 x 400 µm) meant that the area ventral to the scNA reported 
to encompass the preBötC was included in addition to the immediate surrounding area (see 
Figure 5-2 for illustration), ensuring preBötC neurons were definitely counted.  It is 
therefore likely that an overestimation of the number of cells present within the preBötC 
was calculated, but given that the same method of cell counting was carried out for control 
and neonatal-exposed mice, the results can still be directly compared. A high level of 
NK1R expression was found within the area estimated to be the preBötC; with the greatest 
number of immunopositive cells in the medullary section located 480 µm from the LRN. 
Within this region, neonatal-exposed mice had significantly less NK1R expressing cells. 
This suggests that neonatal fentanyl exposure induces a long-term histological change 
within the preBötC. The physiological significance of this reduction in NK1R expression 
remains elusive but it may signify an alteration in the functioning of the preBötC. An in 
vivo study in the adult rat has found that systemically administered fentanyl induces a 
respiratory frequency depression by acting exclusively on NK1R expressing preBötC 
neurons (Montandon et al., 2011). Although not confirmed in this study, these neurons 
likely expressed the µ opioid receptor. Given that a subset of NK1R expressing preBötC 
neurons express the µ opioid receptor (Gray et al., 1999), it is possible that alterations in 
the µ opioid receptor also affected NK1R expression or the presence of the cell itself. 
Double immunostaining of NK1R and µ opioid receptor would help to elucidate this 
(further discussed in section 5.4.4). It is possible that a reduction in the number of preBötC 
NK1R expressing cells in the neonatal-exposed mice is responsible for the altered baseline 
respiratory activity reported in study 4, including the reduced respiratory frequency 
observed in the wakeful state (see section 4.3.2, chapter 4). In support of this theory, 
bilateral destruction of NK1R expressing preBötC neurons in the adult rat induces severe 
respiratory disturbances that are first observed during sleep then progress to wakefulness 
(McKay et al., 2005). The severe breathing abnormalities were due to the fact that the 
preBötC was anatomically ablated. In this study a less dramatic reduction in NK1R 
expressing cells within the preBötC was observed, which could induce more subtle 
changes in respiratory activity such as those exhibited by the neonatal-exposed mice 
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(chapter 4). Neonatal-exposed mice also displayed an increased occurrence of augmented 
breaths under anaesthesia (section 4.3.6, chapter 4). As previously discussed in section 
4.5.3.1 of chapter 4, it is intriguing to speculate that the high frequency of augmented 
breaths exhibited by the neonatal-exposed mice could be an indication of an altered 
preBötC function, which generates an unstable respiratory pattern. This theory is further 
supported by the histological change detected within the region of the preBötC suggesting 
the functional capacity could be altered somewhat. It is important to highlight that further 
work is required before conclusions can be drawn relating to the impact of fentanyl 
exposure on the functional activity of the preBötC (see section 4.5.6, chapter 4 for 
examples of future experimentations).      
 
5.4.2 NK1R expression within the RTN/pFRG was unaltered 
 
Cells within the region of the RTN/pFRG were also found to express the NK1R, which is 
consistent with previous reports (Onimaru et al., 2008). Neonatal fentanyl exposure did not 
evoke any long-term changes in NK1R expression within the RTN/pFRG. The RTN/pFRG 
has been proposed to function as the principal central chemosensory site in the adult rodent 
(Mulkey et al., 2004; Guyenet et al., 2005; Takakura et al., 2008; Marina et al., 2010). The 
fact that neonatal-exposed mice exhibited a normal chemosensory response to hypercapnia 
when awake (section 4.3.4, chapter 4), together with the unaltered NK1R expression within 
the RTN/pFRG in this present study, suggests that neonatal fentanyl exposure does not 
induce lasting effects on the functioning of this neuronal group. Direct recording of 
RTN/pFRG neurons in response to hypercapnia in more reduced brainstem-spinal cord 
preparations in both control and neonatal-exposed mice would further assess the influence 
of fentanyl exposure on neural activity.   
 
5.4.3 Neonatal-exposed mice exhibited a striking reduction in µ opioid 
receptor expression within the VRC 
 
The most notable long-term consequence of neonatal fentanyl exposure was a reduction in 
µ opioid receptor expression within the VRC. In the area of the RTN/pFRG there were no 
µ opioid receptor expressing cells present in both experimental groups, which is congruent 
with previous studies (Gray et al., 1999). This finding is also consistent with previous 
studies that demonstrated RTN/pFRG neurons are insensitive to opioids (Takeda et al., 
2001; Mellen et al., 2003) and supports the theory that fentanyl does not directly perturb 
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RTN/pFRG function in vivo. This absence of expression within the RTN/pFRG also serves 
as a negative control, indicating an adequate specificity of the primary antibody.  In the 
control mice, the µ opioid receptor was highly expressed within the area estimated to 
contain the preBötC and the BC, which has been shown previously in the adult rat 
(Lonergan et al., 2003). The facial motor nucleus was also found to contain a dense cluster 
of µ opioid receptor expressing cells. Interestingly, neonatal-exposed mice displayed 
strikingly less µ opioid receptor expressing cells throughout the VRC, including the 
preBötC. The exact mechanism resulting in this reduced expression is unknown. It is 
possible that this reduction in µ opioid receptor expression is due to a downregulation of 
the receptor induced by repeated fentanyl exposure. As discussed in chapter 3, section 
3.7.1, changes at the level of the µ opioid receptor are believed to underlie the 
development of tolerance to the effects of µ opioid receptor agonists, including fentanyl, 
after chronic exposure. Several radioligand binding studies have revealed that repeated 
exposure to µ opioid receptor agonists in rodents evoke downregulation of the µ opioid 
receptor within the brain through receptor internalisation (Bhargava and Gulati, 1990; 
Bernstein and Welch, 1998; Stafford et al., 2001), thereby reducing the number of 
functional receptors and inducing tolerance. Conversely, internalisation and 
downregulation of the µ opioid receptors evoked by repeated exposure has been suggested 
to actually prevent or delay tolerance (Koch et al., 2005). The results from this current 
study support the theory that repeated opioid exposure elicits downregulation of the 
receptor given the reduced level of expression detected by IHC in neonatal-exposed mice. 
Importantly, this study is the first to examine the long-term effects of fentanyl on receptor 
regulation. It is an intriguing possibility that fentanyl exposure in neonatal life elicits a 
long lasting downregulation of the µ opioid receptor which could account for the altered 
respiratory response to subsequent fentanyl administered in adult life observed in study 4. 
An in vivo study in the adult rat has found that systemically administered fentanyl induces 
a respiratory frequency depression by acting exclusively on preBötC neurons (Montandon 
et al., 2011). If the number of available functional µ opioid receptors within the preBötC is 
reduced in neonatal-exposed mice, then it is plausible that fentanyl’s respiratory depressive 
actions would be attenuated. When in the wakeful state, neonatal-exposed mice did exhibit 
a reduced sensitivity to fentanyl (study 4, section 4.3.3), which fits with this theory and 
suggests that the development of tolerance to fentanyl could be associated with receptor 
downregulation. It is important to highlight however that based on the IHC data we cannot 
conclude that receptor downregulation has in fact occurred. It is possible that the reduced µ 
opioid receptor expression could indicate a loss of the cells themselves. Given the 
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widespread and substantial reduction of µ opioid receptor expression observed in the 
neonatal-exposed mice, it is unlikely that this represents cellular depletion as it would 
likely have a very profound impact on breathing which could be fatal. When baseline 
breathing was examined in the wakeful sate, neonatal-exposed mice did not display any 
respiratory abnormalities (section 4.3.2). This idea of cell loss cannot however be ruled 
out. In order to investigate this, the study could be repeated and brain sections 
counterstained with a primary antibody against neuronal nuclei (NeuN). NeuN is a neuron-
specific nuclear protein that is used as a general neuronal marker (Mullen et al., 1992). If 
the reduction in µ opioid receptor expression is also accompanied by a reduction in NeuN 
expression then this would indicate that there is neuronal loss. Likewise, no change in 
NeuN expression would suggest a downregulation of the µ opioid receptor. The utilisation 
of NeuN immunostaining would also help to dissociate between glial and neuronal cells.  
 
It is important to highlight the fact that changes in receptor expression were not selective to 
the preBötC. A reduced number of µ opioid receptor expressing cells were also found in 
the area believed to be the BC as well as the facial motor nucleus. This suggests that the 
effects of repeated fentanyl exposure are complex and fentanyl may target multiple 
neuronal groups directly or indirectly. It is therefore likely that the respiratory changes 
observed in the neonatal-exposed mice in study 4 are due to complex network effects that 
cannot be elucidated from this study alone. Due to the extensive area of the VRC 
displaying a reduced number of µ opioid receptor expressing cells, it was of interest to 
determine if an area outside the VRC was also affected. We examined an area of the 
hypoglossal nucleus located in the dorsomedial medulla. This motor nucleus contains the 
hypoglossal motoneurons that innervate the GG muscle and is known to express the µ 
opioid receptor (Xia and Haddad, 1991). Furthermore, hypoglossal motor output is 
suppressed by µ opioid receptor agonists in vitro (Lorier et al., 2010) and in vivo (Hajiha et 
al., 2009) and is therefore targeted by fentanyl. Although no quantification was carried out, 
both control and neonatal-exposed mice exhibited a large cluster of µ opioid 
immunopositive cells within the hypoglossal, suggesting µ opioid expressing cells within 
this nucleus were not affected by neonatal fentanyl exposure. This finding is consistent 
with the physiological examination of the GG in study 4 (section 4.3.5), where neonatal-
exposed mice exhibited no change in baseline GG muscle activity. The presence of µ 
opioid receptor expressing cells within the hypoglossal nucleus indicates that fentanyl 
exposure in neonatal life does not induce a global reduction in µ opioid expression 
throughout the medulla.  
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The influence of anaesthesia on the respiratory actions of fentanyl observed in the 
neonatal-exposed mice is an added complexity that is difficult to fully explain based on the 
histological results of this study. When anaesthetised, neonatal-exposed mice exhibited an 
enhanced susceptibility to fentanyl-induced respiratory depression (study 4, section 4.3.7), 
which was in direct contrast to the response observed when awake. The fact that fentanyl 
induced a profound respiratory depression suggests that it was acting on the µ opioid 
receptor to bring about the physiological response. In this study, the reduction in µ opioid 
receptor expression observed throughout the VRC, including that of the preBötC is 
inconsistent with this physiological response to fentanyl. Fentanyl has been shown to act 
on the µ1 receptor subtype to induce its respiratory effects (Colman and Miller, 2001). The 
primary antibody used in the present study targets the µ1 receptor subtype, indicating a 
specific reduction of the µ1 opioid receptor in the neonatal-exposed mice. The effect of 
neonatal fentanyl exposure on the long-term expression of the µ2 receptor subtype was not 
analysed. It is possible that in the absence of µ1 receptors, fentanyl mediates its actions via 
this second µ opioid receptor subtype to induce the marked respiratory depression seen 
under anaesthesia. An assessment of µ2 receptor immunoreactivity throughout the VRC 
could be carried out to determine the extent of its expression. Additionally, application of a 
µ2 receptor antagonist prior to fentanyl administration in vivo would also determine if the 
respiratory depression was mediated via the µ2 receptor in the neonatal-exposed mice.  
 
It is interesting to speculate that the change in µ opioid receptor expression exhibited by 
the neonatal-exposed mice could be related to increased anxiety levels. As previously 
discussed in section 4.5.2.1 in chapter 4, it is possible that neonatal-exposed mice may 
have heightened anxiety in adulthood that could make them more sensitive to stressful 
events including injections. Prior to perfusion fixation, mice were anaesthetised with an i.p 
injection of pentobarbital. It is possible that the injection caused an augmented stress 
response in the neonatal-exposed mice. It is well established that exposure to stress evokes 
a release of endogenous opiates (Amir et al., 1980; Murua and Molina, 1990; Ruiz-Gayo et 
al., 1992). It is therefore possible that a greater release of endogenous opiates occurred in 
response to the pentobarbital injection in neonatal-exposed mice. In theory, the 
endogenous opiates could have activated the µ opioid receptors causing an acute 
internalisation. As a consequence of this, a reduction in µ opioid receptor expression would 
be detected using IHC. If this is the case, then the change in the number of µ opioid 
receptor expressing cells may not be directly related to fentanyl exposure per se and 
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therefore may not represent a long-term change in receptor expression caused by neonatal 
exposure. This theory also fits with the physiological data from study 4. Neonatal-exposed 
mice were insensitive to fentanyl when awake, which could be due to a stress-induced 
release of endogenous opiates caused by the fentanyl injection, thereby reducing the 
number of available µ opioid receptors for fentanyl to subsequently act on. On the 
contrary, when anaesthetised and stress responses were abolished, fentanyl induced a 
profound respiratory depression in neonatal-exposed mice, suggesting the availability of a 
sufficient number of µ opioid receptors. If the reduced receptor density within the VRC is 
due to an anxiety-induced release of endogenous opiates then it would be expected that a 
uniform reduction throughout the brain would be observed. However, as previously 
discussed, there was no apparent reduction in µ opioid receptor expression within the 
hypoglossal nucleus, indicating that the effects were not global, which is inconsistent with 
this theory of endogenous opiate release. It is important to highlight that these potential 
anxiety-related respiratory effects are merely speculative at present, thus it is imperative to 
first establish if neonatal-exposed mice display augmented anxiety. Potential further 
studies to investigate this are detailed in section 4.5.2.1 of chapter 4.   
 
5.4.4 Study limitations and technical issues   
 
One of the main limitations of study 6 was the fact that double staining for NK1R and µ 
opioid receptor was not carried out. The preBötC is known to express the NK1R, and a 
subset of these neurons also express the µ opioid receptor (Gray et al, 1999). It was 
difficult to define the anatomical boundaries of the preBötC using either the NK1R or the µ 
opioid receptor alone. Employing double immunostaining would help to further delineate 
the precise location of the preBötC. Furthermore, double immunostaining would provide 
additional information on the proportion of cells throughout the VRC that coexpress NK1R 
and µ opioid receptor. The number of NK1R expressing cells that exhibit downregulation 
of the µ opioid receptor could also be calculated. Double immunostaining was not 
employed in the present study as both NK1R and µ opioid receptor primary antibodies 
were raised in the rabbit and both fluorescent signals required amplification. To allow for 
double staining a guinea pig anti-NK1R primary antibody was originally tested, however it 
was found to produce inadequate staining. It would be beneficial to optimise a protocol 
allowing for double staining with both rabbit primary antibodies and an amplification of 
both immunofluorescent signals.    
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From the outset of study 6, sections were immunostained for VGLUT2 and ChAT. 
VGLUT2 is a marker for both preBötC and RTN/pFRG neurons, and thus would help to 
identify these neurons. ChAT is expressed in motor neurons and was used to delineate the 
facial motor nucleus, which was one of the reference landmarks. The immunofluorescence 
protocol utilised failed to produce VGLUT2 or ChAT staining. The reason(s) for this is 
unknown. It is possible that the concentration of the primary antibodies was too low or a 
longer incubation time of either the primary or secondary antibodies may be required. The 
addition of a tyramide amplification step may also improve the fluorescent signal. Further 
investigation is certainly necessary to optimise the staining protocol. The quality of 
Phox2b staining varied significantly between brains. Given that an identical staining 
protocol was utilised for every brain, the inconsistences may be related to differences in 
the perfusion quality of the tissue. It is possible that the Phox2b primary antibody is highly 
sensitive to the quality of the fixed tissue.   
 
All imaging and analysis of brain sections was performed using an epifluorescent 
microscope. It would have been advantageous to utilise confocal microscopy, which has 
several advantages over fluorescent microscopy. Confocal microscopy produces images 
that are of a higher resolution with greater contrast due to a reduction in background 
fluorescence and improved signal-to-noise (Sandison and Webb, 1994). Furthermore, the 
laser scanning confocal microscope has the ability to collect serial optical sections through 
the specimen allowing the tissue to be analysed to a greater depth. Using an epifluorescent 
microscope to quantify cells within the VRC would have resulted in an underestimation of 
the total number of cells present. However, given that the same method of imaging and 
analysis was performed for both control and neonatal-exposed tissue, adequate 
comparisons were made. The use of confocal microscopy would therefore not alter the 
conclusions drawn from this study.   
 
5.4.5 Immunohistochemical analysis of juvenile-exposed brains 
 
Taken together, the neonatal and juvenile exposure studies detailed in chapter 4 established 
that the postnatal age of fentanyl-exposure influenced the long-term respiratory effects. It 
appears that repeated neonatal fentanyl exposure is more detrimental to respiratory control. 
Thus, it was of interest to determine if repeated exposure to fentanyl during juvenile life in 
the mouse induces long-lasting changes in receptor expression within the VRC and if these 
differ from those found in the present study (study 6). This study was carried out with the 
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same experimental design and protocol as utilised in study 6. Mice were repeatedly 
administered fentanyl during juvenile life from P9-P13. They received a single i.p dose of 
0.04 mg/kg on each postnatal day and IHC procedures were performed when mice reached 
adulthood. As mentioned previously (section 5.1.1), this study proved to be problematic 
and as a consequence insufficient data was generated. Immunostaining of the NK1R was 
weak and variable and µ opioid receptor staining failed for both control and juvenile-
exposed tissue. As a result no data is shown. The fact that staining was variable in the 
control tissue suggests that the problems were due to technical issues. Since the same 
immunostaining protocol as described for study 6 was employed, it is difficult to determine 
the reasons for the failed staining but some possible explanations can be offered. The 
variability in the quality of NK1R staining could be due to sub optimal tissue fixation in 
some of the brains. The complete lack of µ opioid receptor staining may have also been 
due to problems with the tyramide amplification step. It is possible that the tyramide may 
have expired thus resulting in poor or no staining. This is consistent with the complete lack 
of staining in both control and juvenile-exposed tissue. Further IHC studies within the 
research group utilised a fresh batch of tyramide and obtained adequate NK1R and µ 
opioid receptor staining suggesting this may have been the source of the problem. Due to 
time constraints, the study was not repeated; however it is imperative that these 
investigations are conducted to help unravel the effects of postnatal age of fentanyl 
exposure on the long-term respiratory alterations. The addition of this study will also help 
to further explore the theory of developmental plasticity proposed from study 4 and 5 (see 
section 4.5.5, chapter 4). In light of these technical issues it would be beneficial to increase 
the number of neonatal-exposed and control brains analysed in study 6 to confirm the 
validity of the data. 
 
5.4.6 Summary 
 
Repeated fentanyl exposure during neonatal life evokes long-term changes in respiratory 
activity as well as altering the respiratory responsiveness to fentanyl (chapter 4). The 
fundamental mechanisms giving rise to these respiratory alterations are not fully 
understood, however the data from this study suggests that a substantial reduction in µ 
opioid receptor expression throughout the VRC, including that of the preBötC, could 
underlie these changes. Importantly, the alterations in the level of receptor expression 
reported here do not fully explain the influence that behavioural state has on fentanyl’s 
respiratory actions in neonatal-exposed mice. This complex relationship between 
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behavioural state and the potency of fentanyl-induced respiratory depression certainly 
requires further investigation. Nonetheless, this study has generated novel data regarding 
the effects of repeated neonatal fentanyl exposure on receptor expression within the VRC.  
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Chapter 6. 
General Conclusions 
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For decades, researchers have endeavoured to uncover the underlying neural mechanisms 
of respiratory rhythm generation. The lack of understanding of respiratory rhythmogenesis 
during early postnatal life provided the motivation for conducting some of the work 
detailed in this thesis. In addition, understanding the consequences of external 
perturbations on the respiratory rhythm generating networks has important clinical 
implications. The immaturity of the respiratory system and resultant fragile nature of 
breathing patterns immediately after birth in mammals could potentially make this period 
of life vulnerable to the lasting effects of respiratory depressants and is therefore an 
interesting time period to study.     
 
The studies presented in this thesis utilised the µ opioid receptor agonist, fentanyl, to 
investigate respiratory control in vivo. Fentanyl was originally employed as a 
pharmacological tool to selectively target the opiate-sensitive preBötC whilst leaving the 
opiate-insensitive RTN/pFRG unperturbed. This was an attempt to tease apart the 
functioning of these two proposed respiratory oscillators during early postnatal life and 
determine the level of involvement of the preBötC in respiratory rhythm generation in vivo. 
The respiratory sensitivity to fentanyl during early postnatal life was examined to test the 
hypothesis that the preBötC functions as the dominant respiratory rhythm generator after a 
maturation of respiratory patterns has occurred. 
 
6.1 Critical respiratory maturational time window  
 
One of the main aims of this thesis was to increase the understanding of the respiratory 
control system and the influence of postnatal development on central respiratory control in 
vivo. The first study presented in this thesis demonstrated that the mouse respiratory 
system is immature at birth and generates an irregular respiratory pattern, potentially 
making this time period vulnerable to respiratory perturbations. The postnatal evolution of 
respiratory behaviour in the mouse was characterised and a substantial maturation of 
respiratory patterns was found between P2 and P3. A striking transformation in respiratory 
activity from an unstable pattern consisting of apnoeas and hyperpnoeic episodes, to a 
regular and rhythmic pattern devoid of respiratory abnormalities with a greater respiratory 
frequency occurred. Consequently, a critical developmental time period when the 
respiratory system undergoes a significant step in maturity was identified in the mouse. 
The identification of this short window of respiratory maturation represented an intriguing 
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developmental time period to investigate central respiratory control as well as the 
susceptibility of the immature respiratory system to insults.   
 
6.2 Repeated exposure induces an acute respiratory tolerance to 
fentanyl 
 
Initially, fentanyl was administered repeatedly throughout early life (P1-P5, P9 and P11) to 
determine age-dependent changes in the respiratory sensitivity to fentanyl and test the 
hypothesis that the preBötC functions as the dominant respiratory rhythm generator post-
maturation. However a rapid desensitisation to the respiratory depressive effects of 
fentanyl occurred. It is probable that the repeated fentanyl administration induced a 
tolerance to the respiratory actions of the drug. The mechanism(s) that underlie this 
tolerance cannot de deduced from this study alone. Previous studies have suggested that 
the processes leading to the development of tolerance to µ opioid receptor agonists 
including fentanyl occur at the level of the receptor. Downregulation of the µ opioid 
receptor within the brain through receptor internalisation has been suggested as a 
mechanism of tolerance (Bhargava and Gulati, 1990; Bernstein and Welch, 1998; Stafford 
et al., 2001). Conversely it has been demonstrated that changes in the regulation of µ 
opioid receptors in response to repeated fentanyl administration occurs independently of 
the development of tolerance and is related to the dose itself, with both upregulation and 
downregulation occurring (Yoburn et al., 1993). Additionally, µ opioid receptor 
phosphorylation and desensitisation has been implicated in the development of opioid 
tolerance (Pitcher et al., 1998; Liu and Anand, 2001). It is likely that a complex set of 
cellular and molecular processes are involved in the development of respiratory tolerance 
observed in the study presented in this thesis, however this was not investigated. These 
unanticipated findings sparked further investigations designed to uncover the long-term 
respiratory effects of such exposure, particularly during early postnatal life when the 
respiratory system undergoes significant maturational changes. 
 
6.3 Fentanyl-induced respiratory depression is age-dependent 
 
To prevent repeated exposure to fentanyl and the consequential development of respiratory 
tolerance, a separate study was conducted whereby different mice were studied on each 
postnatal day throughout postnatal development. This allowed our hypothesis to be fully 
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tested. A trend towards an age-dependent increase in sensitivity to fentanyl induced 
respiratory frequency depression after the postulated respiratory maturation step was 
observed i.e. increased sensitivity from P3 onwards, as hypothesised. This finding lends 
support to the hypothesis that the preBötC functions as the dominant respiratory oscillator 
post-maturation. It is also congruent with the findings from previous in vivo studies that 
have explored the acute respiratory effects of riluzole throughout postnatal life in mice (Dr 
Leanne McKay, personal communication, SFN abstract 2009). Riluzole, which depresses 
RTN/pFRG activity, also exerted age-dependent respiratory depressive actions. Riluzole 
was reported to induce the greatest magnitude of respiratory depression in early life (P1-
P3), which is in direct contrast to the age-dependent respiratory effects of fentanyl. Taken 
together, the fentanyl and riluzole experiments suggest that the level of involvement of the 
RTN/pFRG and the preBötC in respiratory rhythm generation change with postnatal 
development, with the RTN/pFRG functioning as the dominant respiratory oscillator in 
early life when the respiratory system is immature, and the preBötC functioning as the 
principal respiratory oscillator driving breathing rhythm after the respiratory system has 
matured. It is however important to consider the high degree of variability in the data from 
both the control and fentanyl experiments reported in this thesis. Increasing the number of 
mice studied at each postnatal age would help to reveal clearer data trends as well as 
increase the validity of the data, which is essential before definitive conclusions can be 
drawn. Furthermore, it should be highlighted that fentanyl’s actions in vivo are widespread 
and not limited to the preBötC, which should also be considered when interpreting the 
effects of fentanyl and the high level of variability in the data.  
 
6.4 Neonatal life is vulnerable to repeated fentanyl exposure 
 
Developing a complete understanding of the effects of exogenous opioids on the highly 
complex respiratory system is desirable and has many clinical implications. Despite the 
profound respiratory depressive actions of µ opioids, the long-term respiratory effects of 
repeated opioid exposure remains to be fully explored both clinically and pre-clinically. 
The longitudinal fentanyl exposure studies detailed in this thesis (studies 4 and 5) have 
demonstrated that a non-destructive, pharmacological depression of the respiratory system 
in early neonatal life using fentanyl can induce long-term changes in baseline respiratory 
behaviour as well as evoke a change in the sensitivity to future fentanyl challenges in 
adulthood. Surprisingly, the change in sensitivity to fentanyl was state-dependent, where 
mice exhibited a reduced susceptibility to a further fentanyl challenge when awake but 
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displayed hypersensitivity under anaesthesia, in that fentanyl evoked a complete 
respiratory failure. This data indicates that anaesthesia represents a particularly vulnerable 
state to opioid-induced respiratory depression. Interestingly, identical exposure during 
juvenile life did not evoke the same long-term effects, with the most notable difference 
being the absence of the lasting hypersensitivity to fentanyl-induced respiratory depression 
under anaesthesia. The mechanisms underlying these long-term breathing changes and 
state-dependent fentanyl effects can only be hypothesised at present. Our findings are 
consistent with the idea that manipulations to the developing respiratory system can have 
profound, lasting changes in respiratory activity, and suggests fentanyl exposure during the 
neonatal period induces developmental plasticity. As previously described in this thesis, 
developmental plasticity in terms of respiratory control is defined as long-term changes in 
the mature respiratory system that are induced by experiences occurring during a critical 
developmental time period, whereas the same experiences after this critical time window 
evoke little or no lasting changes (Carroll, 2003; Bavis and Mitchell, 2008). Collectively 
our data suggests that the first five days of life in the mouse signifies a critical 
developmental time period highly susceptible to opioid-induced developmental plasticity. 
This theory is also congruent with our finding that a significant respiratory maturation step 
occurs between P2 and P3, which could be affected by fentanyl exposure. If repeated 
fentanyl exposure during the neonatal period induces lasting alterations to the function of 
the preBötC remains to be elucidated and certainly warrants further investigation. 
 
Importantly, these studies raise many questions regarding the long-term implications of 
opioid therapy in neonatal humans. The data from this thesis suggests that long-term opioid 
therapy in neonatal humans could predispose a patient to respiratory anomalies later in life 
that may initially manifest in depressed behavioural states e.g. during sleep. Moreover, 
repeated exposure in the neonatal period could induce a lasting and dangerous 
hypersensitivity to the respiratory depressive actions of opioid drugs under depressed 
behavioural states, consequently limiting their therapeutic usefulness. Similar clinical 
longitudinal studies have never been conducted; therefore the clinical risks of opioid 
treatment in humans can only be speculated at this time.  
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6.5 Fentanyl exposure in neonatal life induces long-term changes 
in µ opioid receptor expression within the VRC 
 
The long-term effects of neonatal fentanyl exposure on the expression of NK1R and µ 
opioid receptor expression throughout the VRC were analysed to begin to uncover 
potential mechanisms that underlie the documented long-term respiratory changes of such 
exposure. Neonatal-exposed mice exhibited a significant reduction in NK1R expressing 
cells within the preBötC. However, the most striking consequence of neonatal fentanyl 
exposure was the dramatic reduction in the number of µ opioid receptor expressing cells 
within the VRC including the preBötC seen in adult life. The reduced number of µ opioid 
receptor expressing cells could represent a long-term receptor downregulation. The 
physiological significance of this reduced expression is not fully understood, however it 
could be fully or partially attributable to the respiratory effects reported in the neonatal-
exposed mice in adult life, particularly the altered respiratory responsiveness to fentanyl. 
The impact of arousal state on receptor regulation remains elusive. It is important to 
highlight that investigations of the long-term effects of juvenile fentanyl exposure on 
receptor expression is required to help explain the differences in the respiratory effects 
exhibited by the neonatal and juvenile-exposed mice. This would also enable the theory of 
developmental plasticity to be further investigated.   
   
6.6 Behavioural state and respiratory activity 
 
Respiratory differences between neonatal and juvenile-exposed mice including baseline 
breathing patterns and the striking difference in respiratory response to fentanyl only 
became apparent when the mice were in the anaesthetised state. In terms of respiratory 
function and fentanyl effects during wakefulness, there were only subtle differences 
between the two groups of mice. Studying breathing in the wakeful state alone would have 
drawn a different interpretation of the long-term respiratory effects of fentanyl. This 
highlights the complexity of respiratory control and opioid respiratory depression and the 
fact that in order to gain a full analysis of opioid depression and its effects on respiratory 
control in vivo, respiratory activity must be explored under varying behavioural states.   
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6.7 Future Directions 
 
As previously discussed, to complement the work carried out in the whole animal, it would 
be advantageous to utilise more reduced experimental preparations that maintain 
respiratory-like rhythmic activity  allowing for direct recordings from preBötC neurons. 
This is particularly important for determining the long-term effects of repeated fentanyl 
exposure on the rhythm generating capacity of the preBötC. The use of in vitro 
preparations including the medullary slice and en bloc preparation as well as the working 
heart-brainstem in situ preparation would enable a more comprehensive analysis of 
preBötC activity and respiratory motor output to further aid in the elucidation of the 
complex opioid-induced effects of the central respiratory system. A combination of both in 
vitro and in vivo study approaches could be the key to unravelling the mechanisms 
underlying the long-term respiratory effects of opioid exposure.  
  
In keeping with the clinical relevance of establishing the long-term respiratory effects of 
repeated opioid exposure, investigating the effects of repeated exposure during the prenatal 
period is a possible avenue for further research. Opioid drugs are commonly abused during 
pregnancy (Kaltenbach et al., 1998) therefore determining the potential respiratory effects 
of this prenatal exposure on postnatal breathing is desirable. Given that the preBötC 
becomes rhythmically active at E15.5 in the mouse (Thoby-Brisson et al., 2005) it would 
be particularly interesting to determine the effects of fentanyl-exposure during this small 
time window in prenatal development. Pregnant dams could be injected with fentanyl thus 
also exposing developing fetuses and breathing activity of offspring examined in early 
postnatal life and through to adulthood, under both wakefulness and anaesthesia.    
 
6.8 Concluding remarks  
 
The studies detailed in this thesis have generated novel data regarding both the acute and 
lasting effects of opioid-induced respiratory depression A critical postnatal maturation of 
breathing patterns has been identified in early life and our data provides supports for the 
hypothesis that the preBötC functions as the dominant respiratory rhythm generator post-
maturation. Furthermore, the neonatal period appears to be particularly vulnerable to the 
long-term detrimental impact of repeated opioid exposure. Long-term alterations in the 
respiratory responsiveness to fentanyl after repeated neonatal exposure may be due to 
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downregulation of the µ opioid receptor within the preBötC. Importantly, the studies 
documented in this thesis have provided a solid basis for future research investigating the 
neural control of breathing and in particular opioid-induced alterations of respiratory 
control.   
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Appendix I 
 
Details of solution preparation for perfusion fixation and immunohistochemistry. 
 
4% Paraformaldehyde solution (1 litre) 
 
40 g of paraformaldehyde was added to 400 ml of distilled water (heated to approximately 
68°C). NaOH was then added drop by drop until all the paraformaldehyde was dissolved 
and the solution became clear.  The solution was then filtered into a 1L volumetric flask. 
500 ml of 0.2M phosphate buffer solution was added and made up to 1L with distilled 
water. 
 
30% sucrose solution 
 
30 g of sucrose dissolved in 100 ml PBS. 
 
0.2M Phosphate Buffer (PB) 
 
17.47 g sodium di-hydrogen phosphate (NaH2PO4) and 40.75 g di-sodium hydrogen 
phosphate (Na2HPO4) were dissolved in 2 L distilled water. 
 
0.3M Phosphate Buffered Saline (PBS) 
 
72 g of sodium chloride (NaCl) was dissolved in 200 ml 0.2M PB and 1800 ml distilled 
water. 
 
0.3M Phosphate Buffered Saline and 0.3% Triton X-100 (0.3% 
PBST) 
 
500 ml 0.3M PBS + 1.5 ml triton X-100  
 
 
 
